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ABSTRACT 
Hepatitis B virus (HBV) causes lifelong chronic liver disease in approximately 400 
million people worldwide. The causative factors underlying resolution ofHBV infection and 
the development of chronic hepatitis B are not completely understood, although an 
inadequate anti-viral immune response is considered to be important in establi hing chronic 
symptomatic infection. In this regard, previous studies have demonstrated the signi ficance of 
broad strong innate and anti-HBV adaptive immune responses in inhibition ofhepadnaviral 
replication and resolution of acute hepatitis. 
The contribution of the liver to induction and maintenance of peripheral immune 
tolerance or to decreased immune responsiveness is increasingly recognized. These 
functions may in part be ascribed to the unique cellular composition of the liver, including a 
disproportionately high number of innate immune cell subsets and specialized antigen 
presenting cells. Liver cells, including hepatocytes, also appear to contribute to the immune 
response by interacting with na'ive or activated T cells. 
We hypothesized that hepatocytes can act as effector immune cells and they can 
directly shape hepatic immune responses and that the natural tolerizing properties of the liver 
may contribute to an impaired effectiveness of the anti-viral response in hepadnaviral infection . 
To investigate these possibilities, we utilized experimental hepadnaviral infection in 
woodchucks infected with woodchuck hepatitis virus (WHY), which represents the closest 
virological and pathogenic model of human HBV infection and hepatitis B. 
In the first study, we discovered that normal hepatocytes constitutively expre s CD95 
ligand (CD95L) and can cause death of contacted cells via a CD95L-CD95-dependent 
mechanism. Furthermore, interferon-gamma (lFNy) and, to a lesser extent, tumour necrosis 
factor-alpha (TNFa) can enhance hepatocyte CD95L-mediated cytotoxicity. This suggests 
that the local cytokine environment may modulate the contribution ofhepatocytes to liver 
immunity. Subsequently, we discovered that hepatocytes also express biologically 
competent perforin capable of cell killing. The ability ofhepatocytes to cause cell death by 
two different but complementary mechanisms, differentially regulated by the cytokine 
microenvironment, emphasized the role ofhepatocytes as cytotoxic effectors while 
demonstrating for the first time that perforin is expressed by non-immune cells. 
Further investigations revealed that hepatocyte CD95L and perforin-mediated 
cytotoxicity is significantly augmented during chronic hepadnaviral hepatitis and follow ing 
recovery from acute infection. This could be a consequence of increased intrahepatic 
production ofiFNy due to virus-induced liver inflammation and strengthens the possibility 
that hepatocytes may actively contribute to shaping the local immune environment in 
hepadnaviral infection . On the other hand, a direct contribution of WHY to augmented 
hepatocyte cytotoxicity was excluded in a series of in vitro experiments applying woodchuck 
hepatocyte lines stably expressing WHY genome or its individual genes. 
In a final study, quantitative analyses of intrahepatic hepadnaviral replication and 
molecular markers indicative of activation of innate and adaptive immune responses, using 
real-time RT-PCR assays, revealed that hepadnavirus establishes replication almost 
immediately following exposure to a large, liver pathogenic virus dose and that the innate 
response is promptly activated. However, this response appears to be insufficient in priming 
an effective adaptive T cell response capable of early virus el iminat ion. These findings 
indicate that in contrast to observations in HBY-infected chimpanzees, hepadnavirus is 
recognized immediately after invasion by the hepatic innate immune system. 
II 
Taken together, hepatocytes constitutively display cytotoxic capabilities which are 
susceptible to cytokine-induced augmentation. Hypothetically, this hepatic local cytotoxic 
activity may constrain priming of adaptive T cells by activated innate immune effectors due 
to deletion of virus-specific T cells. This paradigm would favour the expansion of viru 
replication in the liver during the prolonged incubation period typically seen in hepadnavira l 
infection, prior to the extrahepatic development of effective antiviral T cell responses capable 
of resolution of acute hepatitis. The relevance of this paradigm to the establishment of 
chronic hepadnaviral hepatitis will require further investigation. 
Ill 
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CHAPTER ONE: INTRODUCTION 
Hepatitis B virus (HBV) is the largest causative agent ofvirally-induced li ver 
disease worldwide and is responsible for significant morbidity and mortality. Although 
the existence of parenterally transferred hepatitis had been realized as early as the 
1940s (Havens, 1944; MacCallum and Bradley, 1944), identification of HBV subvi ral 
particles constituted by envelope lipo-proteins did not occur until the 1960s with the 
discovery of Australia antigen (Blumberg et al. , 1967). The virion ultrastructure was 
formally demonstrated in 1970 by Dane (Dane et al. , 1970). This was further followed 
by immunological analysis of viral proteins (Milich and McLachlan, 1986; Milich et 
al. , 1986) and molecular analysis of the virus genome (Chisari et al., 1989). Highly 
restricted host-specificity ofthe virus led to the search for appropriate animal models, 
which succeeded in the identification of natural models (Summers et al. , 1978), and 
invaluable transgenic mouse systems of hepatitis B (reviewed in Chisari and Ferrari , 
1995). Subsequent investigations using these models have lead to our current 
understanding that HBV is not a cytopathic virus, rather it is the host's immune 
responses directed against viral antigens which cause the development of hepati tis 
(reviewed in Guidotti and Chisari, 2001). Furthermore, it was established that host 
genetic factors, the dose of invading virus, age at the time of infection, and interactions 
between HBV and the host' s immune system strongly influence the outcome of 
hepadnavirus hepatitis, leading either to recovery from symptomatic infection or 
progression to chronic hepatitis (CH) (reviewed in Webster and Bertoletti, 2002). 
l.l.l Causative agents of viral hepatitis 
Liver inflammation characterized by varied degrees of hepatocyte damage, 
lymphomonocytic infiltrations and coexisting liver regeneration can be caused by one 
of six presently recognized, albeit unrelated viruses. They are designated as A, B, C, 
0 , E and G, and they belong to several different viral families. Their classification is 
predominantly determined on the basis ofthe type of nucleic acid constituting their 
genomes, and primary routes of transmission. 
Hepatitis A virus (HAY) and hepatitis E virus (HEY) are both enteric RNA 
viruses which are disseminated via the faecal-oral route. They are associated with 
unsanitary conditions, including virus-contaminated food and water supplies. Although 
enteric hepatitis has been recognized for centuries, its viral etiology was only 
established in 1973 (Feinstone et al., 1973). Similarly, HEY was not formally 
recognized until 1990 (Reyes et al., 1990). HAY and HEY infections are usually self-
limited and result in complete recovery. However, HEY induces a surprisingly high 
mortality rate among pregnant women with severe or fulminant hepatitis observed in 
I 0-20% of the cases (reviewed in (Koziel, 1996)). The single largest causative agent of 
viral hepatitis is HBY, a DNA virus, with an estimated 400 million serum HBsAg-
positive carriers worldwide. Hepatitis C virus (HCY), comprised of a positively 
stranded RNA genome, affects a further 170 million. Both pathogens are spread 
mainly through body fluids and vertically from mother to infant. These viruses mediate 
significant rates of morbidity and mortality worldwide due to their inherent capacity to 
establish chronic infections. Approximately I 0% of patients infected with 1-1 BY and 
50-85% of those infected with I-ICY develop CH with subsequent development of 
2 
cirrhosis and hepatocellular carcinoma (HC ). While prophylactic vacc ines are 
available for prevention ofHBY, such strategies have not yet been developed again t 
I-ICY infection. Thus, chronic HBY and I-ICY infections represent substantial 
healthcare and sociological burdens requiring antiviral treatment of the affected 
patients. 
Hepatitis D virus (HOY) is an RNA virus which is unique among the hepatitis 
viruses since it requires HBY to establish infection (Rizzetto et al., 1980). Initially 
believed to represent an unidentified HBY antigen, it was further proven to be a novel 
virus which may replicate independently of I-IBV. HDV requires I-I BY or woodchuck 
hepatitis virus (WHY) envelope proteins to initiate infection, and for virion assembly. 
Patients who are co-infected with HBY and HOY are at an increasing risk for 
development of severe liver damage. In these cases, the synergistic effect of immune 
responses mounted against both viruses and the subsequent liver injury is greater than 
that observed during HBV infection alone (Acorn et al., 1995; Chu et al., 1989; 
Karayiannis et al., I 990). However, since both viruses share the same envelope 
proteins, vaccination against HBV also prevents HOY infection. 
Hepatitis G virus (HGY) is an RNA virus originally identified as a causative 
agent of non A-E hepatitis (Linnen et al. , 1996). HGY shares genomic and structural 
similarities with HCV (Bukh et al., 1999; Simons et al. , 1996). In contrast with HCV, 
however, HOY causes a mild self-limiting infection which is of limited pathological 
importance (Linnen et al., 1996). The most recently identified TT virus (TTY) was 
initially thought to be a cause of non-A-G cryptogenic hepatitis ( ishizawa et al. , 
I 997). Subsequent analysis revealed a non-enveloped negative stranded DNA genome 
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(Mushahwar et al., 1999). The viral proteins and replicative strategy of this virus 
remain largely unknown. Identifiable in primates and across a wide range of human 
populations, the infection is particularly prevalent in multiply transfused patients. 
While TTY likely has the ability to infect the liver, the relationship between 'ITV and 
hepatitis has so far been a rare phenomenon. 
1.1.2 Epidemiology of HBV infection 
Despite the availability of an effective prophylactic vaccine, chronic HBV 
infection significantly contributes to worldwide mortality. Current estimates indicate 
that 60% of all cases of HCC occur in patients who are chronically infected with HBY . 
Globally, the rates ofHBV infection vary greatly in different geographical regions. In 
highly endemic regions, such as Southeast Asia and sub-Saharan Africa, where the 
majority of infections occur due to vertical transmission, 15-20% of the total 
population may experience chronic infection with HBV (Chen and Sung, 1978). 
Although prophylactic vaccination does not represent an effective strategy to reduce 
the rates of already established chronic infection (reviewed in (Lok et al. , 1989), the 
advent of a mass immunization program in Taiwan beginning in 1984 has dramatically 
reduced the rates of chronic hepatitis B in babies born to infectious carrier mothers 
(Hsu et al., 1988). Due to universal vaccination in children, the developed world, 
including Europe and North America, have experienced declines in the rates of HBY 
infection among individuals aged 0-19 years (reviewed in (Fung and Lok, 2005). 
However, increased rates oftransmission have been observed in high risk groups, 
including intravenous drug users and male homosexuals (reviewed in (Fung and Lok, 
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2005). Furthermore, the rate of infection remains endemically high in some groups 
including native Canadian populations and those who have recently immigrated to 
Canada from areas where chronic HBV infection is prevalent (Minuk and hanova, 
2003). 
1.1 .3 Clinical and serological profiles of HBV infection 
The course of HBV -induced liver disease is variable. The manifestation may 
include an inapparent disease state which progresses without clinical symptoms, but 
which is biochemically and serologically evident. Alternatively, patients may develop 
symptomatic acute hepatitis (AH) which may result in recovery, progression to Cl-1, or 
rarely to the development of highly lethal fulminant hepatitis. 
Clinically evident acute HBV infection is identifiable in patients following a 
prolonged incubation period of 45-120 days. Prodromal infection, characterized by 
mild fever, anorexia, nausea and vomiting, preceeds the icteric phase of disease. The 
appearance of serum HBV surface antigen (HBsAg) becomes evident 7-9 weeks post-
infection (p.i.) and may rise to 200 J..lg/mL or more, while HBV DNA is detectable in 
serum 2-3 weeks before the onset of HBsAg (Kaneko et al., 1990). 
Typically HBV e antigen (HBeAg) and antibodies to WHY core antigen (anti-
WI-le) appear subsequent to HBsAg and concurrent with elevations in 
aminotransferases (reviewed in (Hoofnagle, 1981 ). Although seroconversion to anti-
HBe antibody (anti-HBe) positivity is associated with a reduction in the level of serum 
HBV DNA and normalization of liver function, it has been firmly demonstrated that 
HBV DNA persists indefinitely in patients following recovery when sensitive 
polymerase chain reaction (PCR)-based assays are utilized (Michalak et al. , 1994). The 
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clearance ofHBsAg and the appearance ofanti-HBs antibodies (anti-HBs) signities the 
end of AH, with anti-HBs persisting for life in most patients. 
Conversely, chronic hepatitis B is characterized by serum HBsAg positivity for 
longer than 6 months with co-incident production of anti-HBc. Typically 5-l 0% of 
adults who become infected with HBV develop chronic liver inflammation, which may 
occur as either persistent (mild) or active (aggressive) hepatitis. However, patients with 
acute icteric hepatitis tend to develop CH less frequently. An additional category of 
chronic HBV infection includes those patients who are persistently serum HBsAg 
positive, but are without apparent clinical symptoms of hepatitis. These "hea lthy" 
chronic carriers are anti-HBc positive and display minimal to mild liver tissue 
histological abnormalities (De Franchis et al. , 1980). 
A predominant factor influencing the development of CH type B is the age at 
which infection is initiated, with up to 90% of infected neonates displaying chronic 
HBV -induced liver disease (Okada et al. , 1976). In areas of endemically high rates of 
vertical transmission, such as Southeast Asia, epidemiological studies strongly support 
the relationship between neonatal infection and CH, with the subsequent development 
of hepatocellular carcinoma (HCC) (Beasley, 1988; Beasley et al. , 1981 ). Although the 
mechanisms underlying the development of HCC in HBV -positive patients are not 
completely understood, HBV DNA integration into the host genome, chronic liver 
inflammation and liver tissue regeneration have been identified as constant features 
(Murakami et al. , 2005). Virus genome integration may di srupt tumor suppressor 
genes or facilitate activation of oncogenes leading to the development of HCC 
(Feitelson et al. , 2002). In addition, HBY X protein has been demonstrated to possess 
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transactivating ability (Rossner, 1992) and may innuence the deve lopment or 
malignancy via modulation of cellular machinery or rendering cell s resistant to 
apoptotic mechanisms. 
1.1.4 Liver morphological changes in HBV infection 
HBV -induced liver disease is characterized by hepatocyte destruction which is 
mediated by inflammatory infiltrate. The histological hallmarks of AH type B are 
intralobular foci of necrotic or apoptotic hepatocytes accompanied by inflam matory 
infiltrations consisting of lymphocytes, macrophages, polymorphonuclear leukocytes 
and, rarely, plasma cells. Hepatocellular damage is characterized by ballooning 
degeneration, wherein hepatocytes exhibit expansion of the endoplasmic reticulum and 
become swollen with fragmenting membranes, and disintegrating nuclei . In addi tion, 
hepatocytes can undergo apoptosis (Lau et al., 1998). The induction of apoptosis may 
occur via multiple mechanisms, including ligation of death receptors expressed on 
hepatocyte cell membranes, or as a result of oxidative stress (reviewed in (Malh i et al. , 
2006)). In either case, cell shrinkage and acidophilic changes in the hepatocyte 
cytoplasm precede the penultimate occurrence of apoptotic bodies following cellular 
fragmentation. The largest of these, representing entire apoptotic cells or Counci lman 
bodies, which were originally described by Councilman in yel low fever (Councilman, 
1890). Interestingly, Councilman bodies may also be observed within centri lobular 
hepatocytes in the absence of lymphocytic infiltrations. In addition, regenerative 
changes are usually observed, including binucleated hepatocytes, while cholestatic 
obstruction is rarely seen. 
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Fulminant hepatitis, representing less than 1% of hepatitis induced b)' IIBV, is 
characterized by large areas of confluent necrosis which is often bridging between 
central veins. This submassive necrosis may include extensive parenchymal collapse 
followed by nodular regeneration with distorted architecture and postnecrotic scarring 
including the appearance of collagen and elastin fibers (Thung et al., 1982). 
CH type B is associated with protracted inflammatory destruction of 
hepatocytes progressing finally to liver fibrosis and cirrhosis. Evaluation of 
histological damage using Knodel! scores (Ishak et al., 1995) consider both 
inflammatory components as well as the extent of fibrosis . Inflammatory activity is 
classified according to the occurrence in three lobular zones: (I) interface zone, (2) 
portal area, and (3) hepatocellular parenchyma. Interface hepatitis, or piecemeal 
necrosis, includes the destruction ofhepatocytes lining the liver lobule limiting plate. 
Such destruction may be focal or extensive, with lymphocytic infiltrators penetrating 
into the hepatic parenchyma or to other portal areas. Portal infiltration is characterized 
by extensive aggregates of both lymphocytes with macrophages and dendrit ic cells, and 
occasionally observed formation of germinal centers. Parenchymal infiltrates are 
histologically similar in both AH and CH, with some differences. Although foci 
consisting of lymphocytes and macrophages are evident, concurrent with apoptot ic 
bodies and "drop-out" hepatocytes (Afford et al., 1995), such foci observed during CH 
often contain an abundance of plasma cells not observed during acute infection. In 
addition, fibrosis characterizes the extent of liver injury and determines prognosis of 
chronic HBV infection. Expansion of the portal areas by collagen formation may 
surround regenerative nodules forming rosettes of hcpatocytes. Conti nued 
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inflammation results in the formation of fibrous septa which extend between portal 
areas. This distorted liver architecture is recogn ized a cirrhosis. Cases ofCH type B 
are often characterized by the presence of ground glass hepatocytes (Huang and 
Neurath, 1979). These slightly larger hepatocytes are sometime seen ingularly or in 
clusters and are recognizable by pale, eosinophilic, granular cytoplasmic inclusions 
which displace the nucleus. Such inclusions are strongly reactive with antibodie to 
HBsAg (anti-HBs) (Meuleman et al., 2006; Wang et al., 2003a; Wu and Lam, 1979). 
Electron microscopy examination reveals both tubular and spherical forms of HBsAg 
particles in the endoplasmic reticulum (ER) (Huang and Neurath, 1979; Meuleman et 
al., 2006). 
1.1.5 Extrahepatic complications of HBV infection 
Extrahepatic manifestations of HBV infection are observed in I 0-20% of HBV-
infected patients, and are clinically represented by: (I) transient serum sickness-I ike 
syndrome, (2) acute necrotizing vasculitis, (3) polyarthritis nodosa, and (4) 
glomerulonephritis. 
Transient sickness is often represented by cutaneous rash. Polyarthritis may 
precede the development of jaundice by several weeks (Alpert et al., 1971 ). The 
condition coincides with decreased levels of complement in the serum of HBsAg-
positive patients (Alpert et al., 1971) and circulating immune complexes containing 
HBsAg, anti-HBs and complement. 
Up to 50% of patients who are diagnosed with acute necrotizing vasculiti are 
serum HBsAg-positive. This disease is rather uncommon in chronic carriers and is 
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more closely associated with recent HBV infection (Guillevin et al., 1992). Periarteritis 
nodosa is a disease affecting small and medium sized arteries, normally associated with 
chronic hepatitis B. Mortality rates of 40% are observed within three years if left 
untreated. Pathogenic role of HBsAg-anti-HBs immune complexes in this disease has 
been documented (Michalak, 1978). 
HBV -associated nephropathy, i.e. membrana-proliferative or membranous 
glomerulonephritis, is identified in both children and adults while apparent liver disease 
may be slight or absent. Areas experiencing a high endemic rate of HBV infection 
report a higher frequency ofHBV-induced glomerulonephritis, which correlates with 
serum HBsAg positivity (Gilbert and Wiggelinkhuizen, 1994). Deposition of immune 
complexes containing HBsAg, HBcAg and/or HBeAg can be detected in basement 
membranes of kidney glomeruli in this disease (Lai et al., 1994; Slusarczyk et al., 
1980). 
1.2 HEPATITIS B VIRUS 
1.2.1 Molecular organization 
Viruses of the hepadnaviridae family, which encompasses orthohepadnaviridae 
(mammalian viruses) and avihepadnaviridae (avian viruses) are among the smallest 
DNA viruses recognized. HBV, the prototypic member of the hepadnaviridae family, 
has a distinctly compact genome which is a circular 3.2 kilobase (kb)-long, partially 
double stranded DNA structure referred to as relaxed circular DNA (rcDNA). This 
unique viral genome is maintained by a short cohesive overlap between the 5 '-ends of 
the plus and minus DNA strands. Both DNA strands bear 5' modifications which are 
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necessary for initiation of virus replication; the 5'-end ofthe DNA minus strand 
contains a covalently linked protein, whereas the plu trand has a 5'-RNA 
oligonucleotide primer attached (Lien et al., 1986; Loeb et al., 1991 ). 
The genome contains four open reading frames (ORF) encoding the four major 
translation products: the virus envelope or surface (S), core (C), polymerase (P) and X 
proteins. Three envelope proteins are encoded by the S ORF, which contain three in-
frame start codons; however these proteins are derived from only two mRNA 
transcripts (2.4 and 2.1 kb) (see Figure 1.1 ). In consequence, these proteins share a 
common carboxy-terminus while differing at the amino-termini, and are referred to as 
large (preS I), middle (preS2) and major or small (S) surface proteins (Gerlich et a!., 
1992). 
The C ORF, contained within the 3.5 kb pregenomic mRNA transcript, encodes 
the virus nucleocapsid protein (HBcAg), as well as an additional protein displaying e 
antigen specificity (HBeAg). HBeAg is generated by post translational modifications 
of the core protein. Although both proteins share nearly identical amino acid 
sequences, except for an additional ten amino acid sequence encoded by the pre-core 
region and deletion of34 residues from the carboxy terminus of the C genomic region, 
they stimulate the production of distinct antibodies; i.e., anti-HBe and ant i-1-IBc 
antibodies (Ou et al., 1986). The core protein is localized within infected hepatocytes 
and virions, while HBeAg can be detectable both within hepatocytes and in circulation, 
but does not comprise the virion (Uy et al., 1986). 
Transcription of the P ORF, also derived from the 3.5 kb pregenomic mR A 
transcript, yields a polypeptide which displays viral reverse transcriptase (RT). and 
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RNase and DNA polymerase activities (Wei and Peterson, 1996). In add ition. this 
protein contains a packaging signal and facilitates reverse transcription of the viral 
pregenome, thus it is indispensable for hepadnavirus replication (Bavand and Laub, 
1988). 
The smallest HBV transcript, 0.7 kb in length, encodes the X protein which appears to 
play multiple roles within the context of cellular activation and oncogenesis. The 
influence of viral X protein on host regulatory elements may include interactions with 
cyclic AMP (cAMP) response element binding protein (CREB) (Maguire et al. , 1991 ) 
or with DNA repair enzymes (Becker et al., 1998). Furthermore, X protein has been 
demonstrated to activate several cytoplasmic signaling pathways including Ras/MAPK 
(Klein and Schneider, 1997) and JNK (Benn et al., 1996). This may be due to its 
inherent ability to release intracellular calcium, thus influencing multiple downstream 
signaling components responsible for, among other things, enhancement of viral 
replication (Lara-Pezzi et al., 1998a; Lee et al., 1995). 
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1.2.2 Ultrastructure 
Analysis of sera from HB V -infected patients by electron microscopy can reveal 
three distinct forms of viral particles. The complete virion or Dane particle (Dane et 
al., 1970) occurs as a 42-4 7 nm sphere that has a distinct outer envelope and internal 
virus capsid. The viral envelope is comprised of proteins carrying HBsAg reactivity as 
well as host-derived lipoproteins, while the viral DNA genome and polymerase are 
packaged within the nucleocapsid. Although Dane particles may exist in the blood at 
levels of 109/ml or greater, subviral particles comprised of HBV envelope proteins may 
occur at astonishingly high levels of 50-300 11g/ml or I 012 particles/mi. These particles 
may exist as spherical (20 nm in diameter) or tubular (up to 230-nm long) forms which 
are devoid of nucleic acids and, hence, are non-infectious, but are highly immunogenic. 
Since antibodies directed against HBsAg provide protective immunity, preparations of 
the subviral HBsAg particles from the blood of infected patients were utilized as HBV 
vaccines before the advent of the recombinant HBsAg vaccines. 
1.2.3 Replication strategy 
Hepadnaviral infection is initiated by virus attachment to an as yet unidentified 
cellular receptor(s). Fusion of the virus envelope with the cells plasma membrane 
facilitates entry of the nucleocapsid into the cytoplasm with its subsequent transport to 
the nucleus (Hild et al., 1998). The virus rcDNA genome is repaired by host D A 
polymerases and ligases (Kock and Schlicht, 1993) yielding covalent ly c lo ed circular 
DNA (cccDNA). Since cccDNA represents the template from which viral replicative 
intermediates are transcribed, the detection of cccDNA provides definitive proof of 
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hepadnaviral replication (Mason et al., 1983). Hepadnaviral replication is unique 
among DNA viruses, since transcription of the cccDNA template by host RNA 
polymerase yields a full-length viral genome or pre-genomic RNA (pgRNA). This 
pgRNA transcript is packaged within the nucleocapsid together with viral polymerase, 
and functions as the transcriptional template from which minus-strand DNA is reverse 
transcribed. Although core proteins may form capsids devoid of nucleic acids, 
encapsidation of subgenomic RNA transcripts is excluded since only the pgRNA 
contains the 5 '-region (denoted E) necessary for encapsidation (Enders et al. , 1987). 
Degradation of pgRNA by viral polymerase is followed by plus DNA strand synthesis. 
utilizing the minus strand DNA as template (Summers and Mason, 1982). In 
consequence, mature nucleocapsid particles containing the rcDNA genome may be 
recycled to the nucleus or packaged into virions. Studies using duck hepatitis B virus 
(OHBV) revealed that nuclear translocation of newly formed nucleocapsids represent 
the default pathway during the initial stages of replication, and precede the synthesis 
and accumulation of viral envelope proteins (Summers et al., 1990) which ultimately 
result in virion assembly and their secretion. 
1.3 HEPADNAVIRAL FAMILY 
1.3.1 Duck Hepatitis B Virus 
DHBV is the prototypic member of the genus avihepadnaviridae, which is also 
comprised of snow goose hepatitis B virus (SGHBV) as well as lesser known viral 
species isolated from geese, storks and varied duck species (reviewed in (Jilbert and 
Kotlarski , 2000). DHBV is recognized, along with WHY (see Section 1.3 .3), as the 
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most widely accepted models for the study of HBV infection. However, important 
differences have been identified between DHBV and the mammalian hepadnaviruses. 
For example, DHBV lacks an X gene, synthesizes two (not three) envelope proteins, 
and the surface of DHBV particles do not exist as freely circulating filaments. 
The validity of DHBV as a model ofHBV infection is supported by similar age 
and dose-related outcomes of liver disease as those observed for HBV and WHY 
infections. Anti-DHBV humoral responses can be detected against both core and 
surface proteins (Halpern et al., 1987; Jilbert et al., 1998), while viral clearance appears 
to proceed mainly via non-cytolytic mechanisms (Jilbert et al. , 1998; Jilbert et al. , 
1992). 
The utility of DHBV as an experimental model to explore the mechanisms of 
immunopathology is reduced due to several key restrictions. Currently, limited 
knowledge of the duck immune system and the lack of reagents to specifically identi fy 
lymphoid cell subsets and other critical components of the immune system precludes 
investigating their involvement in the clearance of DHBV. Furthermore, histolog ical 
damage observed during chronic DHBV infection is markedly less severe than that 
during HBV infection (J ilbert et al. , 1998), with a distinct lack of progressive cirrhosis 
and development of HCC. Thus, DHBV does not facilitate analysis of the pathogenic 
or oncocytic mechanisms underlying the development of chronic liver injury. 
Notwithstanding these limitations, the application of primary duck hepatocyte cu lture 
to analyze DHBV-host cell interactions has provided important insights into a better 
understanding of hepadnaviral replication (Tuttleman et al. , 1986), and has proven 
useful for evaluation of anti-viral therapies (Suzuki et al., 1988). 
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1.3.2 Ground Squirrel Hepatitis Virus 
Ground quirrel hepatitis virus (GSHY) was originally identified in Bcechey 
ground squirrels. GSHY virions are smaller in size than HBY, while an additional 
restriction enzyme cleavage site (Pvu II) is located within the GSHY dsD 1\ genome 
(Marion et al., 1980). Relatively recent identification of another hepadnavirus, which 
endemically infects arctic ground squirrels (ASHY) (Testut et al., 1996), indicates 
further divergence of the hepadnaviral family. Interestingly, both hepadnaviruses cause 
similar liver pathologies and both are infectious to woodchucks (Seeger et al., 1991 ). 
However, when the course of chronic liver disease induced by infection of woodchucks 
with either GSHY or WHY was compared, it was found that while GSHY infect ion 
resulted in similar viral loads and inflammatory disease. However, the abil ity of 
GSHY to induce HCC was noticeably lower than that for WHY (Seeger et al., 1991 ). 
1.3.3 WOODCHUCK MODEL OF HEPATITIS B 
1.3.3.1 Woodchuck Hepatitis Virus 
The discovery of WHY in a colony of captive woodchucks (Mannota monax) at 
the Philadelphia Zoological Gardens (Summers et al., 1978) provided an invaluable, 
mammalian natural model of HBV infection and hepatitis B. This model allows for 
comprehensive studies regarding molecular, immunological and pathological features 
ofhepadnaviral infection. WHY shares considerable structural and molecular 
homology with HBV, including genomic structure, antigen cross-reactivity, tissue 
tropism and pathological features of liver disease which may culminate in the 
development of HCC (reviewed in (Michalak, 1998). 
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WHY virions have a diameter of 45 nm and are slightly larger than HBY. The 
viral envelope is comprised of three viral glycoproteins carrying WHY surface antigen 
(WHsAg) specificity. The 27-nm nucleocapsid, which displays both core (WHcAg) 
and e (WHeAg) antigen reactivities, encapsulates the virus genome and viral 
polymerase, a feature conserved among the hepadnaviruses. The high degree of 
similarity between WHY and HBYgenome sequences (overall 65%) is reflected in a 
high degree of antigenic cross-reactivity between their envelope and core proteins. In 
consequence, commercial assays for the detection ofHBsAg, anti-HBs and anti-WHc 
can be utilized to identify respective WHY proteins or antibody specificities 
1.3.3.2 CHARACTERISTICS OF WHV INFECTION 
1.3.3.2.1 Features of WHV -induced liver disease 
Notwithstanding minor variability, and an apparent lack of progressing liver 
cirrhosis, adult woodchucks infected with WHY have similar courses of in fect ion and 
histologically evident liver disease as observed during HBY infection. The typical 
course of WHY infection, including the time ofthe appearance of viremia and 
development of virus-specific antibodies, may vary among animals inoculated with the 
same source and dose of virus (Michalak, 1998). Furthermore, the development of 
adaptive T cell proliferative responses and occurrence of liver injury may also vary 
(Menne et al., 1998). This suggests that yet unknown host factors are important, 
contributing to both virus expression and immune system-med iated clearance. 
The first molecular indicator of WHY infection is the appearance of WHY 
DNA in the serum or peripheral blood mononuclear cells (PBMC) within 2 weeks p.i. 
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(Guo et al., 2000; Kajino et al. , 1994: Menne et al.. 1998; Michalak, 1998). WilY 
DNA has been identified in the liver as early as 2 weeks p.i. (Guo ct al. , 2000; Kajino 
et al., 1994), although earlier WHY DNA positivity cannot be excluded ·ince such 
molecular analyses have not been performed. Interestingly, WH Ag and anti- WHc 
antibodies appear 4-10 weeks p.i., while antibodies to WHsAg preS I domain may 
appear earlier, which co-incides with the appearance of WHV DNA in serum (Jin et al. , 
1996). In contrast, anti-WHs antibodies, mainly directed against the majorS protein, 
do not normally appear until I 0 weeks p.i . following clearance of WHsAg in those 
animals which resolve AH. 
Since hepadnaviruses are non-cytolytic, liver disease is induced and perpetuated 
by the host's antiviral immune response and is characterized by similar histological 
changes as those identifiable during HBV infection. Proliferative responses of Kupffer 
cells and bile canaliculi are the earliest alterations which are followed by sinusoidal 
accumulations of lymphocytes and neutrophils occurring at 4-6 weeks p.i . This may be 
accompanied by sinusoidal endothelial cell proliferation. Liver architecture is 
progressively disrupted, concomitant with extensive leukocytic infiltrations and 
elevated serum levels of sorbitol dehydrogenase (SOH) indicative of liver injury 
(Menne et al., 1998). Clearance of WHsAg and the development of an ti-WHs 
antibodies typically coincide with a significant decrease in lobular infiltrates while 
portal inflammation may persist. Indeed low grade inflammation persists for years 
following recovery from acute WHV infection (Hodgson and Michalak, 200 I; 
Michalak, 1998). 
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Failure to clear WHY infection resulting in serum WHsAg-positive CH is 
characterized by portal and peri-portal infiltrates, piecemeal necrosis with focal 
parenchymal collapse, as well as proliferation of bile ducts and endothelial cells. 
WHY-induced HCC varies morphologically and different tumours may contain either 
differentiated hepatocytes or undifferentiated cells (Tennant et al., 2004). The 
mechanisms of HCC development likely include persistent hepatocyte regeneration and 
upregulation of anti-apoptotic regulatory proteins by the WHY X protein (Diao et a l. , 
200 I). In addition, DNA integration of the WHY genome, including promoter 
sequences, may lead to the activation of c-myc and n-myc oncogenes (Fourel et al., 
1990; Hsu et al., 1990). 
1.3.3.2.2 WHY-induced hepatitis 
WHY infection has an overall pattern closely comparable to that ofHBY 
infection (see Section 1.1.2.2) and is typically manifested as an acute, symptomatic, 
serum WHsAg-positive infection which is resolved in approximately 85-90% of 
animals. The progression to serum WHsAg-positive CH is observed in I 0- I 5% of 
animals (Korba et al., I 989). More recent studies have demonstrated that recovery 
from AH is followed by indefinitely long persistence of low levels of replicating WHY 
in the liver and the lymphatic system, which is accompanied by small amounts of 
WHY DNA detectable in circu lation (Michalak et al., I 999). 
Recovery from WHY-induced hepatitis is associated with a higher hepatic viru 
load, a greater degree of liver injury and the augmented expression of interferon-
gamma (IFNy) and tmour necrosis factor-alpha (TN Fa) (Hodgson and Michalak, 
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2001). Furthermore, WHY infection induces strong virus-specific T cell proliferative 
responses against epitopes of the virus envelope and core proteins (Menne et at., 1998). 
Interestingly, anti-viral T cell proliferative responses exhibit temporal differences 
characterized by the initial appearance of WHsAg-specific T cells followed by aT cell 
response of larger intensity directed against WHcAg (Menne et at., 1998), as similarly 
observed during HBY infection (Ferrari et at., 1990). Anti-viral T cells have been 
proven indispensable for viral clearance, since immune suppression using cyclosporin 
A prevents recovery and promotes development of CH (Cote et at. , 1991 ). 
While the peak intrahepatic occurrence ofT cells coincides with the largest 
degree of liver injury (Guo et al., 2000; Hodgson and Michalak, 200 I; Menne et at. , 
1998; Wang et al., 2004) observable during AH, anti-viral cytokines such as IFNy and 
TNFa, appear to mediate significant noncytolyic clearance ofhepadnaviruses 
(reviewed in (Guidotti and Chisari, 200 I), and may play a greater role in the 
downregulation ofhepadnaviral replication than the cytolytic removal of infected 
hepatocytes. IFNy and TNFa are not only of paramount importance during AH 
(Hodgson and Michalak, 2001; Nakamura et at., 2001; Wang et at., 2003b), 
contributing to viral recovery, but their expression is sustained within the liver for years 
after resolution of AH in the presence of low levels of replicating WHY (Hodgson and 
Michalak, 2001). Although increased intrahepatic levels ofthese cytokines occur due 
to activation of virus-specific T cells, it has been noted that elevations in intrahepatic 
lFNy can be detected before the onset of histologically evident hepatitis and T cell 
infiltrations (Hodgson and Michalak, 200 I). Furthermore, increased cytolyti c activity 
of innate immune cells (Hodgson et al. , 1999) and decreases in intrahepatic viral loads 
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before the onset of evident hepatitis (Wang et al. , 2004 ), are con istent \Y ith 
observations in the chimpanzee model of HBY which suggest a role for activation of 
innate immunity in hepadnaviral clearance and recovery (Guidotti et al., 1999) . 
As indicated, approximatley I 0-15% of adult animals infected with WHY 
progress to serum WHsAg-positive CH, which is a rate similar to that observed in 
adults infected with HBY. In contrast, WHY inoculation ofwoodchucks during the 
neonatal period may result in the development of CH with a frequency of 60-70% 
(Cote et al., 2000), as similarly observed during neonatal HBY infection of humans. 
Despite the delayed onset of viremia and histologically evident hepatitis fo llowing 
WHY infection of neonates (Cote et al., 2000), both neonatal and adu lt infections 
which progress to chronic disease exhibit similar defects in immune-mediated 
hepadnaviral clearance. The development ofCH is associated with a diminished 
intrahepatic inflammatory response during the acute phase of WHY infection, 
characterized by a lesser degree of hepatic T cell infiltrates (Hodgson and Michalak, 
200 I ; Nakamura et al., 2001 ; Wang et al., 2003b), decreased levels of IFNy and TNFu 
(Hodgson and Michalak, 200 I ; Nakamura et al., 200 I ; Wang et al., 2003b ), and 
increased viral load and antigen expression in the liver (Cote et al. , 2000; Hodgson and 
Michalak, 2001) in comparison with a successful resolution of AH. In contrast with 
recovery from AH, where a strong, multispecific T cell response against several WHY 
antigens occurs (Menne et al., 1998), the development of chronicity is associated with a 
complete or partial absence of virus-specific T cell responses (Menne et al., 2002). 
These findings para llel those observed during CH type B (Ferrari et al. , 1990; Maini et 
al. , 2000; Penna et al., 1997). These results suggest that the development of CH is 
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largely attributed to a dysfunctional or otherwise lacking virus-specific cellular immune 
response (Hodgson and Michalak, 200 I; Maini et al., 2000; Wang et al., 2003b) which 
may develop during a critical pre-symptomatic period (reviewed in (Webster and 
Bertoletti, 2002). Once established, chronic WHY infection presents severa l barriers to 
immune-mediated clearance including downregulation of class I major 
histocompatability complex (MHC) protein display on the surface of infected 
hepatocytes (Michalak et al., 2000; Wang and Michalak, 2006) and the incorporation of 
virus envelope proteins into hepatocyte plasma membranes (Michalak and Churchill, 
1988; Michalak and Lin, 1994). 
1.3.3.2.3 Occult WHV infection 
Hepadnaviral infection may also occur in the absence of symptoms, and remain 
serologically silent for the lifetime of the animal or individual (Michalak et al., 1999; 
Michalak et al., 1994; Penna et al., 1996). Clinical recovery from AH defined by 
normalization of biochemical liver function tests as well as seroconversion to anti-WHs 
antibodies does not truly reflect complete clearance of virus. Traces of WHY genomes 
and replicative intermediates persist in hepatocytes and cells ofthe lymphatic system 
and in the serum throughout life. Harboured virus persists despite both virus-speci fie 
humoral and cellular immunity (Michalak et al., 1999; Michalak et al. 1994; Penna et 
al., 1996). 
The woodchuck model has also firmly demonstrated that vertical transmission 
of WHY occurs not only when the mother has serologically evident chronic WHY 
infection, but also after recovery from AH, during which time they carry low levels of 
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replicating virus (Coffin and Michalak, 1999). It is notable that WilY was con i tcntly 
detectable in lymphoid cells in these offspring, while the liver was not universally 
infected. Furthermore, infection persisted in the complete absence of serological 
markers, including WHsAg and anti-WHc antibodies. Interestingly, in spite of low 
level viral infection, the offspring were not protected following challenge with a larger 
WHY infectious dose (Coffin and Michalak, 1999). 
Although the pathological consequences of HBY infection to the infant born to 
HBsAg-positive, chronically infected mothers are widely recognized, the impact of 
vertical transmission of small quantities of the virus following maternal recovery from 
AH has not been studied. However, evidence from the woodchuck model suggests that 
vertically infected, asymptomatic and serologically undetectable, yet in fect ious HBY-
positive carriers may represent a source of infectious HBY. Furthermore, long-term 
persistence ofHBY in the lymphoid compartment may contribute to the induction of 
diseases not yet attributed to hepadnavirus infection. It is certain that an imals which 
have recovered from acute WHY hepatitis continue to show mild to moderate hepatic 
inflammation for years following resolution of disease (Michalak et al. , 1999). The 
most striking evidence of relevance of occult WHY persistence to pathology is the 
development of HCC in up to 20% of the recovered animals (M ichalak et al. , 1999). 
1.4 ANTIVIRAL IMMUNITY 
The immune system provides multi-layered protection against invasions with 
pathogenic microorganisms, including bacteria, parasites and viruses. Pathogens are 
initially recognized by soluble (naturally occurring lgM, complement proteins) 
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components of the innate immune system. Pathogen recognition subsequently lead to 
activation of cellular subsets (macrophage, dendritic cell [DC], natural killer [NK], 
natural killer T cell [NKT]), resulting in activation of anti-microbial processes 
including phagocytosis, production of anti-microbial agents (e.g., nitric oxide, granule-
associated proteases) and secretion of immunomodulatory mediators (e.g., cytokines 
and chemokines). However, complete pathogen containment and removal requires 
activation of secondary immune defenses which includes pathogen-specific humoral 
and cellular responses. 
In contrast to innate immune responses, adaptive immunity provides long lasting 
protection against microbial infection by antibody neutralization of extracellular 
pathogens, while cellular immune responses combat intracellularly replicating 
microbial agents. Experimental evidence indicates that innate immune cell subsets 
directly contribute to activation of adaptive immunity, and that sign ificant cross-talk 
occurs between antigen presenting cells, NK and NKT cells, as well as CD4+ T helper 
and CD8+ cytotoxic T lymphocyte (CTL) effectors. Thus, host immunity is faci litated 
by complex cellular interactions, which not only provide anti-microbial protection, but 
which may also contribute to immune-mediated pathology, as is the case in virally 
induced hepatitis. 
1.4.1 Innate immunity 
The innate immune system provides the first line of defense against pathogens 
and relies upon a stepwise process which includes pathogen recognition and activation 
of cellular and soluble immune components. Briefly, the decision to respond or not to 
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respond to particular microbial antigens is mediated by innate recognition receptors 
which are invariable, germline encoded receptors expressed on innate immune cell 
subsets, including DC, macrophages, neutrophils (and other granulocyte.), and NK and 
NKT cells. Each of these cell types may respond to infection with unique or partial ly 
overlapping effects, which may be mediated by direct cell-cell interactions, or via 
soluble mediators, which act upon other components of the innate or further 
downstream adaptive immune responses. 
1.4.1.1 Antigen capture and presentation 
Although the engagement and recognition of pathogens may elicit an immediate 
anti-microbial response, which is important for early containment, arguably the most 
crucial role for the innate immune responses is downstream activation of adaptive 
immunity. In this regard, highly specialized professional phagocytic cells mediate 
antigen recognition, uptake and presentation toT cells, facilitating subsequent antigen-
specific responses. 
DC represent the most highly specialized professional antigen presenting cells 
(APC). They may be derived from either myeloid or lymphoid (plasmacytoid) 
progenitors, and are further classified based upon the expression of various receptors, 
in addition to tissue specificity (reviewed in (Heath et al., 2004)). Although the 
functions of particular DC subsets may demonstrate considerable overlap, evidence 
does suggest that some DC types exhibit specialized immunological properties. Thus, 
plasmacytoid DC produce large amounts of type r IFNs (interferon a [IFNa] and 
interferon ~ [I FNP]) following contact with virions (Asselin-Paturel et al. , 200 I; 
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Kadowaki et al., 2001). The importance ofthis event is not fully understood, however, 
it may contribute to control of viral replication or to activation of other DC subsets 
(Diebold et al., 2003). For example, Langerhans' cells are a specialized DC subset 
resident within the skin epithelium which detect invading pathogens and subsequently 
migrate to draining lymph nodes where they prime T cell responses (reviewed in 
(Romani et al., 2003). Their involvement in activation of virus-specific T cells has 
been examined during HBV infection (Allan et al., 2003), and they appear to play a 
limited role in anti-HBV immunity. 
Although DC have recently been identified as effective promoters of adaptive T 
cell responses, macrophages have long been recognized as immunologically important 
phagocytic cells. Circulating bone marrow-derived monocytes differentiate into 
macrophages following extravasation into peripheral tissues. Distinctly heterogeneous 
macrophage subsets, based upon expression of differentiation antigens and surface 
receptors, are localized within lymphoid organs and in non-lymphoid tissues, including 
the liver (Kupffer cells), lung (alveolar macrophages) and nervous system (microglia) . 
Furthermore, monocyte recruitment and macrophage differentiation is observed during 
inflammatory reactions. Thus, anti-microbial immunity is mediated by both resident 
and newly recruited macrophages which contribute to pathogen clearance and 
containment, clearance of apoptotic and necrotic cells, and to tissue remodeling and 
repair (reviewed in (Mellman et al. , 1998). 
Pathogen recognition by the innate immune system can be facilitated by 
receptors (pathogen recognition receptors; PRR) expressed on the cell surface or within 
intracellular compartments, or by those which may also be secreted into circulation or 
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other bodily fluids. Soluble mediators of pathogen recognition may include mannan 
binding lectin (MBL) and c-reactive protein (CRP), both of which are produced by the 
liver during early acute phase responses (Fraser et al., 1998; Gewurz ct al. , 1982). Cell 
surface PRRs represent diverse protein families, each characterized by distinctive 
cellular distribution, capability of antigen binding and activation of downstream 
signaling and response elements (reviewed in (Taylor et al., 2005). Briefl y, PRR 
families include scavenging receptors capable of bacterial or apoptotic cell recognition, 
complement or immunoglobulin receptors which recognize opsonized pathogens, and 
diverse groups of receptors which recognize microbial products, including 
lipopolysaccharide (LPS) (e.g., CD 14) (Wright et al., 1990). More recently, it has been 
determined that a conserved family of Toll-like receptors (TLR) (Belvin and 
Anderson, 1996) is expressed by both humans and mice, and function to coordinate 
intracellular activation in response to pathogenic stimuli (reviewed in (Janeway and 
Medzhitov, 2002). TLRs transmit intracellular signals via a conserved mechanism 
which culminates in nuclear factor kappa B (NFKB) activation and induction of 
phagocytosis, upregulation of costimulatory molecules necessary to induce adaptive 
immune responses, and production of inflammatory mediators important for the 
generation ofT helper I (T H I)-type immunity (Schnare et al. , 200 I). 
1.4.1.2 Soluble components 
1.4.1.2.1 Complement 
The complement system represents not only an important mechanism for 
pathogen lysis and targeted removal by phagocytic cells, but also serves a more vital 
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role as a mediator of inflammation (reviewed in (Barrington et al., 200 I)). Activation 
by pathogen recognition proteins such as MBL, CRP or immunoglobulin (particularly 
lgM) leads to microbial opsonization and injury. Furthermore, small inflammatory 
mediators generated by cleavage of complement components are instrumental for 
guiding extravasation of leukocytes and subsequent pathogen containment. Since the 
complement cascade is highly efficient and self-amplifying, all host cells express 
specific complement regulatory proteins which regulate its early activation (Hourcade 
et al., 1989). Deficiencies in complement regulation or aberrant complement activation 
may result in damage to host tissues. Hepadnaviral-induced production of 
autoantibodies to hepatocyte-specific asialoglycoprotein receptor (ASGPR) has been 
demonstrated to be pathologically relevant due to complement fixation (Diao et al., 
1998). Furthermore, anti-ASGPR-directed complement-mediated hepatocellular injury 
modulates the severity of WHY-induced hepatitis (Diao et al., 2003). Notwithstanding 
its potential involvement in certain autoimmune conditions, complement activation 
supports adaptive immunity by: (I) localization of antigen to follicular dendritic cel ls 
which are important activators of humoral immunity (Papamichail et al. , 1975), (2) 
lowering the threshold for antigen activation of narve B cells (Carter and Fearon, 1992) 
while (3) supporting maintenance of long term memory B cells. 
1.4.1.2.2 Nitric oxide 
Nitric oxide (NO) was formally recognized as a tumoricidal and antimicrobial 
molecule which was produced by activated macrophages via the enzymatic activity of 
nitric oxide synthase (NOS), following microbial recognition (Nathan, 1992). It has 
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been subsequently determined that NO can be produced by many immune cell type , 
including APC such as DC or Kupffer cells, as well as granulocytes and NK cells. NO 
plays multiple roles in immune processes, including differentiation, proliferation, 
cytokine production and expression of costimulatory molecules (Bogdan, 2000). 
Although IFNy and LPS are well characterized mediators of NO production, other 
activators include microbial products which stimulate TLR-dependent signaling, 
including bacterial lipoprotein, tlagellin, or DNA (Thoma-Uszynski et at., 200 I). 
1.4.1.2.3 Immunomodulatory components 
1.4.1.2.3a Chemokines 
Various pathogens induce particular cytokine and chemokine responses 
depending upon the types of recognition receptors engaged. Although 
immunomodulatory soluble mediators are important effector molecules in innate 
activation, they also represent key intermediaries in the successful activation and 
polarization of adaptive immunity. 
Chemokines comprise a complex communication system utilized not only by 
immune cells, but by all cell types, which mediates multiple intracellular signaling 
events. Chemokine responsiveness is determined by the levels of cell type specific 
expression of particular chemokine receptors (Murphy, 2002), which are partially 
redundant and overlapping. The major function of chemokines is leukocyte 
recruitment to sites of inflammation and regulation of trafficking through lymphoid 
organs (reviewed in (Rot, 1992)). The induction of chemokine expression following 
engagement of PRRs, or signaling potentiated by inflammatory mediators such as I FNy 
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or TN Fa (Baggiolini et al., 1997), is particularly important during innate immune 
responses since they encourage leukocyte recruitment and pathogen containment. 
Furthermore, chemokine signaling facilitates priming of adaptive immunity and 
homing of effector T cells into peripheral sites of infection (Weninger ct al.. 200 I). 
1.4.1.2.3b Interferons 
Interferons are soluble factors which are capable of downregulating viral 
infection. Since their discovery, it has been determined that interferons repre ent two 
main types, namely type I and type II, as well as some interferon-like cytokines 
including IL-28A, IL-28B and IL-29 (reviewed in (Pestka et al., 2004). Type IIFNs 
currently represent seven classes which may be further subdivided into multiple 
isoforms, while type II interferon solely consists of I FNy. 
Type I IFNs are biologically active as monomers, each capable of binding a 
common IFNa/p receptor complex which mediates intracellular activation via several 
signaling cascades including JAK/STAT, MAPK and NFKB pathways (rev iewed in 
(Stark et al., 1998). Type I IFNs mediate antiviral activity by different mechanisms 
. including induction of antiviral proteins, such as double-stranded RNA dependent 
protein kinase (PKR) which may degrade viral proteins, and 2'5'-oligoadenylate 
synthase (OAS) which selectively acts to degrade viral mRNA (Sen and Ransohoff, 
1993). They are also important mediators of pathogen-specific immunity during non-
viral infections including Chlamydia (Rothfuchs et al. , 200 1), Leishmania (Diefenbach 
et al., 1998), and Trypanosoma (Une et al., 2000). Briefly, IFNa/P affect DC function 
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(Santini et al., 2000), including antigen presentation and subsequent activation ofT 
cells, B cells, and NK cell cytotoxicity (Nguyen et al., 2002). 
IFNy is a potent activator of DC and macrophages, and plays an c sential role in 
resistance to many pathogens, including intracellular bacteria, parasites, and viruses. 
Although it was initially considered to be produced by activated T ce lls, the importance 
of IFNy during innate immune responses has been highlighted by the observation that 
NK, NKT and phagocytes also produce large quantities of IFNy (reviewed in 
(Lieberman and Hunter, 2002). 
Not surprisingly, regulation of IFNy is complex, however, one key regulator is 
the expression of heterodimeric interleukin-12 (I L-12) (Kobayashi et al. , 1989), and its 
interaction with a dimeric receptor (IL 12R) (Presky et al., 1996). DC production of I L-
12 has been implicated as an important inducer ofiFNy during some intracellular 
infections or in response to LPS. Furthermore, bacterial or parasitic infections or viral 
replicative intermediates have been shown to induce IL-12 production and regulate T 
helper type I (T HI) responses, including IFNy production (reviewed in Trinchieri, 
2003). 
1Ll2R is expressed by activated T cells, however, it is also constitutively 
displayed on NK cells and may contribute to their ability to respond quickly to IL- 12 
with subsequent production ofiFNy (reviewed in Trinchieri 2003). While IL-12 
poc; itively regulates NK cell production of JFNy, artificial activation of KT cel ls via 
synthetic glycolipids is an even stronger inducer of IFNy. The importance of IFNy in 
promotion of immune responses is multifaceted. NK cell-derived IFNy activates 
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macrophages and promotes T cell independent maturation (Gazzinelli et al. , 1994), 
whil~ also activating non-immune cells, including na"ive or virally infected hepatocytes. 
1.4.1.2.3c Tumor necrosis factor alpha 
TNFa i the prototypic member of the TNF superfamily whose members 
mediate diverse biological functions (reviewed in Locks ley et al., 200 I), including 
mediation of lymphoid organogenesis, inflammation and apoptosis. TN Fa and other 
members exist both as membrane bound and soluble isoforms, the latter being 
generated by matrix metalloprotease-mediated cleavage. Membrane bound or oluble 
ligands may interact with several cognate receptors, which may themselves exist as 
membrane anchored or cleaved entities. 
TNF receptors, including CD95 (Fas), TNFR I or TNF-related apoptos i 
inducing ligand receptor (TRAIL-R) may potentiate both apoptotic and proliferative 
signals due to their interaction with various cytoplasmic signaling moieties. In th is 
regard, caspase activation results in cellular apoptosis, while TNF-receptor associated 
factors (TRAFs) activate several proliferative pathways including NFKB, JNK and 
PI3K (Dempsey et al., 2003). Thus, TNF superfamily member-mediated signaling is 
complex and dependent upon the type and activation state of the target cells (Hehlgans 
and Manne! 2002). 
TN Fa-mediated signaling via TNFR I is crucial for pathogen clearance 
including intracellular bacteria, such as Listeria (Pfeffer et al.. 1993), and para ite 
including Leishmania major (Nashleanas et al. , 1998). Furthermore, TN Fa med iates 
protective T HI type responses, particularly in cooperation with IFNy (Bekker et al., 
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200 I) during infection with Mycobacterium tuberculosis. The importance ofT Fa a 
a stimulator of innate immunity is highlighted by cytokine-induced macrophage 
expression of 0 and chemokine-dependent recruitment of inflammatory cells (Roach 
et al., 2002). Indeed, the action ofTNFa on endothelial permeability is a key initiator 
of pathogen-induced inflammation, and promotes adaptive immunity by activation of 
phagocytic cells. Additional TNF receptors aid CD4+ and CD8+ T cell activation and 
are crucial for virus-specific T cell responses (Hendriks et al., 2000). The importance 
ofTNF superfamily members in mediating antiviral immunity has been demonstrated 
by the evaluation of virus genes whose products inhibit TNF-mediated ignaling at 
virtually every step, including expression, interference with ligand-receptor binding, 
and modulation of downstream pathways (reviewed in (Benedict et al., 2002). 
1.4.1.3. Cellular Components 
1.4.1.3.1 Neutrophils 
Neutrophils are highly motile, phagocytic cells which are essential for 
immunity to bacterial and fungal infections. Their microcidal activity is attributed to 
fusion of phagocytic vacuoles with cytoplasmic granules containing hydrogen peroxide 
and superoxide radicals (Holmes et al. , 1967), in addition to cytotoxic granu le proteins 
such as lysozymes (Reeves et al. 2002). While initial works implicated reactive 
oxygen species and hydroxyl radicals to be key med iators of anti-microbial activ ity, it 
has since been determined that both free radicals and protease are cooperatively 
required for effective microbial destruction (Reeves et al., 2002). Cytoplasm ic 
granules typically fuse with endocytic phagosomes after the vacuolar membrane has 
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completely closed, to ensure that potentially damaging free radicals and anti-microbial 
proteins are not externalized. However, overwhelming excess of opsonized particles or 
inflammatory mediators may result in dysregulated degranulation. Neutrophil-
mediated tissue injury has been implicated in the development of hepatiti s in the HBV 
transgenic mouse system (Sitia et al., 2002). In this case, specific blockade of 
neutrophil recruitment and activation by interferons significantly reduced non-specific 
hepatocyte injury. 
1.4.1.3.2 Natural killer cells 
NK cells were initially identified through their ability to kill tumor cells without 
prior sensitization of the host to tumor-specifc antigens, while subsequent studies shed 
light on their participation in the immune response to microbial infection (Bancroft, 
1993). Further evidence has indicated that substantial cross-talk occurs between NK 
and other cell subsets of the innate immune response, including DC, resulting in the 
activation of these and other antigen presenting cells (Gerosa et al., 2002). The 
interaction ofNK cells with APC may occur at sites of inflammation or within 
peripheral lymph nodes (Ferlazzo et al., 2004) and may result in IFNy production or 
increased NK cytolytic activity (Yu et al., 200 l). Reciprocal NK-DC activation likely 
involves both soluble mediators, such as interleukin-2 (lL-2) (Granucci et al., 2004) or 
TNFa (Gerosa et al., 2002), and direct cell contact (Piccioli et al., 2002). 
Observations that NK cells displayed inherent capacity to kill certain tumor 
targets, which showed an inverse correlation between MHC class I expression and 
susceptibility to lysis (Karre et al., 1986) led to the "missing self hypothesis". It is 
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presently recognized that inhibitory NK receptors, which belong to either killer lg-like 
(KIR) or C-type lectin protein families, primarily engage host MHC class I molecules. 
Receptor cross-linkage mediated by host MHC molecules ensures dephosphorylation of 
proteins involved in cell activation, thereby conferring protection from NK cell attack 
(Long, 1999). Loss of MHC class I expression or absence of MHC-related molecules 
(e.g., MHC class Ib proteins) results in a lack ofNK cell inhibition and subsequent 
default activation. 
NK recognition additionally involves activation receptors, such as the recently 
identified NKp46 (Pessino et al., 1998), and NKp44. These receptors appear to 
mediate NK recognition and lysis of virally infected cells (Mandelboim et al., 200 I), as 
well as certain melanoma, adenocarcinoma and hepatoma tumor cell types (Sivori et 
al., 1999). 
Although cellular ligands and receptors mediating NK cell activation are not 
fully identified, it is apparent that NK cells are important immune effector cells during 
bacterial (Tripp et al., 1993) and parasitic infections (Scharton-Kersten and Sher, 
1997). The involvement ofNK cells in host immune responses to viral infection has 
been firmly established (reviewed in (French and Yokoyama, 2003)). NK cel l 
contributions to containment of bacterial or parasitic infections, or to the generation of 
antiviral immunity, may involve either cytokine or cytolytic responses which depend 
upon the site of replication (Tay and Welsh, 1997), and the local cytokine milieu. In 
this regard, lFNa, IFNp, IL-12 and interleukin-15 (IL-15) produced by DC and 
macrophages (Biron et al., 1999) positively contribute to K cell activation and 
cytokine secretion, and influence non-cytolytic adaptive immune responses (Guidotti 
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and Chi ari, 200 I). The importance ofNK cells during viral infection is highlighted by 
the fact that many viruses have developed evasion strategies to specifically avoid NK 
cell recognition and activation. Herpes viruses, including human and murine 
cytomegaloviruses (CMV), downregulate cellular expression of ligand which bind the 
NK activation receptor, NKG2D (Lodoen et al., 2003). Furthermore, HCV envelope 
proteins have been shown to downregulate NK cell responses, particularly cytokine 
production (Pileri et al., 1998). 
1.4.1.3.3 Natural killer T cells 
NKT cells represent a heterogenous lineage ofthymically derived cells which 
are classified into four categories based upon expression ofT cell receptor (TCR) 
variable regions and associated CD antigens (reviewed in (Kronenberg and Gapin, 
2002). Although they constitute less than I% of the T lymphocyte population, their 
ability to rapidly secrete cytokines, such as interleukin-4 (IL-4) and IFNy, impl ies an 
important role in bridging innate and adaptive immunity. NKT cells exhibit diverse 
immunological functions, including prevention of tumor development and metastases 
(Smyth et al., 2002), amelioration of autoimmune and allergic diseases (Hong et a!., 
200 I; Sharif et al., 200 I), and activation of antiviral immunity (Ashkar and Rosenthal. 
2003). 
Since tumor or pathogen-derived ligands which activate NKT cells are not fully 
recognized, CDld-resticted NKT cell function has been experimentally determined by 
applying the marine sponge-derived glycolipid, a-galactosylceramide (a-galcer) 
(Kawano et al., 1997). Thus, a-galcer-pulsed APC rapidly activate NKT-mediated 
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cytotoxicity (Metelitsa et al., 2001) or production ofcytokines, including IL-4 and 
IFNy (reviewed in (Bendelac et al., 1997). 
The role ofNKT cells in promoting viral immunity has not been fully 
elucidated. However, evidence from virus model systems including vaginal herpes 
simplex virus-2 (HSV -2) (Ashkar and Rosenthal, 2003) and respiratory syncytial virus 
(RSV) (Johnson et al., 2002), indicate that NKT cells activate APC and K cells, and 
favor the development of virus-specific, T H 1-type T cell responses and the production 
of IFNy. The involvement ofNKT cells has been implicated during HCV infection, 
since HCV viraemic patients exhibit a lower frequency of invariant NKT cells (Lucas 
et al., 2003), while recovered individuals display an increased accumulation of 
activated NKT cells in the hepatic compartment. In addition, NKT cells were found to 
be selectively depleted during human immunodeficiency virus (HIV) infection, 
possibly contributing to the development of immunodeficiency (Motsinger et al., 
2002). 
The inherent capacity ofNKT cells to produce IFNy following a-galcer 
stimulation has been successfully shown to downregulate herpes virus replication in the 
absence of virus-specific T cell recognition, highlighting the potential therapeutic 
activation ofNKT cells to facilitate viral clearance. Although a natural role for NKT in 
the downregualtion of HBV is not recognized, a-galcer therapy in a HBV transgenic 
model leads to rapid NKT-associated IFNy production, recruitment ofNK and T cell 
subsets, and abrogation of viral replication (Kakimi et al. , 2000). 
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1.4.2 Adaptive immunity 
Following pathogen recognition by components of the innate immune system, 
the sequential and complementary activation of adaptive immune respon es provide 
long lasting immunity. This immunity is conferred by effector and memory T cells, 
and by pathogen-specific antibodies. The interaction of innate immune cells with those 
of the adaptive immune response is not, however, unidirectional. Rather, experimental 
evidence demonstrates the importance of activated T cells in the reciprocal activation 
of innate immune cells, including APC. 
1.4.2.1 Humoral immune responses 
Humoral immunity mediates protection against extracellular microbes by 
specific antibodies. These antibodies are induced following engagement of surface 
immunoglobulin expressed on na"ive 8 cells and their development into antibody 
producing plasma cells. Antibodies may contribute to pathogen inactivation and 
clearance by several mechanisms. Neutral izing antibodies prevent viral attachment and 
entry into host cell and may act as opsonins which promote phagocytosi . 
Furthermore, antibodies efficiently activate the complement cascade, particularly those 
of lgM or IgG subclasses. Natural lgM antibodies, which are produced by 05-
expressing 8 cells, contribute to the initiation of innate immunity to orne pathogens 
via complement fixation and subsequent chemoattraction of phagocytic cell . T helper 
2 (T H2)-type CD4+ T cells promote activation of 8 cells and production of pathogen-
specific antibodies, which may also initiate the complement cascade. Complement 
fixation mediated by antibody recognition of viral antigens on host cell facilitate 
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CDC, while antibody-dependent cellular cytotoxicity (A DCC) is potentiated by the 
interaction of bound immunoglobulin constant regions (Fe) with cellular Fe receptors. 
1.4.2.2 Cellular responses 
CD4+ T H cell responses are initiated by MHC class 11-re tricted presentation of 
exogenously acquired antigens (Cresswell, 1996). Cell-mediated T H cell response are 
divided into two categories, T HI and T H2. The main determin ing factor in the 
polarization of the type ofT H responses is the cytokine milieu present during the clonal 
expansion of the specific T cells (Mosmann and Coffman, 19g9). Thus, the 
development ofT H 1 or T H2 responses are facilitated by exposure to IL-12 (Kobayashi 
et al. , 19g9) or IL-4 (Le Gras et al., 1990), respectively. 
AT HI cell response is characterized by the production of cytokines including 
IL-2 and IFNy, and is often associated with the development of cog+ T cell immunity. 
CD4+ T cells have been shown to provide co-stimulatory activity required for 
maturation of APC and subsequent presentation of antigens to cog+ T cells (Bennett et 
al., 1997). In the absence of maturation signals provided by CD4+ T cells, APC may 
induce cog+ T cell tolerance and inactivation (Curtsinger et al., 2003). In addition, 
lack ofCD4+ T cell help during the development of cog+ T cell adaptive immunity 
results in impaired development of memory T cells, and lack of protective immunity to 
viral and intracellular bacterial infections ( un and Bevan, 2003). In contrast, TH2-type 
cell responses are characterized by CD4+ T cells which produce cytokines including IL-
4 and interleukin-1 0 (IL-l 0), which induce phenotypic and functional maturation of B 
lymphocytes. 
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CDS+ T lymphocytes are important immune effector cells against intracellular 
replicating bacterial, protozoan and viral pathogens. Their activation requires 
presentation of microbial peptides within the context ofMHC class I molecules. 
Generation of such peptides occurs via cytosolic, proteasome-dependent degradation of 
proteins which are subsequently retrogradely transported into the ER where they 
associate with MHC class I heterodimers. Professional APC, such as DCs, are able to 
cross-present exogenous antigens obtained by phagocytic activity via the MHC class I 
pathway, thus possibly precluding the necessity of direct pathogenic infection of the 
DC for CDS+ T cell activation (reviewed in Heath et al. , 2004). Since MHC class I 
molecules are expressed on essentially all ho t cells, primed CDS+ CTL may respond 
against cellular pathogens infecting most tissues. CTL effector functions are mediated 
by direct cell contact and cytolysis, or by soluble mediators including lFNy and T Fa. 
CTL-mediated lysis oftarget cells may proceed via two distinct yet potentially 
overlapping pathways; the granule exocytosis pathway mediated by perforin and 
granzymes, or by CD95L (Fas ligand)-CD95 (Fas) interaction which can in itiate 
apoptosis ofCD95-expressing cells (reviewed in Barry and Bleackley, 2002). CTL-
mediated cytotoxicity significantly contributes to removal ofvirally- in fected ce lls 
(Kagi et at. , 1994) and clearance of intracellular bacteria, including Listeria and 
Chlamydia (Starnbach et at., 1994). 
In addition to mediating cytotoxicity, CDS+ T cells produce pro inflammatory 
and antiviral cytokines, such as IFNy and TNFa. These cytokines have been proven 
essential for successful clearance of WHY (Hodgson and Michalak, 200 I ; Wang et at. , 
2003b) and HBV infections (Guidotti et al., 1996; Guidotti et at. , 1999). 
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1.5 THE LIVER AS AN IMMUNE COMPETENT ORGAN 
The immune system is functionally organized based on the primary lymJ9hoid 
tissues, thymus and bone marrow, and on peripheral secondary lymphoid organ . . 
including lymph nodes, spleen, and mucosal-associated lymphoid tissues. The 
importance of primary and secondary lymphoid tissues in the initial development and 
selection of lymphoid cells, and the potentiation of immune response , respectively. 
have been intensely studied. However, the role ofthe liver as a lymphoid organ is an 
emerging concept based upon clinical and experimental evidence. The observation that 
the liver is inherently capable of tolerance induction following solid organ 
transplantation was made more than 30 years ago (Caine et al., 1969) and has since 
been repeatedly supported by many observations (see Section 1.5 .3.3). The mechanism 
of hepatic induced tolerance during organ transplantation and to dietary food antigens 
are a function of: ( 1) immunomodulatory properties of hepatic parenchymal cells, (2) 
its unique composition of immune cells, and (3) the microvascular structure of the 
liver. The complex interactions between lymphoid cells and APC following antigen 
recognition within the liver are important not only during tolerance induction but may 
contribute to pathogen-specific immune responses. In this regard, the interaction 
between hepatic parenchymal and local immune cells may contribute to clearance or 
persistence following infection with hepatotropic viruses. In addition to tolerance 
induction, other studies suggest that hepatic functions may include induction of primary 
T cell responses or active removal of effector T lymphocytes. This section will 
summarize the current understanding of the function of the liver as an immune 
competent organ. 
43 
1.5.1 Hepatic microenvironment 
The liver displays excretory, detoxifying and metabolic functions. It is located 
between the gastrointestinal portal tract and systemic blood circulations. 
Approximately 80% of the hepatic blood supply enters via the portal vein, which 
collects blood from the gut (from the stomach to the proximal part of the rectum) that is 
rich in food antigens, environmental toxins and bacterial products including LP . 
Additionally, all venous blood from the spleen enters into the portal vein. Thu . all 
recirculating na"ive and activated or memory lymphocytes leaving the spleen are 
inevitably confronted with the specialized microenvironment of the liver. The 
remaining 20% of the incoming blood is supplied by the hepatic artery which mixes 
with the portal blood within the liver sinusoidal spaces. Blood percolates through a 
network of sinusoids which lack a basement membrane but are formed by liver 
sinusoidal endothelial cells (LSEC). Blood is finally directed into terminal central 
veins before entering systemic circulation via the inferior vena cava. 
LSEC are highly fenestrated, allowing macromolecules to enter the underlying 
space of Disse and to directly interact with hepatocytes. Endothelial fenestrations and a 
lack of intercellular LSEC gap junctions also permit contact between hepatocytes and 
cells residing in or circulating through the sinusoidal spaces (Warren et al., 2006), or 
which enter into the space of Disse. The combination of slow blood fl ow, fenestrated 
endothelium, and lack of basement membrane faci litates a unique vascular 
microenvironment which contributes to intrahepatic immunological functions (see 
below). 
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1.5.2 Components of the intrahepatic immune system 
1.5.2.1 Professional antigen presenting cells 
The liver contains a large population of resident macrophages known as 
Kupffer cells. Although they are mostly found within the hepatic sinusoids, they may 
also penetrate into the space of Disse and interact directly with hepatocytes. They are 
highly phagocytic, capable of endocytosis of apoptotic cells (Shi et al., 1996) and 
microbial pathogens. 
Hepatic tissue contains multiple subsets of DC (see Section 1.4.1.1) which are 
known to efficiently activate T cel l responses, including proliferation and the induction 
ofT cell cytotoxicity. DC have been shown to interact with Kupffer cells (Uwatoku et 
al., 200 I), facilitating enhanced cross-presentation of exogenously acq uired antigens 
and priming of anti-microbial responses (Albert et al. , 1998). 
[n addition to professional APC, other studies indicate that LSEC may function 
in an antigen-presenting capacity. LSEC express molecules that promote antigen 
uptake, including the mannose receptor and scavenging receptor. Furthermore, the co-
stimulatory molecules required forT cell activation, including CD40, CD80 and CD86 
are readily detectable on LSEC (Lohse et al., 1996). 
1.5.2.2 NK and NKT cells 
Liver-associated NK cells have been initially identified as "pit cell ··and 
exhibit a phenotype of large granular lymphocytes displaying cytotoxic activity against 
various cell targets, including Y AC I lymphoma cells (Bouwens et a l. , 1987). Liver-
derived NK cells express similar activation and inhibitory receptors as those observed 
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for circulating NK cells. However, K cells are of a disproportionately high frequency 
(31%) among intrahepatic lymphocytes (IHL) compared with the extrahepatic 
compartment (13%). Experimental evidence indicates that hepatic NK cells proliferate 
in response to antigenic stimulation, including viral infections and may be recruited 
into the liver in response to type I and type Tl IFNs (reviewed in (Biron et al. , 1999)). 
While NKT cells represent <5% of peripheral lymphocytes, they represent 20-
40% of IHL (Kiugewitz et al., 2004). Hepatic NKT cells may be activated 
independently ofT cell receptor (TCR) engagement. For example. IL-12 (Ha himoto 
et al., 1995) or interleukin-18 (IL-18) (Leite-De-Moraes et al. , 1999) induce NKT 
activation and production of IF y. In contrast with K cells, activated K T cells do 
not undergo clonal expansion and differentiation. Rather, they undergo activation 
induced cell death (A lCD) within hours after stimulation with either IL-1 2 or anti-CD3 
antibodies (Eberl and MacDonald, 1998), or during infection with Listeria (Szalay et 
al., 1999) or HCV (Nuti et al., 1998). Thus, efficient priming of intrahepatic TH I 
responses may coincide with activation ofNKT cells, reflected by IFNy production, 
and their subsequent transient depletion. 
1.5.2.3 Conventional T cell subsets 
In addition to disproportionate numbers of K and KT cells, the liver differs 
significantly in the phenotypic and functional properties of conventional T cell , 
expressing a. and ~chains of the TCR (denoted a.~ T cells), when compared with those 
in peripheral circulation (reviewed in (Doherty and O'Farrelly, 2000)). Les than 40% 
ofiHL are conventional a.p CD4+ or CD8+ T lymphocytes, while similar subset 
46 
represent 70% of circulating T cells. Among apT cells, those expressing the CD8 co-
receptor predominate, comprising between 60-90% of conventional hepatic T ce lls. 
Although CD8+ T cells represent the majority of conventional T cells within the li ver, 
CD4+ T cells are also detectable and tend to exhibit aT HI phenotype characterized by 
production of cytokines including IL-2 and IFNy. 
1.5.2.4 Non-conventional T cell subsets 
The liver also contains T cell subsets which are atypical, including those which 
are CD4 and CD8 double-negative or double-positive, those that express homodimeric 
CD8a chain in the absence of the CD8p chain, and those whose TCR is comprised of 
the alternate y8 chains. Up to 35% of hepatic T cells express the y8 TCR and, unlike 
conventional T cells, they are believed to be of extrahepatic origin. Hepatic yo T cell s 
support intrahepatic priming ofT H !-type responses to bacterial infections, and 
contribute to liver injury via cytotoxic mechanisms (Ishigami, 1999). However, other 
evidence suggests their involvement in skewing T cell responses towards an 
immunosuppressive T H2 phenotype during the early phase of Leishmania infection 
(Yamashita et al. , 1999). Thus, the contribution of hepatic y8 T cells to immunity may 
include either T H 1 or T H2 responses depending upon the pathogen encountered. 
1.5.2.5 Parenchymal and endothelial cell contribution to immunity 
LSEC are able to present exogenous antigens toT cells, since they 
constitutively express MHC class I and class II molecules, as well as co-stimulatory 
molecules (Lohse et al., 1996). They may even cross-present exogenous antigens to 
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cog+ T cells, a function which is normally an attribute of profess ional APC (Limmer 
et al., 2000). However, LSEC-primed C04+ T cells fail to differentiate towards a T111 
phenotype, but rather secrete cytokines associated with T112-type responses, including 
IL-4 and IL-l 0 (Knolle and Gerken, 2000) . In support of this, stimulation of na'r've 
cog+ T cells by LSEC results in transient proliferation but failure to acquire cytotoxic 
effector function (Bertolino et at., 200 I; Limmer et at., 2000). Thus, the role of LS EC 
in the generation of immunity appears to be, by default, induction of cog+ T cell 
tolerance and prevention of inflammation. It has been speculated that this default 
pathway is essential for maintaining immune ignorance of dietary and neoantigens 
(reviewed in (Knolle and Limmer, 200 I). However, pathogen-induced inflammatory 
reactions including those characterized by TNFa production, downregulate antigen 
presentation by LSEC and promote T H 1-type cellular immunity (Knolle et at. , 1999). 
Both LSEC and hepatocytes express intercellular-adhesion molecule I (!CAM-
I) which binds integrins expressed by activated T cells, including lymphocyte function 
antigen I (LF A-1 ). It has subsequently been shown that T cells may bind to 
hepatocytes (Morita et at., 1994). Furthermore, hepatocytes constitutively express 
MHC class I and CDI molecules, albeit at low levels. Notwithstanding the minimal 
expression of these ligands, hepatocytes are able to induce cog+ T cell activation in 
vitro (Bertolino et at., 199g). Additionally, it has been shown that inflammatory 
cytokines enhance the ability ofhepatocytes to act as APC in vivo. due to upregulation 
of !CAM-I , MHC class I and class Il, and co-stimulatory molecules (Bertolino et a t. , 
2001). 
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1.5.3 Immunological function of the liver 
1.5.3.1 Anti-microbial effector function 
The contribution of hepatocytes to anti-microbial immunity is associated with 
activation of innate immune cell subsets within the liver. The recognition of microbial 
pathogens by macrophages and other cells, result in the production of cytokines, such 
as TN Fa, interleukin-1 (IL-l) and interleukin-6 (IL-6), which induce hepatocyte 
expression of acute phase proteins, including CRP and MBL. Both of these 
compounds are important for control of bacterial infections and aid in the development 
of adaptive immune responses (Fraser et al., 1998). 
Since the majority of the hepatic blood supply is obtained from intestinal 
tissues, intrahepatic immune subsets readily respond to enteric pathogens which may 
penetrate the intestinal mucosa and enter systemic circulation. LPS, a cell wall 
component of Gram-negative bacteria, activates Kupffer cells resulting in the 
production ofpro inflammatory TH I cytokines (Trinchieri, 1998). NK and NKT cells 
may respond directly to superantigens of Gram-positive bacteria, including 
Staphylococcal enterotoxin B (SEB), by producing both IFNy and IL-12. Thu , entry 
of pathogenic bacteria into the hepatic sinusoids induces local anti-microbial re ponses. 
Activation of intrahepatic immunity during infection with Plasmodium berghei 
is important for parasite clearance and protective immunity. In this regard, the 
interaction between IFNy-producing CD8+ T cells and Kupffer cells, leading to 
production of NO, is a key factor providing protection against the exoerythrocytic 
stages of malaria (Seguin et al., 1994). Furthermore, activation ofhepatic NK and 
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NKT cells appears to be required for development of long term memory CTLs and 
protectiv"e T H 1-type immunity (reviewed in (Krzych et al., 2000) . 
1.5.3.2 Lymphocyte retention and removal 
Activation ofT cells leads to clonal expansion and their migration to sites of 
infection, before their homeostatic downregulation. It has been noted that following 
activation by antigenic peptide (Mehal et al., 200 I) or due to extrahepatic viral 
infection (Belz et al., 199S) there is a transient accumulation ofT cells within the li ver. 
While antigen presentation by either LSEC or hepatocytes may increa e antigen-
specific T cell retention (Mehal et al., 200 I), it is not a prerequisite for hepatic T cell 
trapping (Belz et al., 199S). The accumulation of activated lymphocytes predominantly 
involves COS+ T cells, which are subsequently removed by the induction of apoptosis 
(Mehal et al. , 1999). 
Hepatic accumulation ofT cells could be a consequence of interactions between 
adhesion molecules expressed by liver endothelial cells or hepatocytes and their ligands 
which are increasingly expressed on activated lymphocytes. In this regard, L EC and 
hepatocytes constitutively express I CAM-I which is capable of binding LFA-1 
(reviewed in (Knolle and Gerken, 2000). Activated CDS+ T cells express higher levels 
of LF A-1 than C04+ T cells (Mehal et al., 1999) which may partially explain 
preferential COS+ T cell retention by the liver. 
It has also been suggested that the retention ofT ce lls within the liver may be 
facilitated by recognition of apoptotic cells. The concept proposes that the liver 
functions as a graveyard for dying T cells (reviewed in (Crispe et al., 2000). Kupffer 
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cells are capable of recognizing apoptotic cells via the phosphotidyl serine receptor 
(Dini , 2000). It has been found that injection of apoptotic lymphocytes into the portal 
vein results in their retention, which is specifically inhibited following saturation of 
scavenging receptors (Dini, 1998). It has been established that hepatocytes may 
recognize cells or apoptotic bodies following interaction of the primarily hepatocyte-
specific ASGPR with desialylated glycoproteins (Dini et al. , 1992). This interaction 
has been suggested to play a role in the liver sequestration of lymphocytes (Samlowski 
et al., 1984) which may be due to the expression of ligands capable of binding to 
ASGPR (e.g., 8220) following lymphocyte activation (Renno et al., 1996). 
However, hepatic retention ofT cells is unimpaired in CD95-deficient mice 
(Mehal and Crispe, 1998) and thus, trapped cells need not be apoptotic. This may 
suggest that the liver is responsible for initiation of lymphocyte apoptosis. Current 
evidence suggests that this may occur via both active and passive cell death 
mechanisms. Active cell death is induced by ligation of a death receptor (e.g., CD95) 
with its specific ligand (e.g., CD95L), while passive cell death is induced by withdraw! 
of growth factors or inhibition of activation signals. ldenti fication of the pathways 
mediating intrahepatic lymphocyte removal has proven so far to be contradictory. 
Limmer et al. (2000) suggest that antigen presentation is necessary for CD95-
dependent apoptotic signaling, while others report that T cells are trapped independent 
of antigen recognition (Mehal et al., 200 I) and undergo CD95-independent deletion 
(Mehal and Crispe, 1998). Although the study conducted by Mehal et al. ( 1998) did 
not indicate which alternate mechanisms are potentially responsible, other works 
suggest that TN Fa (Weishaupt et al., 2000) or perforin-dependent pathway mediate T 
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cell protraction (Kagi et al., 1994). Nonetheless, the roles of these pathways in hepatic 
removal of lymphocytes are not fully recognized. 
Passive apoptosis of intrahepatic lymphocyte has also been ob erved and may 
be mediated by several mechanisms. It has been suggested that a lack of IL-2 (Dai et 
at., 1999) or presence of transforming growth factor beta (TGFP) and I L-1 0 (S i llett et 
at., 200 I) promote passive cell death of CD8+ T cells. Of note, Kupffer cells (Rai et 
at., 1997) and LSEC (Bissell et al., 1995) produce large amounts of these cytokines 
which have been shown negatively influence the survival ofCD8+ T cells, particularly 
when CD4+ T cells are absent. Since the liver preferentially retains CD8+ T ce ll , the e 
observations suggest that the intrahepatic environment may promote passive CD8+ T 
cell deletion. 
1.5.3.3 Induction of tolerance 
The maintenance of allogeneic liver grafts without the need for 
immunosupression was initially identified in pigs (Caine et al., 1969). Subsequent 
studies in rats (Zimmermann et al., 1979), mice (Qian et al., 1994), and humans 
(Eddleston et al. , 1969) have demonstrated similar tolerogenic states. Thi may be due 
to multiple factors, including intrahepatic elimination ofautoreactive T cells or the 
unique intrahepatic cytokine milieu which does not support TI-ll -type cellular immune 
responses (Tu et al., 1997). Further, it has been found that the liver constitutively 
induces tolerance to food antigens (reviewed in (Knolle and Gerken, 2000) and may 
provide an anti-inflammatory environment allowing escape of metastatic tumour cell 
(Jewell, 2005). Thus, the inherently tolerogenic capacity of the liver may prevent 
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aberrant immune responses or be detrimental for host recognition of malignant tis ues, 
while the mechanisms oftolerance induction seem to overlap with tho e of removal of 
activated lymphocytes trapped in the liver. 
Although intrahepatic trapping of activated T cells preferentially involves CD8+ 
CTLs, tolerance induction has been observed to include both CD4+ and CD8+ T cell 
subsets. However, the mechanisms appear to differ; tolerization ofCD4+ T cell 
involves immune deviation towards aT H2-type response (Knolle et al., 1999), while 
CD8+ T cell activation is abrogated by deletion or immunological ignorance (reviewed 
in (Bertolino et al., 2002). 
1.5.3.4 Induction of primary T cell immune responses 
The data outlined so far implicate an important immunological role of the li ver 
in removal of activated CTLs which may downregulate these cellular immune 
responses. At the same time, the liver also displays an inherent capacity to limi t 
unwanted inflammatory responses to innocuous dietary antigens, which appears to 
occur primarily due to the production of anti-inflammatory cytokines uch as I L-1 0 by 
LSEC and other intrahepatic APC (Knolle et al. , 1999). It is not fully understood how 
the liver overcomes this default state oftolerance to allow activation ofnaYve T cells, 
although this phenomenon has been observed. 
Although the exact mechanisms remain unknown, it is possible that intrahepatic 
priming ofT cells following viral challenge, including infections with hepadnaviruses, 
may be mediated by the induction of type IIFN expression. Type !IF s induce 
production of cytokines, including IL-15, which may promote surviva l of CD8+ T cells 
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(Mattei et al., 200 I) . Furthermore, activation of intrahepatic DC and the 
downr~gulation of LSEC antigen presenting function may shift the balance from 
tolerance to immunity (Knolle and Limmer, 200 I) . Since hepatic DC are maintained in 
a semi-mature state and tend to promote CD4+ T cell regulatory function (O'Connel l et 
al., 2002), the activation of innate cytokine responses, particularly IF ap, may promote 
full DC maturation (Luft et al., 1998) and lead to effective priming of effector T cells. 
1.6 IMMUNOPATHOGENESIS OF HEPADNA VIRAL INFECTION 
1.6.1 Innate immune response 
The incubation period of HBV and other hepadnaviruses i long in comparison 
with other hepatotropic viruses such as HCV. While viraemia is detectable in case of 
HCV infection within 1-2 weeks (Thimme et al., 200 I), HBV infection is 
asymptomatic for 4-7 weeks or up to 6 months, until commencement of vigorous 
replication and development of AH (Whalley et al., 200 I). Whether thi delay 
represents an inherent property of hepadnaviruses or if early viral replication i 
decreased by immune control, is still unrecognized. 
Initial viral infection and immediate activation of innate immune components 
are believed to influence the outcome ofhepadnaviral infection, i.e. , recovery or 
progression to CH. Although a complete assessment of immune activation preceed ing 
acute liver injury is currently lacking, experimental infection of ch impanzee ugge ts 
that hepatic HBV replication is significantly reduced prior to the development of liver 
injury characterized by elevations in the levels of serum aminotran ferae (Gu idotti et 
al., 1999). Further studies have indicated that activation of relatively few numbers of 
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IFNy-producing CD8+ T cells is sufficient to downregulate viral replicative 
intermediates, as much as 50-fold, and that this occurs before the development of A H 
(Wieland et al., 2004b). 
It has been reported that hepadnaviral-induced AH is associated with enhanced 
NK cell cytotoxicity both in humans (Chemello et al., 1986) and, potentially, in 
woodchucks infected with WHY (Hodgson et al. , 1999). Furthermore, it has been 
demonstrated using the HBV transgenic mouse model that activation of KT ce lls by 
a-galcer, with possible bystander involvement ofNK cells, ign ificantly downregulates 
HBV replication in an IFNy-dependent manner (Kakimi et al. , 2000). In addition, it 
has been shown that a-galcer-induced inhibition of viral replication does not require the 
recruitment of other inflammatory cells to the liver (Kakimi et al., 200 I). Whether 
intrahepatic innate immune subsets, including NK and NKT cells, are immunologically 
active during the pre-acute phase of natural hepadnaviral infection, is not fully 
recognized. However, experimental evidence obtained thus far indicate that for 
antiviral responses to be effective, they should include the production of IFNy, TNFa 
and IFNap (Guidotti et al., 1994; Guidotti et al., 1996; McClary et al. , 2000). 
1.6.2 Humoral immunity 
The humoral anti-hepadnavirus response appears to be of paramount 
importance for viral neutralization and recovery. Specifically, the loss of serum 
HBsAg and seroconversion to anti-HBs antibodies is the hallmark of disease re olut ion 
signifying recovery from AH type 8 , while CH is characterized by the continuous 
presence of serum HBsAg. However, even in chronic HBV infection anti-HBs may not 
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be completely lacking and they could be found complexed with HBsAg and deposited 
both in hepatic tissues (Nowoslawski et al., 1972) as well as in extrahepatic locations 
(see Section 1.1.4). 
The importance of antibody responses against HBcAg and I-I BeAg in the 
pathogenicity of liver injury during CH are less clear. However, seroconversion to 
anti-HBe seems to represent a good prognostic indicator and a marker of recovery 
(Hoofnagle, 1981 ), possibly as a result of antibody-mediated clearance of I-I Be-reacti ve 
hepatocytes (Schlicht et al. , 1991). It has been suggested that CDC mediated by anti-
HBc and/or anti-HBe and directed against hepatocytes which express the respective 
antigens may contribute to liver injury particularly in cases of severe CH (Michalak et 
al. , 1995). 
Antibody responses against HBV polymerase and X proteins are not cl inically 
monitored, however they may be reflective of HBY replication (Weimer et al., 1990). 
They are detectable at the highest levels in chronically infected patients while patients 
with AH and asymptomatic carriers may lack anti-HBx reactivities (Stemler et at. , 
1990). 
1.6.3 Cell-mediated immune responses 
Although our understanding of whether innate immune components contribute 
to hepadnaviral clearance is still poorly recognized, it is well known that a 
multispecific, polyclonal and vigorous T HI CD4+ T cell and CD8+ CTL responses are 
necessary for successful viral downregulation and recovery from hepatitis. CD4+ T 
cells exhibit strong proliferative reactivity against several HBV antigens, regardless of 
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the patients' MHC haplotype (Ferrari et al., 1991 ). In agreement with the findings 
implicating the importance ofiFNy and TNFa cytokines for controlling viral 
replication, the appearance of CD4+ T cell responses during AH are found to produce 
high levels ofT H 1 cytokines and, therefore, likely promote efficient activation of virus-
specific CTL (Penna et al., 1997). The importance of CD4+ T cell responses to the 
control of hepadnaviral infection is highlighted by the long-term persistence of HBY-
specific CD4+ T cells identifiable in PBMC derived from patients convalescent from 
AH type B (Rehermann et al.. 1995a). Since HBV DNA can be pers istently detected 
many years following recovery, when sensitive PCR combined with Southern blot 
hybridization analysis of the amplified viral DNA are used (Michalak et al., 1994). the 
peripheral HEY-specific CD4+ T cell pool is possibly maintained by low levels of 
replicating virus (Rehermann et al., 1996). 
Although CD4+ T cell responses are important mediators of hepadnaviral 
clearance, primarily via the production ofT H 1 cytokines, the functionality of virus-
specific CTLs is of critical importance since they recognize vi rally infected hepatocytes 
following TCR ligation with MHC class I molecules presenting viral epitopes (see 
Section I .4.2.2). A vigorous, polyclonal CTL response against multiple HBV epitopes 
can be identified during AH and, s imilarly to CD4+ T cell responses, the polyclonality 
and multispecificity persists for decades following serological recovery from AH 
(Rehermann eta!., I 996). Using the transgenic mouse model of HBV, it has been 
determined that CTLs may contribute to non-cytolytic control of hepadnaviral 
replication (Guidotti et al., I 996), while also contributing to hepatocyte destruction by 
both CD95L and perforin-dependent mechansisms (Nakamoto et al., 1997) . 
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In contrast to those CD4+ T cell responses observed during AH, the HBV-
specific CD4+ T cell responses in patients with CH are much weaker and more 
narrowly focused (Ferrari et al., 1990). Furthermore, these cell s do not efficiently 
produce IFNy (Schlaak et al., 1999). Similarly, the peripheral CTL response to HBV 
antigens is weak or undetectable (Rehermann et al., 1995b). Recent works indicate that 
the intrahepatic CTL response is not completely lacking, as previously thought. Usi ng 
MHC class I tetramers, which identify T cell reactivity based upon the combination of 
MHC and peptide recognition (reviewed in (Ogg and McMichael, 1998)), it has been 
shown thatCH type B is in fact associated with low, although evident intrahepatic CTL 
responsiveness (Maini et al., 2000). The reasons for this remain unclear, however 
CD8+ T cell impairment has also been observed in ca es of AH when viral load were 
high (Maini et al., 1999). In cases ofCH, liver injury is not due to virus-specific CTL 
but has been attributed to bystander recruitment and activation of non-virus-speci fie 
CD8+ T cells (Maini et al. , 2000). Specifically, the frequency of circulating, or liver-
infiltrating CD8+ T cells specific for the 18 - 27 peptide of HBcAg did not differ 
between chronically-infected patients displaying low or elevated serum concentrations 
of ALT, reflective of liver injury. Further, it was demonstrated that patients which 
exhibited severe hepatic infiltrations and increased levels of AL T displayed enhanced 
recruitment of CD8+ T cells which were not reactive to viral antigens, suggesting that 
non-specific CTL contributed to liver injury without control of viral replication (Main i 
et al. , 2000). 
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1.7 PURPOSE OF THE STUDY 
Recent evidence suggests that the liver is de facto an immune competent organ 
with distinct immunological functions. The role ofthe liver in host immunity is likely a 
consequence of interplay between hepatic parenchymal cells, including hepatocytes. 
sinusoidal endothelial cells and resident immune cells, and the immune cells trafficking 
through the liver. The unique hepatic microvascular structure, characterized by the 
absence of a basement membrane and highly fenestrated endothelium, faci I itates these 
cellular interactions. It has been shown that the liver sinusoidal epithelium and 
hepatocytes display an inherent capacity to initiate as well as to inhibit adaptive T cell 
responses. These unique properties may be crucial for promoting both local and 
systemic pathogen- pecific immunity and for maintaining peripheral tolerance again 
hepatotropic pathogens. 
The liver contains a disproportionably high number of innate immune effector 
cells, which are important initiators of specific immune responses. Their presence may 
contribute to the local pathogen containment, as well as to liver injury in infections 
caused by noncytopathic hepatotropic viru es. Experimental evidence provided by 
studies in the HBV transgenic mice implicates the potential involvement of innate 
immune cell in the non-cytopathic, IF y-mediated downregulation ofHBV 
replication. On the other hand, hepatocellular injury, which is a hallmark of iral 
hepatitis, has been attributed to response from both innate and adaptive immune cell 
subsets. Nonetheless, a contribution of the innate immune response to elimination of 
hepadnavirus and to activation of adaptive anti-viral immunity has not been thoroughly 
analyzed during progression of natural hepadnaviral infection, particularly in it early 
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phase which appears to be critical in determining the outcome of hepadnaviral 
hepatitis. 
Experimental infection of adult woodchucks with WHY repre ents the closest 
virological and immunopathogenic model ofhuman hepatiti B. This m del wa 
utilized in the current series of our studies. The objectives of these studies were: 
I. To investigate the mechanism(s) by which hepatocytes may directly contribute 
to local liver immune responses, hepatic tis ue injury or the downregulation of 
immune responses. Using primary freshly isolated hepatocyte as well as 
cultured hepatocytes and liver-derived hepatoma cell lines, to examine whether 
hepatocytes may mediate CD95L- or perforin-dependent cytotoxicity agai nst 
hetero logous cell targets. Also, to determine if pro-inflammatory and anti-viral 
cytokines, such as IF y or TNFa, may influence the cytotoxic potential of 
hepatocytes in vitro. 
2. To determine ifhepadnaviral infection influences the capacity ofhepatocytes to 
act as cytotoxic effector cells via CD95L- and/or perforin-dependent pathways. 
For this purpose, primary hepatocytes will be isolated from woodchucks with 
experimentally induced resolved AH or chronic WHY hepatiti , a well as from 
healthy animals as controls, and their cell killing potential will be evaluated in 
ex vivo cytotoxicity assays directed against heterologous CD95-sen itive or 
CD95-insensitive cell targets. Similar analyses, using cultured woodchuck 
hepatocytes stably transfected with complete WHY genome or individual 
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WHY genes, will be used to investigate whether hepadnavirus or its individual 
translation products may directly modulate hepatocyte cytotoxic ity. 
3. To determine early events occurring in the liver immediately after invasion with 
hepadnavirus and in the pre-acute phase of hepatitis. In particular, to examine 
whether experimental WHY infection activates intrahepatic innate immunity. 
In this regard, quantification ofviral genomes and their replicative 
intermediates, as well as analysis of expression of innate and adaptive immune 
cell markers, cytokines and cell cytotoxicity indicators in liver tissue samples 
serially collected as early as one hour post infection and throughout the course 
of acute WHY -induced hepatitis will be performed. 
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CHAPTER TWO: HEPATOCYTES AS CYTOTOXIC EFFECTOR CELLS 
CAN INDUCE CELL DEATH BY CD95 LIGAND-MEDIA TED PATHWAY 
This study has been published in Hepatology in June, 2006. 1'0/ume 43(6). pp. 123 1- 1240. 
2.0SUMMARY 
The liver plays an increasingly recognized role in the host' s immune responses. 
The direct contribution of hepatocytes as effector cells to local immunity, pathogen 
containment, and liver disease is not determined. The present in vitro tudy examined 
whether hepatocytes can eliminate other cells via CD95LICD95-mediated mechanism 
and whether this cytotoxic activity can be modulated by cytokines such as IF 'Y or 
TNFa. We have found that normal woodchuck and human hepatocytes, both cultured 
and primary freshly i alated, as well as human HepG2 cells, intrinsically tran cribe not 
only CD95 but also CD95L when examined by reverse transcription-polymerase chain 
reaction (RT-PCR) assays. The functional competence ofCD95L, which wa 
detectable in hepatocytes and HepG2 cells by Western blotting, wa confirmed in 
bioassays by induction ofapoptosis ofCD95-bearing P815 and L 102.9 cell targets 
and validated by inhibition of the cell killing with CD95 antagonistic antibody or with a 
general caspase inhibitor. Further, exposure of cultured hepatocytes to IF y or their 
stable transfection with IFNy eDNA or TNFa cO A increased hepatocyte 
CD95LICD95-mediated cell killing. In conclusion, our findings indicate that 
hepatocytes express both CD95L and CD95 and they can induce death of other ce lls by 
the CD95L-dependent mechanism. They also show that IFNy and, to a le er extent, 
TNFa can enhance hepatocyte CD95L-mediated cytotoxicity. This uggests that the 
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local cytokine environment may modulate hepatocyte contribution to the I iver 
immunity. 
2.1 INTRODUCTION 
The removal of antigens and aberrant cells from circulation is a physiological 
function of the liver, making this organ an important contributor to the first line of host 
immune defense. After birth, the liver is the site of production of immune competent 
cells, including NK, NKT and extrathymic T cells (Golden-Mason and O'Farrelly. 
2002), elimination of activated CTL (Belz et at., 1998; Kennedy et at. , 200 I; Mehal et 
at., 1999; Russell et at. , 1998), and synthesis of complement and acute phase proteins 
(Baumann et at. , 1993). The liver is considered to be an immunocompetent organ 
whose contributions towards induction of peripheral irnmunotolerance and surveillance 
against pathogens are increasingly recognized. The role of Kupffer cells and sinusoidal 
endothelial cells in clearance of antigens and cells has been well established (Mehal et 
at., 200 I; Srnedsrod et at., 1990). However, whether hepatocytes can directly eliminate 
cells either passing through, trapped or normally residing in hepatic parenchyma 
remains unknown. In this regard, the endowment of hepatocytes with ASG PR may not 
only facilitate removal of desialylated glycoproteins from plasma (Diao et a t., 2003; 
Stockert, 1995), but also provide a contact between hepatocyte and other cells through 
recognition oftheir surface proteins depleted ofterrninal sialic ac id residues. This may 
initiate a cascade of events leading to elimination of the cells contacted by hepatocytes. 
In the current study, we examined whether hepatocytes are equipped in the molecular 
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machinery to act as cytotoxic effectors and, if so, whether this activity can be modified 
by the local cytokine milieu . 
The cytotoxic cells can induce cell death through interaction of their membrane-
associated CD95L with CD95 receptor on cell target (ltoh et al. 1991 ; uda et al., 
1993) or by release of cytolytic proteins, perforin and granzyme 8 (Kagi et al.. 1994). 
CD95L-induced cell death is a main mechanism by which activated CTL eliminate 
targeted cells (Roth and Pircher, 2004). In this regard, it has been shown that IFNy can 
enhance the CTL CD95L-mediated cell killing (Roth and Pircher, 2004). The CD95L-
CD95 interaction also is crucial for removal of autoreactive T cells during thymic 
maturation (Kishimoto et al., 1998) and in homeostatic protraction ofT and 8 
lymphocytes (Brunner et al., 1995; Lam et al., 1997). It is evident that lymphoid cells 
can display both CD95L and CD95 and act depending upon circum tances either as 
cytotoxic effectors or as targets for the cytotoxic reactions. Furthermore, expression of 
CD95L is not restricted to activated T cells, NK and NK T cells (Osh imi et al., 1996; 
Russell and Ley, 2002), but is also evident in cells at the immune privi leged ites 
(Griffith et al., 1995). 
Considering normal liver ti ssue, hepatocytes were found to be CD95L 
nonreactive by immunohistochemical methods (Afford et al., 1999; Roskams et al., 
2000). However, the ligand expression was detected by immunostainings or in situ 
hybridization in hepatocytes in HCC (Roskams et al. , 2000), alcoholic hepati tis (Galle 
et al., 1995), liver allograft rejection (Afford et al., 1999), and Wilson's disea e (Strand 
et al., 1998). This may suggest that CD95L is in fact expressed in normal hepatocytes 
but at levels which are not detectable by conventional methods, while hepatocytes in 
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some pathological conditions carry the ligand at quantities more readily identifiable by 
the same approaches. .. 
In contrast to CD95L. it is well established that hepatocytes are CD95-bearing 
cells and their apoptosis can be swiftly induced by anti-CD95 antibody (Ogasawara et 
al. , 1993) or by binding of CD95L (Nakamoto et al., 1997). Therefore, it has been 
postulated that certain liver diseases or their distinctive morphological stages could be a 
consequence of interaction between a hepatocyte's CD95L and its cognate receptor in 
either a suicidal or fratricidal manner (Afford et al. , 1999; Galle et al., 1995; Roskams 
et al. , 2000; Strand et al., 1998). 
In the present work, we investigated whether normal cultured hepatocytes, 
primary hepatocytes and HepG2 cells, manifest a phenotype of cytotoxic effector cells 
and, if so, whether they can kill other cells via a CD95L-activated pathway. Although 
the presence and functionality of the cytotoxic machinery was investigated using 
primary hepatocytes obtained from healthy human liver, in the majority of experiments 
we used hepatocytes from healthy woodchucks known to be susceptible to WHY. 
These animals represent an excellent natural model of HBV infection (Michalak, 2000; 
Tennant et al., 2004). We utilized woodchuck hepatocytes as cytotoxic effectors to 
facilitate future investigations on their potential involvements in the li ver innate 
immunity and the development of different forms and outcomes of viral hepatitis. In 
addition, due to the critical role of intrahepatic IFNy and TNFa in the recovery or 
progression to chronic viral hepatitis (Hodgson and Michalak, 200 I; Wieland et al. , 
2004a), the effect ofthese cytokines on the hepatocyte-mediated cell killing was 
investigated. 
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2.2 MATERIALS AND METHODS 
2.2.1 Cell lines 
Woodchuck WCM-260 hepatocyte line was established from the liver of a 
healthy woodchuck, as reported (Diao et al., I 998; Lew and Michalak, 200 I) . The 
cells were maintained in Hepato-STIM culture medium (Becton Dickenson, Bedford, 
MA) and demonstrated stable growth, consistent morphology, and transcribed albumin 
and ASGPR when passaged weekly (Diao et al., I 998; Lew and Michalak, 200 I). 
Human HepG2 cells (ATCC HB-8065; American Type Culture Collection, Rockvi lle, 
MD), and murine mastocytoma P8 I 5 (ATCC TIB-64) and lymphoma LSI 02.9 cells 
(A TCC HB-97), both constitutively bearing CD95 (Ebata, 200 I; Hodgson, I 999), were 
cultured as reported (Diao et al., I 998; Hodgson et al., 1999; Lew and Michalak, 200 I). 
2.2.2 Preparation of hepatocytes and lymphoid cells 
Hepatocytes were isolated from livers of healthy woodchucks by two-step 
collagenase microperfusion (Churchill and Michalak, 2004). Preparations were at least 
98% pure by phase-contrast microscopy. PBMC were prepared from the same animals 
and from a healthy human by Ficoli-Hypaque gradient centrifugation (Pharmacia 
Biotech, Quebec, Canada) (Lew and Michalak, 200 I). Primary human hepatocytes 
were simi larly isolated from healthy portions of resected liver tissue and were 
subsequently cryopreserved and supplied by Dominion Pharmakine (Derio-Bizkaia, 
Spain). Animal experimental protocols were approved by the Institutional Presidents' 
Committee on Animal Bioethics and Care. 
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2.2.3 Treatment of hepatocytes with IFNy or TNFa. 
WCM-260 hepatocytes were treated with woodchuck IFNy (wiFNy) or TNFu 
(wTNFa) using two approaches. First, the cells were exposed to bioactive recombinant 
wiFNy or wTNFa (rwiFNy and rwTNFa, respectively) produced in the baculovirus 
expression system, as recently reported (Wang and Michalak, 2005). After 18-h 
exposure to 1 0-fold dilutions of the cytokines, cytotoxic activity of WCM-260 was 
measured (see below) and compared to naive hepatocytes or those exposed to culture 
supernatant from insect cells infected with wild-type baculovirus (Wang and Michalak, 
2005). In addition, mRNAs from WCM-260 hepatocytes treated with rwiFNy ( !50 
U/ml) or rwTNFa (35 U/ml) were analyzed (see below). Secondly, WCM-260 were 
stably transfected with the complete wiFNy or wTNFa eDNA (GenBank access ion 
number AF232728 for wiFNy (Michalak et at., 2000) and AF333967 for wTNFa 
(Hodgson and Michalak, 2001)) using pcDNA3.1 vector-based expression constructs 
(Invitrogen, Carlsbad, CA) and Lipofectamine 2000 (Invitrogen). Cells transfected 
with empty pcDNA3.1 were used as controls. Transcriptional activity ofwiFNy and 
wTNFa in WCM-260 hepatocytes was ascertained by RT-PCR using primers and 
conditions reported (Wang and Michalak, 2005). To verify biological activity of the 
cytokines expressed, WCM-260 hepatocytes exposed to or transfected with wiFNy or 
wTNFa eDNA were examined for MHC class I antigen display by flow cytometry 
(Wang and Michalak, 2005). 
2.2.4 RNA extraction and reverse transcription 
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Total R A was extracted from 2 x I 05 -I x I 06 cultured or primary woodchuck 
and human hepatocytes, HepG2 cells, woodchuck or human PBMC, and from 100 mg 
of normal woodchuck spleen using Trizol reagent (Invitrogen). RNA (2 ~tg) was 
reverse transcribed to eDNA in a 20-, .. d reaction volume with 200 U Moloney murine 
leukemia virus reverse transcriptase (Invitrogen), as described before (Coffin and 
Michalak, I 999). 
2.2.5 Cloning of woodchuck gene sequences 
For cloning of woodchuck CD95L and CD95, cD A transcribed from 
woodchuck spleen or PBMC R A was amplified by PCR using degenerate primer 
deduced through interspecies comparison of sequences available in GenBank. PCR 
amplicons were cloned into the dual promoter vector PCRII using the TOPO TA 
cloning system (Invitrogen) and sequenced. Woodchuck-specific primers spanning 
introns were designed, the gene fragments amplified, cloned, their sequence determined 
and submitted to GenBank (accession numbers AF 152368 and A Y993960 for 
woodchuck CD95L and CD95, respectively). 
2.2.6 RT-PCR and Southern blot hybridization 
Transcription ofCD95L and CD95 genes in test cD A samples wa a e ed 
by PCR. Thus, the CD95L 508-base pair (bp) fragment was amplified with sense 
primer 5'-CAGCTCTICCACCTGCAGAAGG and antisense primer 5'-
AGA TTCCTCAAAA TTGA TCAGAGAGAG during 32 cycles, each cycle at 95 °C for 
15 sec, 55 °C for 30 sec, and 72 °C for 60 sec. Detection of the CD95 500-bp fragment 
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was facilitated with sense primer 5'-GATGGAGGGCATGGTTTAGAAGTG and 
antisense primer 5'-AGCAGCTGGAGTTTCTGCTCAGC during 34 cycles. each cycle 
at 95 °C for 15 sec, 60 °C for 30 sec, and 72 °C for 60 sec. Woodchuck p-actin was 
amplified as a loading control (Hodgson and Michalak, 2001). Specificity ofthe PCR 
products was routinely confirmed by Southern blotting with appropriate probes and 
autoradiography (Hodgson and Michalak, 200 I ; Michalak et al., 1999). 
2.2.7 Real-time RT-PCR 
To quantify expression ofCD95L, CD95 and (3-actin, real-time RT-PCR was 
established using the Lightcycler Faststart Master SYBR I kit (Roche Diagnostics, 
Laval, Quebec, Canada) and the Roche LightCycler (Roche Diagnostics). React ions 
were performed in 20-~1 volumes, each containing 2 111 of eDNA derived from 
approximately 50 ng RNA using the following primer pairs: sense primer 5'-
CCATTTAACAGGTAAGCCC and antisense primer 5'-TCATCATCTTGCCCTCC 
for CD95L, sense primer 5'-GTGCACCACGTGTGAACA TOGA AT and antisense 
primer 5'-T AA TCGGGAGTAGCAGTAGCAGGA for CD95, and primers 5'-
CAACCGTGAGAAGA TGACC and 5'-ATCTCCTGCTCGAAGTCC for p-actin. 
2.2.8 CD95L detection by Western blotting 
Cell suspensions were treated with ice cold RIPA buffer (1% NP-40, 0.5% 
DOC, 0.1% SDS, 150 mM NaCI in 50 mM Tris, pH 8.0) and cellular debris removed 
by centrifugation. Lysates were separated by SDS-PAGE at I 0-20 ~tg protein/ lane and 
then blotted onto a nitrocellulose membrane (Amersham Biosciences, Piscataway, NJ) 
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by semi-dry transfer using the Bio-Rad SD cell system (Bio-Rad, Mississauga, Ontario. 
Canada) (Michalak et at. , 2000). As positive controls, freshly isolated human and 
woodchuck PBMC were examined at 20 11g protein/lane. The blots were blocked with 
5% skim milk in Tris-buffered saline, pH 7.4, overnight at 4 °C. Both transmembrane 
(38 kDa) and soluble (28 kDa) isoforms ofCD95L were detected using rabbit anti-
murine CD95L IgG (Santa Cruz Biotech, Santa Cruz, CA) followed by HRP-
conjugated goat anti-rabbit IgG F(ab'h antibodies (Jackson ImmunoResearch, West 
Grove, PA). The signals were visualized using an ECL detection kit (Sigma, Oakville, 
Ontario, Canada). 
2.2.9 Preparation of target cells for cytotoxicity assays 
P815 and LSI 02.9 cells were subcultured to a density of 5 x I 05 cells/ml and 
labeled with 50 ~tCi of 3H-adenine (Perkin Elmer, Wellesley, MA) for 18 h prior to the 
JAM cytotoxicity assay. The cells were washed 3 times in HBSS (Invitrogen), re-
suspended in RPMI medium34 at I xI 05 cells/ml, and immediately used. 
2.9.10 JAM cytotoxicity (DNA fragmentation) assay 
WCM-260 hepatocytes, HepG2 cells or WCM- 260 transfected with w!NF-y or 
wTNF-a eDNA were grown to confluence (- 6 x 104 cells/well) in 96-well flat-bottom 
cell culture plates. 293 human embryonic kidney (293HEK; ATCC reference number 
CRL-1573) cells were utilized as effector cells as a noncytolytic negative control (data 
not shown). In some experiments, WCM-260 were treated with rwiFNy or rwTNFa at 
- 95% confluence for 18 h prior to the assay. In the case of primary hepatocytes, the 
cells were aliquoted at 6 x I 04/well in 200-111 volumes. 3H-adenine-labeled P81 5 or 
70 
LSI 02.9 cells were added at 20 x I 03, I 0 x I 03, 5 x I 03 and, occasionally, at 40 x I 03 
cells in quadruplicate to experimental wells yielding final effector:target (E :T) ratios of 
6: I, 3: I, 1.5: I and 12: I, respectively. Plates were centrifuged for 5 min at 45 x g and 
incubated at 37 °C in 5% C02 for 18 h. Well contents were harvested onto glass fibre 
mats (Perkin Elmer, Wellesley, MA) u ing a 96-well harvester (Tomtec, Hamden, CT). 
Counts per minute (cpm) were measured using a Top I 0 beta counter (Becton 
Dickinson, San Diego, CA) and percent lysis was determined by applying the formula: 
percent specific lysis = (control cpm- experimental cpm)/control cpm x I 00, where 
control cpm for each target cell type were obtained in the absence of effector cells. 
Freshly isolated woodchuck PBMC were used in parallel experiments at E:T ratios of 
50: I, 25: I and 12.5: I, as described before (Hodgson et al., 1999) (data not shown). 
Specificity ofCD95L-mediated lysis of P815 cells was confirmed u ing an antagonistic 
anti-CD95 monoclonal antibody (mAb) (Jo2; Becton Dickinson), as described 
(Hodgson et al., 1999). In the case of L I 02.9 cells, caspase-dependent initiation of 
apoptosis wa blocked by pre-treatment of the cell with the pan-ca pa e inhibitor z-
VAD-fmk (Biomol, Plymouth, PA) at 150 ~~M for 4 h. 
2.9.11 Statistical analyses 
Results were analyzed by unpaired Student's t test with Welch 's correction 
using GraphPad Prism software (GraphPad oftware Inc., San Diego, CA). 
Differences between experimental conditions were considered to be significant when 
two sided P values were less than 0.05. 
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2.3 RESULTS 
2.3.1 Hepatocytes constitutively transcribe CD95L 
Initial experiments were performed using a non-quantitative RT-PCR to 
determine whether hepatocytes express genes encoding for the CD95 Land its receptor. 
As shown in Figure 2.1 A, CD95L mRNA was without difficulty detected in human and 
woodchuck lymphoid cells, as well as in HepG2 cells and in woodchuck WCM-260 
hepatocytes. Importantly, pure preparations of isolated woodchuck and human 
hepatocytes also displayed CD95L mRNA. In addition, transcription ofCD95 mRNA 
was evident in woodchuck PBMC and hepatocytes, although CD95 mRNA was not 
detected in human PBMC and HepG2 cells due to the woodchuck-restricted specificity 
of the CD95 PCR primers used (Fig. 2.1 A). 
When expression ofCD95L was quantified by real-time RT-PCR in samples of 
whole liver tissue, in hepatocytes isolated from these livers, and in autologous PBMC, 
no statistically significant differences in the mean levels ofCD95L mRNA were found 
(Fig. 2.1 B). Similarly, the mean CD95 mRNA levels were not statistically different 
between the liver, primary hepatocytes and peripheral lymphoid cells (Fig. 2.1 B). A 
possibility that primary hepatocytes might be contaminated with lymphoid cel ls was 
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excluded based on the absence ofCD3 eDNA signals (data not shown), as analyzed by 
RT-PCR using conditions previously reported (Hodgson and Michalak, 2001 ). 
2.3.2 Hepatocytes display CD95L protein 
To determine whether CD95L mRNA tran cription was accompanied by 
CD95L protein, hepatocyte lysates were probed with anti-CD95L ant ibody by Western 
blotting. Fig. 2.1 C shows that WCM-260 hepatocytes and HepG2 cells, as well as 
hepatocytes isolated from 6 different woodchucks, revealed the 38-kDa membrane-
bound isoform ofCD95L, which was also evident in control woodchuck and human 
PBMC. In addition, WCM-260 exhibited the 28-kDa isoform representing pre-formed 
soluble CD95L, which was also detected in woodchuck P8MC (Fig. 2.1 ). 
Densitometry analysis ofthe 38-kDa bands suggested that the protein occurred in 
WCM-260 and HepG2 cells at about 9-fold and 2- fold greater levels than in 
woodchuck and human P8MC, respectively. Primary hepatocytes contained 
approximately twice the protein of PBMC i olated from the same woodchucks when 
adjusted to the same total protein concentration (Fig. 2. 1 C and data not hown). 
2.3.3 Hepatocyte CD95L-mediated cytotoxicity 
Hepatocyte cytotoxicity was evaluated using a JAM DNA fragmentation assay 
which employed constant numbers ofhepatocytes as effectors, and increasing numbers 
of CD95-bearing P815 or LSI 02.9 cells as targets. As shown in Figure 2.2 and 
2.28 , WCM-260 hepatocytes killed both cell types in a manner dependent on the target 
numbers. The killing was significantly reduced (P < 0.05 or P < 0.00 1) after 
pretreatment of P815 cells with an antagonistic CD95-blocking antibody, Jo2 (F ig. 
2.2A), or when LSI 02.9 cell death was measured in the presence ofz-VAD-fmk (F ig. 
2.28). HepG2 cells also killed P81 5 and L I 02.9 targets, although a tati tically 
significant inhibition by Jo2 mAb or z-VAD-fmk was usually seen at lower numbers of 
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Fig 2.2. Hepatocyte killing of P815 and L 102.9 cell targets mediated by CD95 L. 
WCM-260 hepatocytes (A and B), HepG2 cells (C and D) and primary woodchuck (E) or 
human (F) hepatocytes were used as effectors against CD95-bearing P815 (A, C, E and 
F) or LS 102.9 (B and D) cells in the JAM DNA fragmentation assay. Jo2 mAb was used 
to block CD95L-dependent killing ofP815 cells (A, C, E and F), while lysis of LSI 02 .9 
cells was inhibited with pancaspase z-V AD-fink inhibitor (B and D). Data bars shown in 
A to Dare mean values ± SEM from three separate experiments with 3-6 experimental 
wells per condition tested. ForE, hepatocytes isolated from 3 healthy woodchucks were 
used as effector cells, while F demonstrates target cell killing mediated by primary 
human hepatocytes. Results are shown as mean values± SEM, with each experiment 
having been performed with 4 - 8 experimental wells per each E:T ratio. Data bars 
marked with** are significant at P < 0.005 and with* at P < 0.05 when compared with 
the cells not treated with Jo2 mAb or z-V AD-frnk inhibitor. P value for data bars marked 
with + is 0.07. 
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targets (Figs. 2.2C and 2.20). Primary hepatocytes isolated from healthy woodchucks 
(Fig. 2.2E) and those derived from healthy human liver (Fig. 2.2F) also eliminated 
CD95-sensitive P815 cells. Inhibition of the 095 ligand-receptor interaction by Jo2 
mAb markedly (P = 0.07) or significantly (P < 0.005 and P < 0.05) reduced the level of 
P815 cell killing. 
2.3.4 IFNy and TNFa upregulate CD95L transcription in hepatocytes 
In the first step, to learn whether exposure to IFNy or TN Fa would induce a 
measurable biological effect in hepatocytes, WCM-260 cells were examined for 
expression of class I MHC after treatment with rwiF y ( 150 U/ml) or rwT Fa (35 
U/ml) or after transfection with the cytokine eDNA. Thus, clas I MH display was 
increased by 14.2-fold in hepatocytes exposed to rwlFNy (Fig. 2.3A) and by 12.9.-fold 
in those transfected with wiFNy eDNA (Fig. 2.38). Exogenous rwTNFa increa ed the 
expression by 2.4-fold (Fig. 2.3A), whereas tran fection wTNFa cO A induced a 2.8-
fold increase (Fig. 2.3B). Therefore, both treatment approaches with IFNy or T Fa 
enhanced expression of a functionally important molecule on hepatocytes. 
The effect ofrwlFNy or rwTNFa on CD95L mRNA in hepatocytes wa 
quantified by real-time RT-PCR. CD95L mRNA was upregulated (P < 0.00 I) by 
rwiFNy, but not by rwTNFa (Fig. 2.3C). CD95L mRNA was also meaningfully (P < 
0.00 I) elevated in hepatocytes transfected with w!F y or wT Fa cO A, when 
compared to controls transfected with empty vector (Fig. 2.30) . These data clearly 
showed that IFNy is a potent inducer of CD95L transcription in hepatocyte and 
suggested that TNFa may exert a similar effect under certain condition . 
2.3.5 IFNy but not TNFa enhances hepatocyte CD95L-mediated cytotoxicity 
As shown in Figure 2.4, exposure of WCM-260 to increasing concentrations of 
rwlFNy enhanced hepatocyte cytotoxicity towards P815 and LSI 02.9 targets. Thus, 
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Fig 2.3. Evaluation of the effects ofiFN-y and TNF-a on class I MH antigen display 
and CD95L gene expression in hepatocytes. The class I MHC heavy chain detection by 
flow cytometry in WCM-260 hepatocytes (A) exposed to or (8) stably transfected with 
wiFN-y or wTNF-a and in control cells. For A, the cells were exposed to 150 U/ml of 
rwiFN-y, 35 U/ml ofrwTNF-a or to a supernatant from insect cells infected with wild-
type baculoviral vector (wt super) for 18 h prior to staining with 81 b.B9 mAb. Intact 
WCM-260 cells not exposed to any of the above and stained with 8 I b.B9 mAb were 
used as an additional control. ForB, WCM-260 hepatocytes were transfected with 
wiFN-y (pcDNA3.1 wiFN-y), wTNF-a (pcDNA3.1 wTNF-a) or with empty cDNA3 .1 
vector and probed with Blb.B9 mAb. Non-transfected WCM-260 were used as an 
additional control. For C and D, CD95L mRNA was quantified by real time RT-PCR in 
WCM-260 hepatocytes exposed to rwiFN-y or rwTNF-a. or transfected with these 
cytokine genes, respectively. Data are represented as mean percentage expression values 
± SEM from 3 separate experiments after normalization to woodchuck ~-actin and by 
taking expression of a given gene in unstimulated hepatocytes (C) or in hepatocytes 
transfected with empty cDNA3.1 vector (D) as I 00%. Data bars marked with ** are 
significant at P < 0.00 I relative to respective contro ls. 
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Fig 2.4. Exposure to IFN-y enhances hepatocyte CD95L-mediated cell killing. WCM-
260 hepatocytes were stimulated with 15, 150 or 1500 U/ml rwiFN-y and used as 
effectors at 6 x l 04 cells/assay against indicated numbers of P815 (A) or LSI 02.9 (B) 
targets and their cytotoxicity measured by JAM assay. Data represent mean values ± 
SEM obtained from two separate experiments, each performed in duplicate. Data bars 
marked with** are significant at P < 0.01 and those with* at P < 0.05 when compared 
with cells not exposed to the cytokine (unstimulated). Preincubation with Jo2 mAb 
reduced killing ofP815 cells. Data bars marked with + are significant at P < 0.05 when 
compared to target cells not treated with the antibody. 
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rwiFNy significantly (P < 0.00 I) increased hepatocyte killing of P815 (Fig. 2.4A) and 
LSI 02.9 (Fig. 2.4B) under the majority of the conditions tested, while rwTNFa had no 
measurable effect (data not shown). It is important to indicate that an MTT assay 
showed that neither rwiFNy nor rwTNFa affected the viability of hepatocyte , P81 5 or 
LSI 02.9 cells at the concentrations used (data not shown), excluding the po ib ility that 
the cytokines may affect cell survival during the a say. Furthermore, P815 ce ll ly is 
was inhibited by pretreatment with Jo2 mAb (Fig. 2.4A), which was consi tent with 
previous observations (see Figure 2.2). 
2.3.6 Transfection with IFNy or TNFa eDNA enhances hepatocyte D95L-
mediated cell killing 
As illustrated in Figure 2.5, transfection of WCM-260 hepatocytes with eDNA 
of either wiFNy or wTNFa enhanced CD95L-mediated killing of P815 and L I 02.9 
targets. Thus, transfection with wiFNy eDNA significantly (P < 0.0 I) increased 
elimination of P815 cells, which was consistent with the CD95L mR A upregulat ion 
illustrated in Fig. 2.3C. 
This killing wa blocked by 59-85% (P < 0.05) after pretreatment of P815 cell with 
Jo2 mAb (Fig. 2.5A). Elimination ofLSI02.9 targets was also significantly enhanced 
(P < 0.05 or P < 0.01) when compared to control cells trans fee ted with the empty 
cO A3 .1 vector. AI o, transfection of WCM-260 hepatocytes with wTN Fa cD A 
increased (P < 0.05 or P < 0.0 I) their cytotoxic activity towards P815 and L I 02.9 
targets (Fig. 2.5A and Fig. 2.5B, respectively), which was consistent with increased 
CD95L mRNA levels seen in Fig. 2.30. 
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Fig 2.5. Transfection with IFN-y or TNF-a eDNA upregulates hepatocyte C01)5L-
mediated cytotoxicity. WCM-260 hepatocytes stably transfected with wlFN-y 
(pcDNA3.1 wiFNy) or wTNF-a (pcDNA3.1 wTNFa) were used as effectors at 6 x I 04 
cells/assay against indicated numbers of P815 (A) or LSI 02.9 (B) target cells in the JAM 
assay. Preincubation of P815 cells with Jo2 mAb significantly decreased their killing by 
hepatocytes. Data bars marked with** are significant at P < 0.0 I and with * at P < 0.05 
when compared with WCM-260 transfected with empty cDNA3.1 vector (pcDNA3 .1 ). 
Data bars marked with + are significant at P < 0.05 when compared to P815 cells not 
treated with Jo2 mAb. 
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2.4 DISCUSSION 
Hepatocyte in normal livers have been considered to be CD95L nonreacti ve 
and their ability to induce cell death had not been investigated. In thi tudy, we 
documented by tandard RT-PCR that both cultured hepatocytes and primary 
hepatocytes from livers not compromised by a disease process constitutively tran cribe 
genes encoding molecules of the CD95L/CD95 pathway. To assess whether CD95L 
was displayed at functionally adequate levels in hepatocytes, previously e tabli hed 
cytotoxic assays with heterologous cells as targets were adopted. The result showed 
that hepatocytes not only transcribe CD95L mRNA and synthesize the ligand, but can 
efficiently eliminate other cells via a CD95L-mediated mechanism. Furthermore, the 
CD95L-dependent cell killing was enhanced when hepatocytes were exposed to IF -y 
or transfected with IFN-y or TN F-a eDNA, suggesting that hepatocyte cytotoxicity in 
vivo can be modulated by these cytokines. 
Expression ofthe genes encoding effector molecules of the CD95L/ 095 
pathway was until now an attribute of activated T cells, K and K T ce ll (Oshimi et 
a!., 1996; Russell and Ley, 2002). However, our analysis showed that the levels of 
CD95L and CD95 transcription in hepatocytes and lymphoid cells were not 
meaningfully different (Fig 2.1 ). However, both cultured and fresh ly iso lated 
hepatocytes displayed greater amounts ofCD95L protein than lymphoid cell , 
suggesting that CD95L eDNA could be tran lated more efficiently in hepatocyte . 
Previous attempts to identify CD95L protein in normal hepatocytes were not 
successful, however, the ligand has been detected in hepatocytes in some liver 
disorder and during allograft rejection (Afford et at., 1999; Galle et al. , 1995 ; 
86 
Roskams et al., 2000; Strand et al., 1998), and in HepG2 cells (Strand et al.. 1998). In 
our study, a membrane-bound CD95L 38-kDa protein was evident in woodchuck 
cu ltured and primary hepatocytes, and in HepG2 cells. In addition, a 28-kDa protein 
representing the soluble form of the ligand was seen in woodchuck W M-260 
hepatocytes and PBMC. Our success in identifying CD95L could be due to immediate 
isolation and preservation of RNA and proteins, using detection assays of superior 
sensitivity, and a remote possibility that woodchuck hepatocytes may carry greater 
amounts of CD95L transcripts and protein than hepatocytes in the pecie previously 
investigated. 
Hepatocyte ability to eliminate cell targets via the CD95LICD95 pathway wa 
examined by the JAM cytotoxicity assay (Ayres et al., 2003; Matzinger, 1991 ). The 
validity of the finding that woodchuck and human hepatocytes, as well as HepG2 cells, 
el iminated CD95-bearing cells was ascertained using P815 pre-incubated with Jo2 
mAb. This antibody is uniquely noncytolytic to P815 cells, and block recognition of 
cell surface CD95 by CD95L (Hodgson et al., 1999; Kuwano and Arai, 1996). 
Additional evidence was provided using LSI 02.9 cells treated with z-V AD-fmk, an 
inhibitor of caspase-dependent initiation of apoptosis (Sarin et al. , 1998). Thus, 
utilization of two different cell targets and two inhibitors blocking either CD95 or the 
intracellular cascade initiated by the CD95 ligand-receptor interaction clearly 
demonstrated ability ofhepatocytes to induce cel l death via the CD95L-CD95 
mechanism. This hepatocyte property, wh ich is apparent in both healthy woodchuck 
and human primary hepatocytes, has not been documented before. 
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Constitutive expression of both CD95L and CD95 in hepatocytes cou ld be 
considered to be a paradox, however, this finding follows the blueprint seen in ditfcrent 
lymphoid cell subtypes in which both molecules are displayed (Suzuki and Fink. 2000). 
Although at this stage we cannot dissect whether a single hepatocyte expres es both of 
the molecules simultaneously, it is possible that the display of functional CD95L 
depends, like in lymphoid cells, on cell activation (Roth and Pircher, 2004; uzuki and 
Fink, 2000). Since CD95L protein in lymphoid cells is sequestered intracellularly and 
directed into secretory vesicles (Kojima et al., 2002), this may prevent or postpone the 
ligand exposure on the effector surface and initiation of cell death via CD95L-CD95 
interaction. The same could be true for hepatocytes. 
Because of our interest in the mechanisms of liver injury in viral hepatitis and 
the fact that early and strong intrahepatic IFNy and TNFa response is paramount to the 
resolution ofhepadnaviral infection (Hodgson and Michalak, 200 I ; Wieland et al. , 
2004a), we wanted to determine whether IFNy and TNFa may influence hepatocyte 
CD95L-mediated cytotoxicity. As we uncovered, wlFNy and, under certain cond itions, 
wTNFa, augment hepatocyte CD95L-dependent cell killing. Since IFNy has been 
known to enhance CD95L expression in both lymphoid and nonlymphoid cells (Moers 
et al. , 1999; Roth and Pircher, 2004), the increases in hepatocyte CD95 L mRNA and 
CD95L-dependent cell killing upon exposure to wiFNy were consistent with the 
predicted outcomes. In addition, these data provided an independent confirmation that 
CD95L synthesized by hepatocytes is functionally competent and its expre ion can be 
regulated by extracellular factors. Further, CD95L expression can also be enhanced by 
TNF-a through activation of F-KB (Gaur and Aggarwal, 2003), which subsequently 
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binds to the CD95L promoter (Matsui et al., 1998). Although CD95L mR !\ 
upregulation and an increase in CD95L-depcndent cell killing were observed alkr 
transfection ofhepatocytes with TNFa eDNA, exogenous TNFa did not produce such 
an effect. The reason behind this is not clear. The data on class I MHC expression 
suggested that TN Fa was recognized and activated downstream signalling in 
hepatocytes under both treatment conditions. Nonetheless, considering the results as a 
whole, IFNy was consistently more potent than TNFa in enhancing hepatocyte CD95L-
mediated cell killing. 
The identification in this study of the constitutive expression of functionally 
competent CD95L in hepatocytes and demonstration that IFNy and, to some degree, 
TNFa can modulate hepatocyte CD95L-dependent cell killing provide new insights 
into the intrinsic properties of liver parenchyma. Our results imply that hepatocytes are 
not just passive objects of actions exerted by other cells, but they can be active players 
determining fate of the cells brought in contact with their surface. Their cytotoxic 
activity may contribute to physiological and post-hepatectomic regeneration of liver 
parenchyma (Desbarats and Newell, 2000), removal of aberrant hepatocytes (Gal le et 
al., 1995; Strand et al. , 1998), and elimination of activated T lymphocytes (Kennedy et 
al., 200 I; Mehal et al., 200 I), including those specific for viral pathogens. It also is 
conceivable that hepatocyte cytotoxic activity, which is not readily apparent in normal 
liver, but can be heightened during int1ammatory processes, may contribute to the 
pathogenesis of different forms of a given liver disease, including viral hepat itis which 
is normally accompanied by upregulated intrahepatic expression of I FNy and TN Fa 
(Hodgson and Michalak, 200 I). These issues will require further examination. 
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Overall , the resul ts of our study imply that investigations on immunological processe 
engaging the liver need to consider hepatocytes as active contributors. 
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CHAPTER THREE: HEPATOCYTES CAN INDUCE DEATH OF 
CONTACTED CELLS VIA PERFORIN-DEPENDENT MECHANISM 
Tit is stui~l' It as bee11 accepted for puhlicmio11 i11 lfepatology . .Jamtm)' :!008 ( /11 pres.1) 
3.0 SUMMARY 
The liver displays unique immunological properties including the ability to 
remove aberrant cells and pathogens and to induce peripheral immunotolerance. We 
have previously demonstrated that hepatocytes can cause cell death by a CD95L-
mediated mechanism. Here, we provide evidence that hepatocytes can kill other cel ls 
via a perforin-dependent pathway. Using cultured woodchuck hepatocytes and human 
liver cells, as well as freshly isolated woodchuck, mouse and human hepatocytes, we 
show that hepatocyte-mediated death ofCD95-deficient target cell requires 
microtubule polymerization, a feature of the granule exocytosis-mediated cytotoxicity. 
Neutralizing anti-perforin antibodies and short hairpin RNA (shRNA) directed again t 
perforin mRNA confirmed the involvement ofperforin in hepatocyte-mediated ce ll 
killing. In conclusion, this study shows that hepatocytes express biologically 
competent perforin capable of killing susceptible cells and emphasizes the role of 
hepatocytes as cytotoxic effectors. This also is the first demonstration of perforin in a 
non-lymphoid cell type. 
3.1 INTRODUCTION 
It is now acknowledged that the liver is an immunocompetent organ capable of 
performing multiple immunological functions, including removal of aberrant cells, 
containment of pathogen and maintenance of peripheral immune tolerance (Cri src. 
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2003; Racanelli and Rehcrmann, 2006). The liver also plays a central role in 
elimination of activated T lymphocytes. In this regard, the intrahepatic accumulation 
of activated T cells has been observed after their systemic activation with anti-CD3 
antibodies, in extrahepatic viral infections, and after antigen-specific stimulation of 
transgenic T cell receptors (Crispe, 2003). Although a mechanism underlyi ng T cell 
retention is unknown, it is presumed that inusoidal endothelial ce lls and macrophages 
are involved in this process (Park et al., 2002). However, the structure of hepatic 
vasculature also allows for direct contact between lymphocytes and hepatocytes which 
underlie the sinusoidal lining (Warren et al. , 2006). It is therefore feasible that 
hepatocytes also recognize and act on activated T cells, as well as on other circulating 
cells. This hepatocyte-lymphocyte interaction could be facilitated by the binding of the 
8220 (CD45RO) epitope, which is displayed on activated lymphocytes (Huang et al., 
1994), to the essentially hepatocyte-restricted ASGPR (Ashwell and Harford, 1982). 
We have reported that normal primary and cultured hepatocytes con ti tutively 
express CD95L and are capable of inducing death ofCD95-bearing cells (Guy et al., 
2006). Cytokines such as IFNy and TNFa, enhance expression ofCD95L in 
hepatocytes and augment CD95L-dependent cell killing in vitro (Guy et al., 2006). In 
addition, expression of functional CD95L can be induced on hepatocytes by 
transfection with HCV core protein (Ruggieri et al., 2003) and there i an increa ed 
apoptosis of intrahepatic T cells in H V transgenic mice (!ken et al., 2006). Taken 
together, the cytotoxicity ofhepatocytes can be modified by a viral in fect ion and/or an 
inflammatory process engaging the liver. Neverthele s, a blockage of either CD95 on 
cells targeted by hepatocytes (G uy et al.. 2006) or CD95L on hepatocyte (I ken et al.. 
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2006) does not completely abrogate hepatocyte-mediated cytolysis. implying that 
hepatocytes may also cause cell death by a CD95L-independcnt mcchani~m. 
The granule exocytosis pathway has been recognized as a key element 
controlling the initial expansion ofCD8+ CTL and the homeostatic contraction of 
activated CTL (de Saint Basile and Fischer, 2003), and is required for efficient lysis of 
virally infected or malignant cells (Trapani and Smyth, 2002). Its function is attributed 
to polarized release of the cytolytic protein perforin and associated serine protcascs 
which culminate in perforin-mediated membrane remodeling, mannose-6-phosphatc 
receptor-mediated uptake of granzymes, and perforin-facilitated disruption of 
endosomal trafficking (Trapani and Smyth, 2002). 
Because recent findings indicate that hepatocytes can induce cell death and that 
the CD95L-dependent mechanism may not be the only one involved in this procc s 
(Guy et al., 2006; Iken et al., 2006), we examined whether hepatocytes express perforin 
and can utilize the granule exocytosis pathway to kill other cells. Although we 
investigated primary mouse and human hepatocytes, the majority of the experiments 
were performed using hepatocytes from woodchucks known to be susceptible to WHY. 
The woodchuck-WHY system is an excellent natural model ofhuman HBY infection in 
which the contribution ofhepatocytes to liver immunity and di ease can be investigated 
(Hodgson and Michalak, 200 I; Michalak, 2000). Demonstration that hepatocytes can 
initiate cell death by both CD95L- and perforin-dependent mechanisms and that these 
activities can be differentially modulated by the cytokine milieu further support the 
notion that hepatocytes may play diverse effector roles in both physiological and 
immunopathological processes occurring in the liver. 
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3.2 MATERIALS AND MEHTODS 
3.2.1 Cell lines 
Human liver HepG2 cells (ATCC HB-8065 ; American Type Culture Collection. 
Rockville, MD), CD95-bearing murine mastocytoma P815 cells (ATCC TIB-64). and 
CD95-deficicnt human chronic myelogenous leukemic K562 cells (ATCC CCL-243) 
were cultured as described (Guy et al.. 2006; Hodgson et al., 1999). Jurkat cell 
(ATCC Tl B-152) and CTLL-2 cells (ATCC TI B-214) were maintained according to 
ATCC guidelines. Woodchuck WCM-260 hepatocyte cell line was established fi·om 
the liver of a healthy woodchuck and were maintained as reported (Churchi ll and 
Michalak, 2004; Diao et al., 1998). 
3.2.2 Primary hepatocytes and lymphoid cells 
Hepatocytes were isolated from livers of outbred CDI mice (Charles Ri ver 
Laboratories, Wilmington, MA), rats and healthy woodchucks by two-step collagenase 
microperfusion (Churchill and Michalak, 2004). Preparations were at least 98% pure 
by phase-contrast microscopy. T and NKT ce ll contamination was excluded by RT-
PCR for CD3 mRNA (Guy eta!., 2006; Hodgson and Michalak, 200 I). Presence of 
NK and NKT cells was excluded by negative RT-PCR for NKp46 mRNA using sense 
primer 5' -TTGCCACCTAGTGACAG and antisense primer 5'-
CACCAGGAGCATCACC. PBMC were prepared by Ficoii-Hypaque gradient 
centrifugation (Pharmacia Biotech, Quebec, Canada) (Hodgson et al., 1999). Pure 
primary human hepatocytes (DPK-HCWP-H) isolated by micropcrfusion of a healthy 
portion of the liver of a 58-year old male donor were supplied by Domin ion 
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Pharmakine (Derio-Bizkaia, Spain). Animal experimental protocols were approved by 
the Institutional Presidents' Committee on Animal Bioethics and Care. 
3.2.3 Hepatocyte treatments with recombinant IFNy or TNFa 
WCM260 hepatocytes were exposed to rwiFNy or rwTNFa generated in the 
baculovirus expression system (Wang and Michalak, 2005). Cel ls were treated for 18 h 
with 150 U/ml of rwiFNy or 35 U/ml of rwTNFa or were left untreated. 
3.2.4 RNA extraction and reverse transcription 
Total RNA was extracted from cultured or primary hepatocytes, HepG2 cells 
and PBMC using Trizol reagent (Invitrogen, Carlsbad, CA). DNA contamination was 
removed using a DNase digestion kit (Sigma-Aldrich, Oakville, Ontario, Canada). 
RNA (2 jlg) was reverse transcribed to eDNA as described (Guy et al., 2006) . 
3.2.5 Cloning of woodchuck gene sequences 
Cloning of woodchuck perforin, granzyme B and NKp46 gene fragments was 
performed by RT-PCR utilizing degenerate oligonucleotide primers using a strategy as 
previously described (Hodgson and Michalak, 200 I) . Woodchuck perforin, granzyme 
Band NKp46 sequences were submitted to the GenBank under accession numbers 
AF298158, A Y993961 and EF5262 16, respectively. 
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3.2.6 RT-PCR and Southern blot analysis 
A 302-bp fragment ofperforin sequence wa amplified with sen e primer 5'-
G A TC AACAA TGJ\CTGGCGGG and antisense primer 5'-TGJ\AGTGGGTGCC 
GTAGTTGTGG. The granzyme B 204-bp fragment was detected using sense primer 
5'-CCCAGACTATGATGCT and antisense primer 5'-CAACTfT CCTCCTGC. 
Woodchuck P-actin eDNA was amplified in parallel as a load ing control (Guy ct al.. 
2006). Specificity of the PCR products was confirmed by Southern blot hybridization 
(Hodgson and Michalak, 200 I). 
3.2.7 Real-time RT-PCR 
Real time RT-PCR was established using the LightCycler Faststart Master 
SYBR I kit (Roche Diagnostics, Laval, Quebec, Canada) and the Roche LightCycler 
(Roche Diagnostics) using the perforin-specific primer pair outlined above and P-actin-
specific primers reported before (Guy et al., 2006) . 
3.2.8 Perforin detection by Western blotting 
Cell suspensions were treated at 4 °C overnight with lysis buffer containing 
I 0% glycerol, I% Nonidet P-40, 200 mM sodium vanadate, 200 mM sodium fluoride 
and a protease inhibitor cocktail (Sigma-Aldrich). Proteins were separated at 60 ~tg per 
lane by PAGE under non-reducing conditions and transferred to lmobilon-P membrane 
(Millipore, Cambridge, Ontario, Canada). Lysates of rat spleen and mouse brain erved 
as positive and negative controls, respectively. Blots were incubated 'vvith rabbit ant i-
perforin antibodies obtained from two different sources (Torrey Pine BioLabs. 
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Houston, TX and Cell ignaling Technology. Danvers. MA) at I 0 ~Lg protein/ml lor 18 
hat 4 °C. A final incubation with HRP-conjugatcd secondary antibody for I hat 
ambient temperature was followed by visualization using an ECL detection kit (Perkin 
Elmer, Wellesley, MA). 
3.2.9 Perforin detection by flow cytometry 
Suspensions containing I x I 06 WCM-260 hepatocytes, HepG2 cells, primary 
mouse hepatocytes or mouse CTLL-2 cells, as perforin-positive control s, were fi:xcd in 
2% paraformaldehyde for 20 min, permeabilized with 0.1% Triton-X in the presence of 
I 0% normal goat serum, and incubated with anti-perforin antibodies (Cell Signaling 
Technology) at I: I 00 dilution or rabbit lgG overnight at 4 °C. Cells were washed 3 
times by centrifugation, stained with Cy-5-goat anti-rabbit antibodies (Jackson 
lmmunoresearch, West Grove, PA), and analyzed using a BD Facscalibur flow 
cytometer (BD Biosciences, Mississauga, ON, Canada). 
3.2.1 0 JAM cytotoxicity (DNA fragmentation) assay 
WCM-260 hepatocytes and HepG2 cells or WCM-260 treated with rwlFNy or 
rwTNFa were grown to confluence (- 6 x I04 cells/well) in 96-well tlat-bottom cell 
culture plates (Guy et al., 2006). Primary fresh mouse, woodchuck or human 
hepatocytes were aliquoted at 6 x I04/well in 200-, .. d volumes. 3H-thymidine-labeled 
P815 or K562 cells were added at 20 x I 03, I 0 x I 03, 5 x I 03 and, occasionally. at 40 :x 
I 03 cells in 4 -8 experimental wells yielding final effector : target (E:T) ratios of 3: I. 
6: I, 12: I and 1.5: I, respectively. Plates were centrifuged for 5 min at 45 x g and 
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incubated at 3 7 °C in a 5% co~ atmosphere for 18 h. Well contents were harvested 
onto glass fibre mats (Perkin Elmer) using a 96-well harvester (Tomtcc, Harnden. CT). 
Counts per minute ( cpm) were measured using a Top I 0 beta counter (Becton 
Dickinson) and percent lysis was determined as prev iously reported (Gu)' ct al., 2006). 
Freshly isolated woodchuck and human PBMC were used in parallel as control · (Guy 
et al., 2006). Specificity ofCD95L-mediated lysis of P815 cell wa confirmed using 
an antagonistic anti-CD95 Jo2 mAb (Becton Dickinson), as reported (Guy et al. , 2006; 
Hodgson et al. , 1999). Inhibition of microtubule-dependent granule release was 
facilitated using I mM colchicine (Sigma-Aldrich) (Hodgson et al., 1999), which we 
determined to be without toxic effect on target cells by MTT survival assay analyses. 
JAM assays were additionally performed in the presence of neutralizing anti-perforin 
antibodies (Torry Pines Biolabs) or a control rabbit IgG (Sigma-A ldrich) at tina! 
concentrations of I 0 1-lg/ml. 
3.2.11 Silencing of perforin gene by RNA interference 
Silencing of perforin gene expression was facilitated u ing PCR generated Pol 
II I promoter-shRNA gene constructs, as recently described (Castanotto et al. , 2002). 
This strategy employed a universal forward primer, denoted as 5'-U6 primer, which 
was used together with the appropriate reverse primer which targeted either a perforin-
specific 19-nt sequence (Ma et a l. , 2004) or a 19-nt fragment of a control cramblt:d 
RNA equence (Qiagen, Mississauga, ON) (see Fig. SA and Table Table I ). The 
resulting 3 13-bp amplicons were purified using Wizard PCR prep columns (Promega. 
Madison, WI). Confluent cultures of WCM-260, HepG2 and Jurkat ce lls, as well as 
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primary mouse hepatocytes were transfected with 250 ng of the puri ficd products using 
Lipofectamine 2000 reagent (Invitrogen). Arter 24 h. cells were collected and 
evaluated for perforin mRNA by RT-PCR. Cells were examined by an MTT assay to 
confirm that treatment with either perforin-specific or scrambled shRNA did not impair 
their viability. In parallel, transfected WCM-260 and HepG2 cells, and primary mouse 
hepatocytes were seeded in 6-well (for RNA and protein extraction) and 96-well (for 
JAM assays) tissue culture plates and cultured for 72 h. The level ofperforin mRNA 
was evaluated by RT-PCR and that ofperforin protein by Western blotting with anti-
perforin antibodies (Cell Signaling Technology), while killing of P815 and/or K562 
cells was measured by JAM assay at E:T ratio 1.5: I, as described above. 
3.2.12 Statistical analyses 
Results were analyzed by one way ANOVA or unpaired Student' s-f test with 
Welch's correction using GraphPad Prism software (GraphPad Software, Inc ., San 
Diego, CA). 
3.3 RESULTS 
3.3.1 Granule exocytosis contributes to hepatocyte killing of CD95-positive cells 
We have previously documented that normal hepatocytes transcribe CD95L and 
can induce death of CD95-bearing cells (Guy et al., 2006). However, pretreatment of 
CD95L-sensitive P815 target cells with Jo2 mAb, which blocks CD95 (Guy et al. , 
2006; Hodgson et al., 1999), significantly inhibited but did not completely abrogate the 
killing (Fig. 3.1 A). This suggested that hepatocytes could be equipped with an 
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Fig. 3.1. Dependence of hepatocyte killing of CD95-bearing target cells on CD95L and 
microtubule polymerization. WCM-260 hepatocytes and primary human hepatocytes 
were used as effectors against CD95-positive P815 cell targets in the JAM DNA 
fragmentation assay. P815 targets were pre-treated(+) or not(-) with the antagonistic 
anti-CD95 Jo2 mAb before incubation with hepatocytes in either the presence(+) or 
absence (-) of colchicine (A and B). Data bars represent the mean± SEM of three 
separate experiments each with 4-6 experimental wells per condition tested. Inhibition of 
cytotoxicity was significant for data bars marked with * at ?<0.05 and with • at 
? <0.0001. 
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alternate, CD95L-independcnt cytotoxic mechanism. WCM-260 hepatocyte 
cytotoxicity against P815 targets was examined in the presence of both anti-CD95 Jo2 
mAb and colchicine, an inhibitor of microtubule polymerization. Killing of P815 was 
significantly reduced (P<O.OS) but not abolished by Jo2 
mAb (Fig. 3.1 A) (Guy ct al. , 2006). Treatment with both colchicine and Jo2 rn/\b or 
colchicine alone eliminated P815 lysis (Fig. 3.1 A), suggesting that hepatocytcs 
concomitantly utilize CD95L and granule exocytosis. Primary human hepatocytcs used 
as effectors in similar experiments gave comparable results (Fig. 3.1 8). J\ contribution 
of alternative cytotoxic mechanisms dependent upon expression ofT Fa or TNF-
related apoptosis inducing ligand (TRAIL) was excluded since WCM-260 hepatocytes 
do not transcribe TNFa (data not shown) and P815 cells are resistant to TRAIL-
mediated lysis, as reported (Kayagaki et al. , 1999; Takeda et al., 200 I) . 
3.3.2 Hcpatocytes constitutively transcribe perforin and granzyme B 
Granule exocytosis-mediated apoptosis is reliant upon expression of perforin 
and various serine proteases, including granzyme B. As shown in Figure 3.2A, 
perforin and granzymc 8 mRNAs were detectable in human HcpG2 ce lls and in 
woodchuck WCM-260 hepatocytes. Furthermore, perforin mRNA was also 
consistently detectable in pure primary woodchuck and human hepatocytes (Fig. 3.2A). 
Woodchuck primary and cultured hepatocytes and human HepG2 cells also were 
granzyme 8 mRNA positive (Fig. 3.2A), which was seemingly lacking in human 
primary hepatocyte (Fig. 3 .2A). Absence of granzyme 8 express ion docs not. 
however preclude perforin direct cytotoxic action, as perforin-dependcnt yet granzymc 
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Fig. 3.2. Identification ofperforin and granzyme Bin hepatocytes. (A) Expression of 
perforin and granzyme B (GrB) mRNA in human HepG2 cells, woodchuck WCM-260 
hepatocytes and in primary hepatocytes isolated from three healthy woodchucks ( 1-3) 
detected by RT-PCR using 500 ng total RNA per reaction. Perforin mRNA in normal 
human hepatocytes was amplified using 500 to 50 ng total RNA per reaction . PBMC 
from a healthy human (hPBMC) and a healthy woodchuck (wPBMC) and plasmid D As 
served as positive controls. Water instead of eDNA was used as a negative control. P-
actio served as a housekeeping gene transcription control. (B) Perforin detection by 
Western blotting in primary rat, woodchuck (wHeps) and mouse hepatocytes, and in 
cultured WCM-260 and HepG2 cells. Total protein derived from rat spleen and brain 
served as positive and negative controls, respectively. The positions of 70-kDa and 60-
kDa isoforms ofperforin are indicated by arrows. (C) Perforin protein was detected by 
flow cytometric analysis ofWCM-260, HepG2 and primary mouse hepatocytes using 
perforin-specific antibodies (shaded region) or control rabbit IgG (outlined region). 
Mouse CTLL-2 cells served as a positive control. 
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8-indepcndcnt target cell killing has been reported ( hresta et al.. 1997). A possibilit) 
that preparations of primary hepatocytes may contain traces or lymphoid cells \\as 
excluded based on the absence ofCD3 and Kp46 mR A v .. hich are spcc ilicall) 
expressed in T, NK and/or NK T cells (data not shown). 
3.3.3 Hepatocytes are endowed in perforin protein 
Perforin is initially synthesized as a 65-kd protein which is sequentially 
glycosylated yielding an intermediate 70- kd protein, followed by proteolytic cleavage 
resulting in a 60-kd isoform ( Uellner et al., 1997). When lysates of cultured hepatocyte 
lines and primary hepatocytes were analyzed by Western blotting (Fig. 3.28), the 
results showed that woodchuck WCM-260 and human HepG2 cells preferentially 
displayed the 70-kDa perforin isoform, while freshly isolated woodchuck, mouse and 
rat hepatocytes displayed the 60-kDa isoform (Fig. 3.28). These results were validated 
using two different preparations of anti-perforin antibodies (data not shown). 
Furthermore, the existence ofperforin was confirmed by flow cytometry analysis (Fig. 
3.2C). A distinct shift in fluorescence intensity after staining with perforin-specific 
antibodies clearly demonstrated perforin protein presence in both cultured and primary 
hepatocytes. 
3.3.4 Hepatocytes kill CD95-deficient cells 
WCM-260 hepatocytes and human HepG2 cells were examined as effectors in 
JAM DNA fragmentation assays against CD95-deficient K562 cells. Both woodchuck 
WCM-260 (Fig. 3.3A) and human HepG2 (Fig. 3.38) eliminated CD95-deficient K562 
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Fig. 3.3. Hepatocyte killing ofCD95-deficient K562 target cells. The cytotoxicity of 
WCM-260 hepatocytes (A) or HepG2 liver ce lls (B) against CD95-ncgative, perforin-
sensitive K562 targets was measured by the JAM assay using 6 x 104 e ffectors and 
indicated numbers of target cells per assay in the presence of colchicine. PBMC obtained 
from three healthy woodchucks (C) or three healthy human donors (D) were examined in 
parallel against 5 x 103 K562 targets at the indicated E:T ratios. Data represent mean 
values ± SEM obtained from 3 experiments with 4-6 experimental wells per condition. 
Data bars marked with ** are significant at P<O.O 1 and with * at P <0.05 when compared 
with untreated controls. 
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cells which was significantly (?<0.05 or P<O.OO I) inhibited by colchicine, confirming 
that target cell death was dependent on microtubule polymerization. Comparable 
results were obtained when woodchuck P8MC (Fig. 3.3C) or human P8MC (Fig. 
3.30) were used as effectors in control experiments. 
3.3.5 Hepatocyte cytotoxicity is inhibited by anti-perforin antibody 
Hepatocyte cytotoxicity was measured in the presence of neutralizing anti-perforin 
antibodies. Killing of K562 by WCM-260 and HepG2 was significantly reduced in the 
presence of the antibodies in comparison with either untreated cells or those incubated 
with a controllgG fraction. Specifically, WCM-260-mediated killing was diminished 
by 55-60% (Fig. 3.4A), while that induced by HepG2 cells by 24-29% (Fig. 3.48). 
Killing ofK562 by both WCM-260 and HepG2 was disrupted by colchicine to a 
significantly greater degree than by anti-perforin antibodies, with approximate 
reductions of 90% and 60%, respectively (Figs 3.4A and 3.48). 
3.3.6 Perforin-specific shRNA inhibits hepatocyte cytotoxicity 
Perforin-specific RNA interference (RNAi) can reduce the cytotoxicity of human NK 
cells (Ma et al., 2004). Since the sequence of the human perforin gene targeted by 
RNAi (Ma et al., 2004) is conserved between human, mouse and woodchuck, we 
employed a PCR-based approach for the generation of this perforin-specific shRNA 
(see Fig. 3 .SA). Transfection with si-Perf effectively reduced the levels of perforin 
mRNA (Fig. 3.58) and perforin protein (Fig. 3.5C) in both WCM-260 hepatocytes and 
HepG2 cells. While the reductions in perforin mRNA and protein express ions were not 
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Fig. 3.4. Inhibition ofhepatocyte killing ofCD95-de:ficient, perforin-sensitive K562 
cells by anti-perforin antibodies. WCM-260 hepatoc/te (A) or HepG2 liver cell (B) 
killing was measured by the JAM assay using 6 x 10 effectors and 4 x 104 K562 targets 
per assay, performed in the presence of neutralizing anti-perforin antibodies, control 
rabbit IgG or colchicine. Data bars represent the mean ± SEM of three separate 
experiments each with 4-6 experimental wells per condition. Inhibition of cell killing is 
significant for the data bars marked with** at P <0.001 and with * at P <0.05 relative to 
untreated or control IgG-treated cells. 
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as profound in HepG2 ce lls as in WCM-260 hepatocytes. this was not unexpected since 
HepG2 cells are known to be difficult to transfect with either pia mid DN/\ or 
oligonucleotides. A reduction in perforin mRNA level was also observed in Jurkat 
cells lransfected with si-Perf(data not shown) . JAM assays revealed that killing of 
K562 by WCM-260 or HepG2 was significantly (P<O.OO I) impaired aller their 
transfection with the si-Perfsequence (Fig. 3.50). Significant (P<O.OI) reductions in 
target cell killing were also seen when si-Perf-transfected WCM-260 or HepG2 cells 
were used as effectors against P815 targets (Fig. 3.50). 
3.3.7 Primary hepatocytes kill CD95-deficient cells 
To ascertain whether hepatocytes may utilize the perforin pathway in vivo, we 
examined whether primary hepatocytes freshly isolated from mice, healthy 
woodchucks or a human are competent to kill K562 targets. Figure 3.6A documents 
that killing of K562 cells by primary mouse hepatocytes was significantly (P = 0.0003) 
reduced in the presence of anti-perforin antibodies but not controllgG. Inclusion of 
colchicine also meaningfully (P<O.OOO I) reduced target cell lysis. Transfection of 
primary mouse hepatocytes with si-Perf, but not with a scrambled shRNA sequence, 
led to a significant (P = 0.04) decrease in perforin protein expression, as evidenced by 
Western blot analy is (Fig. 3.68). In addition. JAM cytotoxicity assay revea led that 
transfection of hepatocytes with si-Perf, but not with a si-scrambled sequence, 
significantly (P = 0.00 14) reduced killing of K562 targets by hepatocytcs. Figure 3.7 
documents further that fresh, primary woodchuck or human hepatocytes not subjected 
to culture were also effective mediators ofC095-independent ce ll death . Inclusion of 
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Fig. 3.6. Killing of CD95-deficient target cells by primary mouse hepatocytes. The 
cytotoxic potential of hepatocytes freshly isolated from three outbred mice was examined 
by the JAM DNA fragmentation assay using 6 x 104 hepatocytes and 4 x 1 04 K562 
targets. (A) Hepatocytes and target cells were incubated in the presence or absence of 
control rabbit IgG, anti-perforin antibodies or colchicine. Reductions in target cell lysis 
in comparison with untreated or control IgG-treated groups where** is significant at 
P<0.005 . Decreased perforin protein (B) or K562 target cell killing (C) following 
transfection of mouse hepatocytes with si-Perf or si-Scrambled. In (B), a representative 
Western blot demonstrating decreased perforin protein and a graphic presentation of the 
means± SEM ofthe densitometric values of the signals obtained from three separate 
experiments after normalization to P-actin protein showed as a percentage of the means 
given by untreated hepatocytes. In (C), killing of 4 x 104 K562 cells by 6 x I 04 untreated 
or transfected hepatocytes determined by the JAM DNA fragmentation assay. Bars 
represent mean values ± SEM obtained from three experiments with 4-12 experimental 
wells per condition. Differences between experimental conditions were significant at 
P<O.Ol when* or P<0.005 when**. 
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Fig. 3.7. Killing ofCD95-deficient cells by primary woodchuck and human hcpatocytes. 
The cytotoxic capacity ofhepatocytes freshly isolated from 3 healthy woodchuck (A) or 
a healthy portion of a human liver (B) was examined by the JAM DNA fragmentation 
assay using K562 cells as targets. Colchicine significantly (P<O.OS) inhibited target cell 
apotosis as compared to untreated controls when indicated by*. Data represent mean 
values± SEM with 4-6 experimental wells per condition. 
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colchicine again signiticantly (?<0.005 or ? <0.05) dccn.:ased elimination or K562 
targets, confirming a requirement for microtubule polymerization in killing o f CD95-
negative cells. 
3.3.8 Hepatocyte killing of CD95-deficient cells is not modulated by IFNy 
Since IFNy and TNFa augment hepatocyte CD95L-dependent cytotoxicity (Guy ct at. , 
2006), we investigated ifthese cytokines also enhance perforin-mediated cell killing. 
WCM-260 hepatocytes were exposed to either IFNy or TN Fa under conditions 
determined previously (Guy et al., 2006). It was found that perforin mRNA was 
significantly (P<O.OOI) upregulated in PBMC in response to treatment with IFNy, but 
not with TNFa (Fig. 3.8A). In contrast, the level ofperforin mRNA in WCM-260 
hepatocytes was not influenced by either IFNy or TNFa (Fig. 3.8A). Concomitantly, 
while IFNy-stimulated PBMC were significantly (P<O.O I) more cytotoxic than 
untreated PBMC (Fig. 3.88), the cytotoxic activity of WCM-260 remained unchanged 
(Fig. 3.8C). The data suggest that perforin expression could be modulated by IFNy in a 
cell type-specific manner. 
3.4 DISCUSSION 
It has become apparent that the liver can de facto be considered as an 
immunocompetent organ and may act as a final repository for activated CD8+ T cells 
(Crispe et al. , 2000). While the exact mechanisms of intrahepatic retention and 
induction ofT cell apoptosis are not defined, hepatocytes can act as cytotoxic effector 
and eliminate cell targets via the CD95L-CD95 pathway 
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Fig. 3.8. IFNy differentially modulates perforin gene expression in hepatocytes and 
PBMC. (A) Perforin mRNA expression in normal woodchuck PBMC and WCM-260 
hepatocytes following stimulation with 150 U/ml wriFNy or 35 U/ml wrTNFa as 
determined by real time RT-PCR. Data represent the mean ± SEM of the val ues obtained 
from three experiments after normalization to P-actin, and are displayed as a percentage 
ofthe means given by untreated PBMC or WCM-260 where** is significant at P<O.OO I. 
The cytolytic activity ofiFN-y-stimulated PBMC (B) or WCM-260 hepatocytes (C) was 
evaluated against K562 target cells in JAM assay using untreated effectors as controls. 
Results are shown as mean values± SEM from 4-6 experimental wells per each E:T ratio. 
Data bars marked with * are significant at P<O.Ol. 
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(Guy ct al.. 2006; lken et al., 2006). Therefore. hepatocytes may contribute to removal 
of activated lymphocytes or other cell either passing through or residing in the liv~r . It 
is well understood that CTL and other activated lymphoid cells. such as K T cells. 
can eliminate targeted cells through CD95L-CD95 interactions or a a result or 
polarized release of cytolytic granules containing perforin and erine proteases (Barry 
and Bleackley, 2002). However. the usage of a cytolytic granule e:xocytosis pathway 
by non-lymphoid cells has not been previously reported. 
Our initial experiments from this study, in which CD95-bearing P815 cell served as 
targets, clearly demonstrated that killing by hepatocytes was dependent upon both 
CD95L-CD95 interactions and microtubule polymerization. This was consistent with 
earlier studies utilizing lymphoid effectors against P81 5 targets (Hodgson et al. , 1999: 
Spaner et al., 1998). The finding that colchicine alone, in the absence of CD95-
blocking Jo2 antibodies, near completely inhibited P815 cell killing suggests that 
hepatocytes may contain CD95L within cytoplasmic granules, as has been reported for 
lymphoid effector cells (Kojima et al., 2002). Previous reports implied that 
hepatocytes do not express perforin or granzyme B, as determined by 
immunohistochemical or in situ hybridization methods (lbuki et al., 2002; Tordjmann 
et al., 1998). However, both cultured hepatocytes and, more importantly, primary 
hepatocytes derived from rodents and a human express perforin and, in the case of 
rodent hepatocytes and human HepG2 cells, granzyme B mR As when ana lyzed by 
RT-PCR. as our current study showed. Furthermore, immunoblot and flow cytometry 
analyses of the perforin mRNA-pos itive cells confirmed that perforin protei n is 
normally displayed by hcpatocytcs. Interestingly. hepatocyte cell line showell a 
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perforin isoform corresponding to a 70-kDa intermediate form, wherca a mature 60-
kDa isofonn was detected in primary hcpatocytes and splenic ti ssue. /\! though the 
significance ofthis discrepancy is unclear, both cultured and primary hepatocytes 
efficiently killed CD95-deficient K562 target cells. 
Killing ofCD95-negative cells by hepatocytes was significantly reduced 
following inhibition of microtubule polymerization. These results provide the first 
experimental evidence that hepatocytes can be cytotoxic in a manner independent or 
CD95-activation. Additional experiments with neutralizing anti-perforin antibodies 
confirmed that killing of CD9Y targets was perforin-dependent. However, anti-
perforin antibodies were less inhibitory than colchicine. This finding is not unexpected 
since colchicine is highly efficient in preventing granule exocytosis and release of 
perforin, while antibodies act following degranulation and this process is certain ly less 
effective in neutralizing perforin and may require a much higher concentration of anti-
perforin antibodies than that used. 
Our results have also firmly demonstrated that perforin-specific shR A, 
targeting a sequence previously shown to abrogate N K cell cytotoxic ity (Ma et al., 
2004), impaired the ability of both cultured and freshly isolated primary hepatocytes to 
kill cells. Silencing ofperforin gene expression in WCM-260 and HepG2 ce lls also 
significantly reduced killing ofCD95-positive targets, which is consistent with our 
earlier findings (see Figs 3. 1 and 3.3A) indicating that the apoptosis of P815 was at 
least in part, perforin-dependent. 
The levels ofperforin mRNA expression and CD95-independent cell killing 
were not influenced by exposure of hepatocytes to I FNy or T ra. Th i · is in contrast 
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with the augmented transcription of perto rin and the increased apoptosis of target cells 
alter exposure of lymphoid cells to IFNy. This discrepancy requires further 
investigation. however, differential regulation of perforin expression has also been 
postulated for NK cells and T lymphocytes (Lacorazza et al., 2002). Opposing effects 
ofiFNy on the activity of the cytotoxic pathways utilized by two ce ll types close ly 
interacting with each other under phys iologica l or pathological cond itions uggest an 
important role for this cytokine in altering hepatocyte cytotoxic potential and in 
modulating hepatocyte interactions with lymphoid and other cells. 
Autocidal death ofCD8+ T cells requires perforin (Spaner et al., 1998), while 
perforin-deficient mice infected with lymphocytic choriomeningitis virus (L MY) 
show accumulation of virus-specific CD8+ T cells in lymphoid organs and the liver 
(Matloubian et al., 1999), implicating the importance of perforin in the contraction of 
CTL. Constitutive expression of perforin may suggest that hepatocytes can contribute 
to removal of activated CD8+ T cells. The contact between hepatocytes and cells 
predestined for elimination could be facilitated by interaction between terminally 
desialiated proteins exposed on target cells and hepatocyte ASGPR. Neuraminidase 
treatment of lymphocytes has been shown to enhance their retention in the liver 
(Samlowski et al., 1984), while we have observed that treatment of P81 5 and K562 cell 
targets with neuraminidase enhances their killing by hepatocytes (unpublished 
observation). 
On the other hand, expression ofCD95L may also imply the potential of 
hepatocytes to eliminate CD4+ T cells (Suzuki and Fink, 2000). In the case ofhepatie 
inflammation, which is normally accompanied by augmented levels of intrahepatic 
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I rNy and/or TN Fa (Hodgson and Michalak, 200 I). hepatocyte CD95 L-depcndent 
killing might be heightened resulting in the preferential elimination of CD4+ T c~:lls . 
In viral hepatitis, this may constrain a collaborative net\'vOrking between virus-spccilic 
CD4+ and CD8+ T cells, and differentially modulate clearance of virus and the 
outcome of hepatitis. At this stage, this sequence of events remains hypothetical, but 
our results provide the framework for further test ing of this concept. 
Overall, we have shown that hepatocytes, which are a non-lymphoid ce ll type, 
are functionally competent to eliminate cells by a perforin-mediatcd mechanism. Our 
study strengthens the notion that hepatocytes are active contributors to both 
physiological and pathological processes occurring in the liver (G uy et al., 2006). The 
cytotoxic activity ofhepatocytes may influence the pathogenicity of liver diseases, 
including those caused by hepatotropic viruses. 
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CHAPTER FOUR: HEPADNAVIRAL INFECTION AUGMENTS 
HEPATOCYTE CYTOTOXICITY MEDIATED BY BOTH CD95 LIGAND AND 
PERFORIN-DEPENDENT PATHWAYS 
4.0 SUMMARY 
We recently demonstrated that normal hepatocytes express CD95L, can 
eliminate contacted cells via the CD95L-CD95 pathway, and that this cytotoxic activi ty 
can be augmented by IFNy. We have also documented that hepatocytes are endowed in 
perforin and granzyme B, and can extinguish other cells via the granule exocytosis 
mechanism. The current study aimed to assess whether hepadnavirus infection 
modifies hepatocyte-mediated cell killing during active infection and after recovery 
from self-limited acute hepatitis (SLAH) in the woodchuck model of hepatitis B. We 
discovered that hepatocytes isolated during both chronic viral hepatitis and following 
SLAH display significantly greater cytotoxicity towards cell targets than those from 
healthy animals, and that both hepatocyte CD95L- and perforin-dependent cell killing 
are augmented. In supplementary experiments, woodchuck hepatocytes transfected 
with WHY X gene, but not those transfected with complete WHY DNA or virus 
envelope or core gene, expressed substantially higher levels ofCD95L and perforin 
mRNAs, and killed cell targets more efficiently. Also. exposure of hepatocytes to 
IFNy, except those transfected with WHY X gene, profoundly enhanceJ their 
cytotoxicity. In conclusion, hepatocyte CD95L and perforin-mediated cytotoxicity is 
significantly augmented during natural hepadnaviral infection and after resolution of 
hepatitis. This could be a consequence of increased intrahepatic production of IF y 
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due to virus-induced liver intlammation, although a role for dc fcctiw virus replication 
associated with over-expression of virus X protein can not be entirely excluded. 
4.1 INTRODUCTION 
The liver performs multiple immune-like functions, including the removal of 
aberrant cells, elimination of pathogens, and induction of peripheral immunotolerance 
(Racanelli and Rehermann, 2006). This organ also appears to be the primary site of 
elimination ofT cells, particularly activated CTL (Crispe et al. , 2000). Hence, the liver 
is not only a component of the innate immune defense but it may modulate 
effectiveness ofT lymphocyte responses, of which those directed against antigens 
critical for the development of hepatic injury might be of a particular importance. 
Although the data accumulated imply that the above processes could be to a large 
degree mediated by LSEC (Diehl et al. , 2007) and intrahepatic immune cel ls, especial ly 
macrophages (Mehal et al., 2001), a contribution ofhepatocytes also is highly probable 
due to the structure of hepatic vasculature (Warren et al., 2006) and to the recently 
discovered hepatocyte cytotoxic effector activity (Guy ct al., 2006). In this regard, it 
was found that normal primary hepatocytes as well as hepatocyte lines constitut ive ly 
express CD95L and they can eliminate other cells via the CD95L-CD95 mechanism. 
As well , hepatocyte CD95L expression and CD95-dependent cell killing can be 
significantly augmented in vitro following exposure to IFNy and. under certain 
ci rcumstances, TN Fa (Guy et al., 2006). Furthermore. it was recently found that 
hepatocytes also express perforin and can utilize an exocytic pathway to kill both 
CD95-deficient and CD95-bearing cells (Guy et al. , 2008. in press. see Chapter 3). 
126 
,------------------------~---- - ---- - ----
Interestingly, in contrast to lymphocytes, hepatocyte perforin-dcpendcnt killing is not 
influenced by IFNy or TNFa. Taken together, hepatocytes, similarly as lymphocytes, 
are endowed in two distinct cytotoxic effector mechanisms. However, in contrast to 
lymphocytes, hepatocyte cytotoxicity mediated by these pathways could be 
di fterentia lly modulated by the local cytokine milieu. The in vivo relevance of these 
findings may pertain not only to fratricidal cell death during the development and 
progression of liver disease, but implicate further an active cytotoxic role for 
hepatocytes as they may interact with lymphocytes and other cells either trafficking 
through or infiltrating the diseased liver. Furthermore, the notion that the liver 
eliminates activated lymphocytes and maintains a uniquely tolerogenic environment 
might in part be related to the cytopathic capability of hepatocytes. 
Antiviral specific T cell responses, especially that mediated by CTL, are 
thought to be of primary importance in the control of HBV infection (reviewed in 
(Guidotti and Chisari, 2000). The same cytotoxic activities, as well as pro-
infammatory cytokines released are main contributors to liver damage manifesting as 
hepatitis. The activated CTLs may also play a role in non-cytopathic clearance of 
hepadnavirus through production of IFNy and TN Fa and by a feedback stimulation of 
other immune cells, such as NK, NK T cells and macrophages. It has been postulated 
that while CTL-mediated, perforin- and CD95L-dependent hepatocyte injury is 
predominantly responsible for induction of hepatitis, downregulation o fviru s 
replication in hepatocytes is chiefly a consequence ofintrahcpatically produced IFNy 
and TNFa (Guidotti et at., 1996; Kakimi et at., 2000). Moreover, while /\1-1 and 
recovery from acute infection are associated with vigorous, polyclonal and 
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multispecific CTL and T helper type I responses to HBY antigens, Cll is accompani~d 
by a low number of circulating and intrahepatic virus-spccitic CD8+ and CD4+ T cells. 
The reason behind this remains unknown, but an active contribution of hepatocytcs has 
to be considered in the context oftheir cytotoxic potency recently identified. 
IFNy and TNFa have been proven to be indispensable for recovery from 
hepadnaviral infection, both in experimental HBY infection in chimpanzees and in 
woodchucks infected with WHY (Hodgson and Michalak, 200 I). Uprcgulated hepatic 
expression of these cytokines was also found, although to a lesser extent than in CI-L to 
continue for years after resolution of SLAH in the context of persistent low level 
replication of WHY and intermittent minimal to moderate inflammatory changes in 
hepatic tissue ofthe woodchucks recovered (Hodgson and Michalak, 2001). It was 
postulated that antiviral cytokines, in particular IFNy, may play a central role not on ly 
in recovery from AH but also in the long-term control of occult hepadnavirus infection 
in the liver (Hodgson and Michalak, 200 I). Since IFNy, and under some conditions 
TNFa, efficiently upregulates hepatocyte CD95L-dependent cytotoxicity, this activ ity 
may contribute to a dynamic equilibrium in which the persistently multiplying virus is 
kept under confinement through immune pressure exerted, among others, by virus-
specific CTL, while the cytokine-triggered hepatocytes may defend themselves by 
eliminating these highly cytopathic cells which are brought in contact with their 
surface. 
To recognize the cytotoxic capabilities of hepatocytes in the course of 
hepadnaviral infection and to learn whether the poss ibility outlined above may exist, 
we investigated primary hepatocytes freshly isolated from woodchucks with CH or 
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experimentally induced SLAH. We have found that the potential of hepatocyte to ki II 
other cells is con i tently augmented both in Cl-1 and long after recovery from SLAH. 
The increased killing was unlikely a direct con equence of viral replication in 
hepatocytes, as in vitro experiment with recombinant WHY in cultured hepatocyte 
suggested, but rather a result of enhanced hepatic IF y production due to active or 
residual inflammation. 
4.2 MATERIALS AND METHODS 
4.2.1 Cell lines 
CD95-bearing murine mastocytoma P815 (A TCC TIB-64; American Type 
Culture Collection, Rockville, MD) and lymphoma LSI 02.9 cells (AT C HB-97), and 
CD95-deficient human chronic myelogenous leukemic K562 cells (AT C CCL-243) 
were cultured as described (Guy et al., 2006; Hodgson et al., 1999). Woodchuck 
WCM-260 hepatocyte cell line was established from the liver of a healthy woodchuck 
and the cells were phenotypically characterized and maintained as reported ( hurchill 
and Michalak, 2004; Diao et al., 1998). The parental WCM-260 wa utilized to deri ve 
stably transfected cell lines expressing a complete WHY genome or WHY individual 
genes (Wang and Michalak, 2006). 
4.2.2 WHY infection 
Eighteen adult woodchucks were investigated. Five were healthy WHY-naive animals 
which served as controls. Seven ofthe remaining 13 (Table I) were infected with 1.1 x 
10 10 DNase-protected virus genome equivalents (vge) of WHY/tm2 inoculum 
(GenBank acces ion number A Y628095) (Coffin et a l. , 2004), a reported ( ficha lak et 
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al., 1999). The status of WHY infection was monitored by testing serial erum samples 
for WHsAg, anti-WHs and anti-WI-le with assays reported before (Coffin et al., 2004; 
Michalak et al., 1999). SLAH was diagnosed in all 7 animals. Six other woodchucks 
had serum WHsAg-positive CH acquired in the wild prior to arrival to our co lony 
(Table I). Liver histology was examined in serial biopsies and at the time of hepatocyte 
isolation, following previously established criteria (Hodgson and Michalak, 200 I ) . The 
examination at the time of autopsy confirmed diagnosis of either CH or resolved AH 
with minimal to moderate inflammatory changes, as reported (Coffin et al., ~004: 
Hodgson and Michalak, 200 I ; Michalak et al., 1999) (Table I). 
4.2.3 Primary hepatocytes 
Hepatocytes were immediately isolated by two- tep collagenase microperfusion 
of liver tissue fragments obtained from each animal by procedures previously reported 
(Churchill and Michalak, 2004). Hepatocytes were at least 98% pure by phase-contrast 
microscopy and viability was consistently determined to be greater than 80% as 
determined by trypan blue exclusion. Potential contaminations with T lymphocytes, 
NK cells and NK T cells were excluded by analysis of total RNA extracted from 
hepatocyte preparations for expression of woodchuck CD3 and NKp46 using RT-PCR 
as reported (Guy et al., 2006; Hodgson and Michalak, 200 I ). Animal experimental 
protocols were approved by the Institutional Presidents ' Committee on Animal 
Bioethics and Care. 
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Table 4.1. Serological and histological characteristics of WHY infection in animals 
with self-limited acute hepatitis or chronic hepatitis investigated in this study 
-----· -- ·~ -Status of WHY Observation Serum Duration of Anti-WHc Duration of His tological 
Infection and period WHsAg WHsAg pos itivity anti-WI-le dgree of 
Animal (mo)* pos itivity (lllO) ( 1110) hepatitis 
No./Sex 
--··-----
--------- ----·---~-··--·- --
Resolved 
hepatitis 
1/F 5.5 + + 4.5 0 
2/F 8 + + 7 0.5 
3/F 6 + 2.75 + 4.5 0.5 
4/F 21 + 0.75 + 19.5 0 
5/F 8.25 + 2 + 6 0.5 
6/F 31 + 2.5 + 29.5 0.5 
7/M 10.25 + + 5 .5 
Chronic 
hepatitis 
8/F 33.75 + 33.75 n.t. n.t. 2 
9/F 6.5 + 6.5 n.t. n.t. 2 
10/M 12.5 + 12.5 n.t. n.t. I 
11 /M 7 + 7 n.t. n.t. 1.5 
12/M 25 .25 + 25.25 n.t. n.t. 2 
13/M 33 + 33 n.t. n.t. 1.5 
mo, months; F, female; M, male; n.t., not tested. 
* from the time of inoculation with WHY for animals with resolved hepatitis or the 
time of the arrival to colony for animals with serum WHsAg-positive chronic hepatitis. 
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4.2.4 Hepatocytes transfection with WHY DNA 
Hepatocytes tably expressing either a complete WHY genome. individual 
WHY genes or empty vector (control) were established using WCM-260 hepatocytes. 
as recently reported (Wang and Michalak, 2006). Plasmids carrying WHY gene 
sequences encoding functionally distinct proteins were constructed u ing the eukar otic 
expression vector pcDNA3.1 (Invitrogen, Carlsbad, CA). A plasmid containing 
approximately 1.1 times the length of the WHY genome (p-WHY) was produced by a 
two-step PCR amplification of wild-type WHY/tm3 DNA sequence (GenBank 
accession number A Y334075) (Michalak et al., 2004). To examine whether individual 
WHY proteins could influence the cytotoxic capacity of hepatocyte , W M-260 cells 
stably expressing pcDNA3.1 plasmids containing complete WHY envelope large (pre-
S I) protein (p-WHs), core protein (p-WHc) or X protein (p-WHx) were generated 
(Wang and Michalak, 2006). The display of WHY translation product or relea e of 
infectious virions by hepatocytes were ascertained as reported (Wang and Michalak, 
2006). 
4.2.5 Hepatocyte treatment with IFNy 
WCM-260 hepatocytes stably transfected with either complete WHY genome, 
virus individual genes or with empty vector were exposed to bioactive rwl F y 
generated in the baculovirus expression system as reported (Wang and Michalak, 
2005). The cells were treated for 18 h with 150 Ulml ofrwiFNy, while untreated 
controls were cultured under the same conditions in the absence of the cytokine (Guy et 
al., 2006). 
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4.2.6 RNA extraction and reverse transcription 
- 6 Total RNA was extracted from 2 x I O' or I x I 0 cultured or primary 
hepatocytes or from control HepG2 cells, and from I 00 mg of woodchuck liver ti sue 
using Trizol reagent (Invitrogen). Potential D A contamination wa removed LL ing 
R ase-free, D ase dige tion kit (Sigma-Aldrich, Oakville, Ontario, anada). R A (2 
11g) was reverse transcribed to cD A in a 20-~.d reaction volume, as described (Guy et 
al., 2006). 
4.2.7 Real-time RT-PCR 
Expression ofCD95L, CD95, perforin, granzyme Band P-actin in primary and 
cultured hepatocytes was quantified by real time RT-PCR employing the LightCycler 
Faststart Master SYBR I kit (Roche Diagnostics, Laval, Quebec, Canada) and the 
Roche LightCycler (Roche Diagnostics), as recently described (Guy et al. , 2006) . 
Woodchuck CD3, IFNy and TNFa mRNA were quantified in liver tis ue u ing primers 
and real-time RT-PCR conditions· reported elsewhere (Wang et al., 2007). erial 
dilutions containing known copy numbers of there pective recombinant gene 
fragments were included as quantitation standard . The copy number in te t sample 
were determined with LightCycler quantification software (Roche Diagnostic ) and 
were normalized against expression of P-act in, as described (Guy et al. , 2006). 
4.2.8 Preparation of target cells 
P815, L 102.9 and K562 cells were subcultured to a den ity of 5 x I 06 cell /ml 
and labeled with 50 1-1Ci of 3H-thymidine (Perkin Elmer, Wellesley, MA) for 18 h prior 
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to the JAM cytotoxicity D A fragmentation a say, as reported (Guy et al .. 2006). The 
cells were \-vashed 3 times in Hanks' balanced salt solution (Invitrogen). re-suspendeJ 
in RPMI-1640 medium, and immediately used a targets. 
4.2.9 JAM Cytotoxicity (DNA fragmentation) assay 
Primary fresh woodchuck hepatocytes were aliquoted at 6 x I 04/well in 200-~d 
volumes in 96-well flat-bottom cell culture plates, as reported (Guy et al. , 2006). 
Stably transfected WCM-260 hepatocytes were grown to confluence ( - 6 x I 04 
cells/well) in the ame type of plates. 3H-thymidine-labeled P815, L I 02.9 or K562 
cells were added at 4 x 104,2 x 104, I x 104, and 5 x 103 into 4-8 experimental wells 
each, yielding final effector: target (E:T) ratios of 12: I , 6:1, 3: I, and 1.5: I , 
respectively. Plates were centrifuged for 5 minutes at 45 x g and incubated at 7 °C in 
a humidified 5% C02 atmosphere for 18 h. Well contents were harvested onto glass 
fibre mats (Perkin Elmer) using a 96-well harvester (Tomtec, Hamden, T). Counts 
per minute ( cpm) were measured using a Top I 0 beta counter (Becton Dickin on, an 
Diego, CA) and percent lysis was determined a reported (Guy et al., 2006). 
4.2.10 Inhibition of hepatocyte-mediated cytotoxicity 
Jo2 mAb (Becton Dickinson), which blocks CD95 on P81 5 ce ll without 
inducing lysis, has been shown to effectively abrogate hepatocyte- and lymphoid cell-
mediated killing ofP815 target cells (Guy et al., 2006; Hodgson et al. , 1999). This 
mAb was used to confirm specificity of hepatocyte CD95L-mediated killing. 
Inhibition of microtubule-dependent granule release was facilitated u ing I mM 
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colchicine (Sigma-Aldrich) to confirm perforin contribution to hepatocyte cell killing. 
as described (Hodgson et al., 1999). 
4.2.11 Statistical analyses 
Results were analyzed, where appropriate, by one way ANOV A or unpaired 
Student's-t test with Welch's correction using GraphPad Prism software (GraphPad 
Software, Inc., San Diego, CA). Differences between experimental conditions were 
considered to be significant when two-sided P values were les than 0.05. 
4.3 RESULTS 
4.3.1 Hepatocyte cytotoxic phenotype in WHV infection 
It has been shown that augmented hepatic IFNy, TN Fa, as well as CD3 
expression accompanies not on ly active liver inflammation, which is a hallmark ofCH , 
but also, although to a much lesser extent, residual inflammation persisting after 
resolution of AH in woodchucks (Hodgson and Michalak, 200 I) . However, it 
remained unknown whether hepadnaviral infection modifies or not, expres ion of genes 
affiliated with hepatocyte cytotoxic activity. To address this, transcription of IF y, 
TNFa and CD3 in the livers and the genes encoding effector molecules of the CD95L-
CD95 and perforin pathways in hepatocytes were quantified in woodchucks with 
SLAH or CHand in healthy animals (Fig. 4.1 ). As expected, CH was accompanied by 
histologically evident necroinflammation (Tab le 4. 1) and significant ly (P<O.O I ) 
enhanced intrahepatic expression of IF y TNFa and CD3 mR A, while minimal 
inflammatory alterations occurring after LAH (Table 4.1) were assoc iated v. ith 
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Fig. 4.1. Expression of selected cellular genes known to be associated with progressing 
liver inflammation and those encoding molecules affiliated with hepatocyte cytotoxic 
activity. The mRNA levels ofthe indicated genes were quantified by real-time PCR in 
the total liver tissue (A) or in essentially pure hepatocytes (B) from woodchucks 
convalescent from SLAH (n=7) or with progressing CH (n=6) and WHY-naive, control 
animals (n=5). Transcription of each gene was analyzed in triplicate in both the livers 
and hepatocytes preparations obtained from each animal analyzed and was nonnali zed 
against expression of woodchuck ~-actin, as a housekeeping gene. Data arc presented as 
mean copy number± SEM. Expression levels significantly different at P <0.05 were 
marked with *. 
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significant (P<O.Ol) increases of hepatic IFNy and CD3. but not T Fa rnRNA levels 
when compared to those in healthy woodchucks (F ig. 4.1 A). There al o were 
sign ificant differences (P<0.05) in the hepatic expression of IFNy and T Fa, but not 
CD3. between animals with SLAH and CH (Fig. 4.1 A). 
Hepatocytes from animals convalescent from LAH or with CH tran ribed 
CD95L at ignificantly (P<O.OI) greater level than those from healthy control (Fig. 
4.1 B). It is of note that CD95 expression wa also augmented (P<O.O I) in hcpatocytes 
after SLAH. In contrast, perforin and granzyme B mRNA levels were not 
meaningfully different, although the perforin expression tended to be greater in 
hepatocytes from animals with SLAH than in those with CH or from healthy 
woodchucks (Fig. 4.1 B). Analysis of the data on the expression of the ame genes in 
hepatocytes purified from 13 additional animals with SLAH did not change tht: validity 
ofthe above ob ervations (data not shown). 
4.3.2 Resolution of hepatitis is followed by persistently augmented hepatocyte 
cytotoxicity 
Since hepatocytes obtained after resolution of SLAH transcribed significantly 
more CD95L and also tended to express more perforin mRNA than those from healthy 
controls (Fig. 4. 1 B), it was of interest to assess whether their cell killing capacity was 
also augmented. For this purpose, hepatocytes were purified from three pair of 
woodchucks, wherein each pair consisted of one animal with SLAH and one healthy 
an imal. Liver perfusion and hepatocyte isolations for each pair were performed in 
parallel and hepatocyte cytotoxicity was measured imultaneously in the same JAM 
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DNA fragmentation assay. The RT-PCR analysis of these three animal pairs showed 
that hepatocytes from recovered animals exh ibited not only significantly greater levels 
ofCD95L mRNA (?<0.001) but also perforin mRNA (?<0.05), which corresponded to 
17.5-fold and 2.2-fold increases, respectively, compared to hepatocytes from healthy 
controls (Fig. 4.2A). In agreement with the RT-PCR results, the same hepatocytes also 
were significantly more cytotoxic toward CD95-bearing LSI 02.9 (Fig. 4.28) and P81 5 
(Fig. 4.2C) cell targets. The contribution of the CD95L-CD95 pathway was confirmed 
by pretreatment of P815 cells with an antagonistic CD95 Jo2 mAb (Fig. 4.2C). 
Furthermore, the increased perforin expression in hepatocytes from animals 
convalescent from SLAH (Fig. 4.2A) correlated with augmented killing ofCD95-
deficient, perforin-sensitive K562 cells (Fig. 4.2D). The involvement of microtubules 
in this process, characterizing perforin-mediated cell killing, was ensured by significant 
(P<O.OO I or ? <0.05) reductions in K562 cell death in the presence of colchicine, an 
inhibitor of microtubule polymerization (Fig. 4.2D). 
4.3.3 Comparable hepatocyte cytotoxic activity accompanies CHand convalescent 
period after SLAH 
Despite evident hepatic inflammation and significantly greater expression of 
IFNy, TNFa and CD3 in the livers of animals with CH than in those with SLAH (F ig. 
4.1 A), hepatocytes isolated from woodchucks with CH showed the levels of CD95L, 
perforin or granzyme 8 mRNA comparable to those in hepatocytes from woodchucks 
with resolved AH (Fig. 4.1 B). To assess the cytotoxic potential of hepatocytes from 
these two stages of WHY infection, hepatocytes were isolated in pairs from 4 
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Fig. 4.2. The resolution of acute WHY hepatitis is accompanied by increased hepatocyte 
cytotoxic activity. Hepatocytes isolated in parallel from three pairs of healthy animals 
(n=3) and woodchucks who spontaneously resolved SLAH (n=3) were analyzed for 
expression of the cytotoxicity-affiliated genes by real-time RT-PCR (A) and for the 
ability to kill CD95-bearing LS 102.9 (B) and P815 (C) cells, and CD95-deficient K562 
cell targets (D) in JAM DNA fragmentation assays. Expression of each gene tested (A) 
was analyzed in triplicate in each hepatocyte preparation and normalized against ~-actin. 
The CD95-specific Jo2 mAb was applied to abrogate CD95L-CD95-mediated killing of 
P815 cell targets (C), while colchicine was used to disrupt perforin-mediated, 
microtubule-dependent killing ofCD95-deficient K562 cells (D). The results of JAM 
DNA fragmentation assays are shown as mean values± SEM with each experiment 
performed with 4-8 experimental wells per condition. Differences in the levels of gene 
expression (A) or in the cytotoxic capacity (B-D) between hepatocytes isolated from 
animals recovered from SLAH and healthy woodchucks were significant for* at ? <0.05 
and for** at ? <0.001. Jo2 mAb or colchicine-dependent inhibition of cell killing was 
significant in comparison with untreated controls for* at ? <0.05 and for** at P<O.OO I. 
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woodchucks. each pair comprised of one convalescent and one animal with CH. The 
RT-PCR analysis showed again .. (see Fig. 4.1 B) no differences in the hepatocellular 
levels ofCD95L, perforin or granzyme B gene expressions between SLAH and CH 
(Fig. 4.3A). Similarly, hepatocytes from both infection groups killed CD95-bearing 
and CD95-deftcient target cells to the comparable degrees (Fig. 4.38 ), suggesting that 
hepatocyte CD95L- and perforin-dependent cytotoxicity were similarly augmented in 
these two contrastingly different forms of hepadnaviral infection. 
4.3.4 Transfection with WHV X gene but not with complete WHV DNA modifies 
hepatocyte cytotoxic activity 
Our previous findings demonstrated that IFNy and, to a lesser extent, TNFa 
upregulate hepatocyte expression ofCD95L and enhance hepatocyte CD95L-CD95-
mediated cell killing (Guy et at., 2006), while having no effect on the transcription of 
perforin gene and rate ofperforin-mediated cytotoxicity (Guy et at. , 2008, in press, , ce 
Chapter 3). To test whether expression of the complete hepadnavirus genome or genes 
encoding individual WHY proteins, in the absence of liver inflammation, may 
influence hepatocyte cytotoxic activity, the cell killing potential of cultured hepatocytes 
transfected with whole WHY DNA or individual WHY genes was examined. Rea l-
time RT-PCR analysis revealed that cultured woodchuck hepatocytes stably expressing 
complete WHY DNA or those translating WHY pre-S I (large) envelope or WHY core 
protein do not differ in the levels ofCD95L or perforin mRNAs when compared with 
hepatocytes transfected with empty vector (Fig. 4.4A). However. interestingly, 
transcription of the WHY X gene significantly (P<O.Ol ) upregulated both CD95L and 
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Fig. 4.3. Expression levels ofthe cytotoxicity-affiliated genes and the cell ki lling 
potency displayed by hepatocytes obtained after resolution of acute WHY infection and 
during active chronic WHY hepatitis. Primary hepatocytes were isolated from animals 
with CH (n=2) and with past SLAH (n=2). The gene expressions quantified by real-time 
RT-PCR were normalized against expression of P-actin (A). The cytotoxic capacity of 
hepatocytes was examined by JAM DNA fragmentation assays using CD95-bearing 
LS 102.9 and P815 cells and CD95-deficient K562 cell targets (B). Results are shown as 
mean values ± SEM with each experiment performed with 4-8 experimental wells per 
condition. 
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Fig. 4.4. Expression of the cytotoxicity-affiliated genes and the cell killing capacity of 
woodchuck hepatocytes transfected with complete WHY genome or WHY subgenomic 
sequences encoding individual viral proteins. WCM-260 hepatocytes stably transfectcd 
with empty pcDNA3.1 vector (control) or with p-WHY, p-WHs, p-WHc or p-WHx were 
analyzed for expression ofCD95L and perfor1n by real-time RT-PCR (A). Data were 
nonnalized against P-actin expression and are presented as mean± SEM relative to 
control cells transfected with empty pcDNA3.1 vector which were assigned the value of 
100%. The cytotoxic activity ofhepatocytes transfected with pcDNA3.1 alone, p-WHY 
and p-WHx was evaluated by JAM assays against CD95-bearing LS 102.9 (B) and P815 
(C), and CD95-deficient K562 (D) ce11 targets, with each assay performed in triplicate 
with 4-8 experimental wells per condition. Differences in expression of the cytotoxicity-
affi liated genes (A) or in the cytotoxic activity (B-D) after hepatocyte stable transfection 
with complete WHY genome or individual WHY genes were significant in comparison 
with control cells transfected with empty vector for * at P<O.O 1 and for ** at P<O.OO I. 
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perforin mRNA levels in hepatocytes (Fig. 4.4A). In agreement with these findings. 
transfection with complete WHY genome or empty vector did not modulate hepatocyte 
killing ofCD95-bearing LSI 02.9 (Fig. 4.48) or P815 (Fig. 4.4C) cells. while 
transfection with p-WHx significantly (P<O.OOI or P<O.Ol) enhanced elimination of 
both these cell targets (Figs. 4.48 and 4.4C). Furthermore, perforin-dependent 
hepatocyte-mediated killing ofCD95-deficient K562 cells also was meaningfu lly 
(P<O.O I) augmented following transfection of hepatocytes with p-WHx but not with 
the complete WHY DNA or empty pcDNA3.1 vector (Fig. 4.4D) 
4.3.5 IFNy augments CD95L-dependent cell killing by hepatocytes transcribing 
complete WHV DNA but not WHV X gene alone 
To ascertain whether hepatocytes expressing complete WHY genome retain 
their cytotoxic competence and whether the cell killing displayed by hepatocytes 
transfected with p-WHx can be further enhanced, relevant WCM-260 cell lines and 
control WCM-260 hepatocytes were treated with rwfFNy and their cytotoxic activity 
measured against CD95-bearing LSI 02.9 targets. The results showed that while 
rwlFNy stimulation ofhepatocytes transfected with empty pcDNA3.1 vector (Fig. 
4.5A) or with complete WHV DNA (Fig. 4.58) significantly (P<O.OO I or ? <0.05) 
enhanced their cytotoxic capacity, the same treatment was unable to increase the 
number of cells killed by hepatocytes transfected with p-WHx (Fig. 4.5C). This raises 
a possibility that hepatocytes expressing the X gene alone achieved their maximum 
cytotoxic potency prior to exposure to the cytokine and, thus, their killing capac ity can 
not be flllther augmented by !FNy. 
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4.4 DISCUSSION 
Liver inflammation caused by hepadnaviral infection is associated with 
elimination ofhepatocytes and other cells ofthe liver parenchyma, and the degree of 
hepatic tissue injury may vary significantly and range from massive to minimal. It has 
been generally accepted that the induction of hepatitis is largely a consequence of 
activation of virus-specific CTL and bystander recruitment of other inflammatory cells, 
including leukocytes and macrophages (Sitia et al., 2004; Sitia et al., 2002; Thimme et 
al., 2003). Nonetheless, the degree to which these cells directly or indirectly contribute 
to apoptotic or necrotic death of liver cells remains uncertain. Also, it is not clear 
whether cells other than inflammatory infiltrate contribute to or modify the degree of 
liver damage during viral hepatitis. Since our previous findings revealed that 
hepatocytes constitutively express functionally active cytolytic effector molecu les 
CD95L (Guy et al., 2006) and perforin (Guy et al., 2008, in press, see Chapter 3), and 
can efficiently eliminate cell targets, we investigated in the present study whether 
hepadnaviral infection can influence hepatocyte cytotoxic potency mediated by these 
molecules. 
The results obtained in the initial phase of the current study confirmed that not 
only WHY-induced CH but also that resolution ofSLAH is accompanied by 
upregulated hepatic transcription of IFNy and, to a Jesser extent, TN Fa which occurred 
in the context of minimal to moderate inflammatory alterations in the livers of the 
convalescent animals (Hodgson and Michalak, 200 I). Our previous in vitro finding 
(Guy et al., 2006) demonstrated that stimulation with IFNy or TNFa of hepatocytes 
increased their cytotoxicity mediated by CD95L. In general, the results of the current 
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study are consistent with these previous findings and they suggested that an enhanced 
CD95L-dependent cytotoxic phenotype exhibited by hepatocytes might be a 
consequence of intrahepatic elevations in IFNy and TNFa due to active or residual liver 
inflammation. Although chronic WHV hepatitis was associated with a signiticantly (P 
< 0.05; Fig. I) higher hepatic expression of these two cytokines, the level ofCD95L 
transcription did not differ between animals with CH and those recovered from acute 
hepatitis. This may suggest that even a moderate increase in intrahepatic I FNy and/or 
TNFa, as observed after resolution ofSLAH, upregulates expression ofCD95L in 
hepatocytes to the highest level. The significance of the augmented CD95L expression 
is not clear but, hypothetically, it may contribute to removal of other cells, for example, 
activated lymphocytes, as well as pertain to fratricidal lysis ofhepatocytes in inflamed 
livers. ln this regard, CD95 was found to be readily detectable on activated lymphoid 
cells inti ltrating the I iver (Luo et at., 1997). During virus-induced I iver inflammation, 
cytokine-mediated upreguation of CD95L may play a role in hepatocyte self-protection 
and limit immune-mediated hepatic tissue damage. In a similar manner, it has been 
proposed that expression ofCD95L by a-cells in pancreatic islets may temporarily 
protect juxtaposed ~-cells from initial lys is mediated by small numbers of infiltrat ing~­
cell-specific T cells (Signore et at., 1998). However, severe pancreatic infiltrates 
finally overcome the protection afforded by a-cell expression of CD95L and induce ~­
cell death and insulitis via both CD95L and perforin-dependent mechanisms (Pearl-
Yafe et at., 2006). In an analogous manner, sustained and amplified inflammation, 
which is evident during chronic hepadnaviral infection (Maini et at. , 2000), 
accompanied by augmented CD95L expression by hepatocytes may be insufficient to 
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limit the extent of liver damage in severe or advanced hepatitis. There also e.-..:i sts a 
possibility that during chronic hepadnaviral hepatitis. viral proteins may intluence the 
relative susceptibilities of either lymphoid cells or hepatocytes to elimination via 
cytotoxic mechanisms (Michalak et al. , 2000; Nakamoto et al., 1997). 
Interestingly, resolution of acute WHY hepatitis was al so associated with 
upregulated CD95 expression by hepatocytes. It has been suggested that hepatocyte 
expression ofCD95L and CD95 may not be tightly correlated with each other (Luo et 
al., 1997), leading to potential pathogenic effects occurring via a trans mechanism 
wherein CD95L-positive hepatocytes may induce lysis of neighboring hepatocytes 
which are CD95-expressing. In spite of the classical view that the CD95L-CD95 
interaction results in cell death, recent evidence implies a dual role for the CD95L-
CD95 interaction-triggered signaling, wherein CD95L expression results in 
autoproliferation ofCD95-positive cells (Siegel et al., 2000), possibly as a result of 
cellular activation following reverse signaling through its cytoplasmic tail (Suzuki and 
Fink, I 998; Suzuki and Fink, 2000). Taken together, the CD95L-CD95 interaction 
may alternatively be utilized by hepatocytes to promote regeneration. In this regard, 
liver regeneration following partial hepactectomy has been shown to be impaired in 
CD95-deficient mice (Desbarats and Newell, 2000). However, it remains 
undetermined whether hepatocytes required engagement of CD95 or whether 
regeneration occurred as a result ofCD95-mediated signaling and activation of other 
cells. 
Despite increased expression of hepatocellular CD95L in response to IFNy and 
TNFa (Guy et al., 2006), constitutive transcription ofperforin is not upregulated in 
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hepatocytes by these cytokines (Guy et al., 2008, in press, see Chapter 3). Nonetheless. 
the current study demonstrated that hepadnaviral infection invariably leads to an 
increased usage ofthe exocytic pathway by hepatocytes to kill target cells. The data 
from infection with LCMV in perforin-deficient transgenic mice suggest that the 
perforin pathway is fundamental to control the expansion of CTL during LCMV 
infection and its absence is associated with greater hepatic infiltrations constituted by 
both CDS+ and CD4+ T cells (Matloubian et al., 1999). Thus, the perforin pathway 
may represent an alternate mechanism by which hepatocytes may regulate lymphocyte 
trafficking through and their infiltration into the liver. It is interesting to note that 
while recovery from self-limited acute hepadnaviral infection was accompanied by a 
significant increase in hepatocyte expression of perforin and enhancement of 
hepatocyte-mediated lysis of CD95-deficient target cells, the levels of granzyme 8 
mRNA were comparable in hepatocytes derived from healthy animals or from those 
which spontaneously resolved acute WHY infection (Figures I and 2). The apparent 
discrepancy between increased perforin but not granzyme 8 expression is not 
uncommon. Thus, it has been noted that CTL infiltrating the livers in patients 
chronically infected with HCV may differentially express perforin or granzyme 8 
(Pham et al., 2003) . Although the mechanisms underlying discordant display of 
perforin and granzyme 8 are not completely understood, transcriptional regulators are 
known to differentially influence perforin and granzyme B expression (Mori et al. , 
1998; Salcedo et al., 1993). Furthermore, co-expression of these effector molecules is 
not absolutely required, since perforin has been demonstrated to mediate granzyme-8-
independent cytotoxicity (Shresta et al. , 1997). Although investigations determining 
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transcriptional regulation of perforin and granzyme B expression, and the identi tication 
of perforin-dependent, granzyme-B independent cytotoxicity have been invest igated in 
lymphoid effector cells, similar regulatory or effector pathways could also be 
operational in hepatocytes. 
I-ICY has been demonstrated to influence hepatocyte expression ofCD95L via a 
direct effect of the virus nucleocapsid protein (!ken et al., 2006; Ruggieri et a l. , 2003). 
Since primary woodchuck hepatocytes isolated after resolution of acute WHY hepatit is 
demonstrated increased expression and usage ofCD95L as well as perforin in 
comparison with healthy controls, we aimed to determine whether the observed 
differences were due to a direct viral influence. The expression of the HBY X gene has 
been shown to upregulate CD95L mRNA and protein in hepatocytes (Lee et al. , 2002; 
Lin et al., 2005a), a finding which we have confirmed in the current study by 
examining consequences ofthe WHY X gene expression on hepatocyte transcription of 
the cytotoxicty affiliated genes. This effect may be indirect, since human HepG2 cells 
transfected with the HBY X gene have been shown to produce TN Fa. (Lara-Pezzi et al. , 
1998b), which we have found to augment expression ofCD95L in cultured woodchuck 
hepatocytes (Guy et al., 2006). The HBY X gene has also been shown to induce 
secretion of interleukin-18 (IL-18) resulting in autocrine or paracrine upregulation of 
CD95L in hepatoma cells (Lee et al., 2002). Demonstration in our study of upregulated 
transcription of perforin in hepatocytes transfected with WHY X gene is a novel 
finding which adds a further dimension to already well documented transactivating 
capacity of hepadnaviral X proteins (reviewed in (Murakami, 200 I). On other hand, 
the finding that expression of a complete WHY genome does not upregulate CD95L or 
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perforin transcription and hepatocyte cytotoxicity may appear contradictory. However. 
as we have recently documented (Wang and Michalak, 2006) expr€!ssion of either the 
complete WHY genome or the WHY X gene alone, may have completely oppositt: 
effects. Thus, by studying presentation of MHC class I heavy chain on woodchuck 
hepatocytes, we have found, similarly as obser ed in the current tudy, that while 
WHY X gene expre sion significantly augmented the display of MH eta I ant igen, 
expression of complete WHY genome as well as the virus genes encoding for envelope 
and core proteins was without any measurable effect. 
The present study is the first to demonstrate that hepadnaviral infection 
influences the cytotoxic phenotype of hepatocyte and that thi happen irre pecti ve of 
whether liver disease induced is active or quiescently progresses following resolution 
of acute hepatitis. The experimental evidence accumulated in our study implies that the 
increased cytotoxic capability of hepatocyte observed in the course of hepadnaviral 
infection is are ult of virus-induced liver inflammation and predominantly, although 
unlikely exclusively, is induced and maintained by augmented intrahepat ic production 
of IFNy and TNFa. The results obtained seem to negate a possibility that the 
augmented hepatocyte cytotoxic potency could be a direct consequence of virus 
replication advancing in these cells, although a role for defective viru propagation 
associated with over-expression of virus X protein can not be entirely excluded. The 
study provides further evidence that hepatocytes are cytotoxic effectors and can be 
active contributors to the variety of physiological and pathological proce ses engaging 
the liver, including the development and progres ion of hepadnaviral hepatitis. 
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CHAPTER FIVE: INTRAHEPATIC INNATE AND ADAPTIVE IMMUNE 
ACTIVITY IMMEDIATELY AFTER VIRUS INVASION AND IN THE PRE-
ACUTE AND ACUTE PHASES OF HEPADNAVIRAL INFECTION 
S.OSUMMARY 
Previous studies ofHBV-infected patients, in experimentally infected 
chimpanzees and in HBV transgenic mice have demonstrated the importance of broad 
anti-viral innate and adoptive responses in inhibition ofhepadnaviral replication and 
recovery from hepatitis. However, there are no systematic studies or conclusive 
delineations of virolog ical and immunological events occurring immediately after 
hepadnavirus invasion and during the pre-acute phase of hepadnaviral infection. These 
very early events might be of primary importance in determining the prolonged 
incubation period normally observed in hepatitis B and the intrin ic propen ity of 
hepadnavirus to persist. The aim of the current study conducted in the woodchuck 
model of self-limited acute hepatitis B was to determine the intrahepatic kinetics of 
hepadnavirus replication and activation of cell subsets of the innate and adoptive 
immune responses, cytokines and the immune cell effector molecules in sequential 
liver biopsy samples collected from one hour post-infection forward by quantifying 
expression of relevant genes by sensitive assays based on real-time polymera e chain 
reaction. The results revealed that despite a prolonged asymptomatic period preceding 
the appearance of hepatitis, low-level virus replication is established in the liver a 
early as one hour post-infection. Further, viru invasion leads within 3 - 6 hours to 
upregu lated hepatic transcription of genes indicative of activation of antigen presenting 
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cells and NK cells, including significant augmentations in the intrahepatic leve ls of 
IFNy and IL-12 mRNA. Subsequently, NKT cell activation became evident at 48 - 72 
hours post-infection. This phase was associated with a significant reduction in the 
hepatic virus replication, suggesting that this early innate response was, at least 
partially, successful in limiting virus propagation. Nonetheless, this early response was 
not followed by T cell activation and liver infltration until 4-5 weeks later when 
hepatitis became evident. Collectively, the results obtained imply that hepadnavi rus 
replication is established in the liver almost immediately following exposure to a large, 
liver pathogenic dose and that the local anti-viral innate response is promptly activated. 
However, this initial response appears to be insufficient in prompting an effective 
adaptive virus-specific T cell response capable of early virus elimination, as is the case 
in the majority of self-limiting infections caused by other viral pathogens. 
5.11NTRODUCTION 
HBV is the prototypic member of the Hepadnaviradae family of small, 
enveloped, primarily hepatotropic DNA viruses which cause acute and chron ic 
hepatitis and hepatocellular carcinoma (reviewed in Chisari and Ferrari, 1995). 
Hepadnaviruses display highly restricted host specificity. Thus, HBV infection is 
limited to humans and higher primates, while WHV, despite sharing significant 
structural, genomic and antigenic similarities with HBV, infects the eastern North 
American woodchuck (Marmota monax) (Michalak, 1998). Notwithstanding their 
limited host ranges, HBV and WHV induce similar courses of liver di sease which are 
preceded by a long incubation period ranging from 6 weeks to 6 months for hepatitis B 
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and from 4 to I 0 weeks for WHY hepatitis (Chisari and Ferrari, 1995; Menne and Cote, 
2007). In contrast with viraemia and the appearance of adaptive T cell immunity in a 
few days after invasion with most viral pathogens, significant increases in HBV 
replication are not observed until 3-5 weeks p.i . in chimpanzees, while activation of 
HBV-specific adaptive immunity occurs several weeks later (Bertoletti and Ferrari , 
2003; Guidotti eta!., 1999; Thimme et al., 2003). 
Despite the delay in activation ofHBV-specific T cell responses, a robu ·t, 
multispecific T cell reactivity seems to be essential for both induction of AH and the 
significant reduction in virus load and clinical recovery (Penna eta!., 1996; Penna et 
a!., 1997), although it is unable to entirely clear the virus (Michalak eta!., 1994; 
Rehermann eta!., 1996; Rehermann eta!., 1995a). Experimental ev idence acquired 
from the woodchuck model of hepatitis B, as well as the chimpanzee and H B V-
transgenic mouse systems, have clearly indicated the importance of hepadnavirus-
specific CD4+ and CD8+ T lymphocytes and antiviral cytokines, such as I FNa/~, IF y 
and TNFa, in the downregulation of virus replication (Hodgson and Michalak, 200 I ; 
Menne et al., 1998; Menne eta!., 2002; Nakamura et al. , 200 I). While bystander 
recruitment of non virus-specific T cells and other immune subsets greatly contribute to 
liver inflammation and hepatocyte destruction (Maini eta!., 2000; Sitia et al., 2002). 
the role of antiviral cytokines, particularly IFNy, has been ascribed to the ability to 
noncytopathically inhibit hepadnavirus replication (Guidotti et a!., 1994; Guidotti eta!., 
I 999). Elevations in the intrahepat ic expression of IFNy appear sufficient in 
chimpanzees to reduce HBV viraemia before the peak onset ofviru -induced hepatitis, 
as ev idenced by augmented serum alanine aminotransferase (AL T~ (Guidotti eta!.. 
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1999)]). Also, an increased intrahepatic expression of IFNy is consistently detected fo r 
many years following recovery from WHY-induced AH. implying its role in contro l of 
residual (occult) WHY replication continuing after resolution of AH (Hodg on and 
Michalak, 200 I). 
NK and NKT cells are components of the innate immune system. These cells 
are enriched among the resident lymphomononuclear cells in the liver, which are 
capable of producing IFNy and other cytokines within minutes following viral invasion 
(reviewed in (Biron et al., 1999)). The results from studies in HBY transgenic mice 
suggest that artificial activation ofNKT cells via the CD ld-restricted glycolipid a-
galcer can downregulate viral replication (Kakimi et al., 2000; Kakimi et al. , 200 I), 
while non-classical NKT cells may recognize HBY antigens exp~e sed in the liver 
(Baron et al., 2002). It has been suggested that NK or NKT -derived lFNy may be the 
principal mediator of HBY -downregulation in acutely infected chimpanzees (Guidotti 
et al., 1999), while evidence from the woodchuck model suggests that activated, 
cytotoxic NK or NKT cells may contribute to hepatocyte killing and recovery from 
WHY infection (Hodgson et al., 1999). 
Nonetheless, despite findings suggesting that hepadnaviruses may directly 
activate intrahepatic immune cells capable of producing cytokines promoting antiviral 
defense and favoring a TH 1-type T lymphocyte response (Guidotti et al., 1999; Th imme 
et al. , 2003), comprehensive data from a natural model ofhepadnaviral infection are 
lacking. Furthermore, characterization of the liver immune response immed iate ly 
following hepadnavirus invasion has not yet been accomplished. The aim of the 
current study was to recognize, using the woodchuck model ofHBY infection, the 
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nature and the kinetics of intrahepatic immune responses occurring immediately after 
exposure to WHY and during the pre-acute and acute phases ofhepadnaviral infection 
by quantifying hepatic transcriptional activity of genes encoding for pro inflammatory 
and antiviral cytokines and for markers specifYing individual immune cell ub et . 
5.2 MATERIALS AND METHODS 
5.2.1 Study design 
Prior to the study, liver biopsies (LBx I; see Fig. 5.1) were obtained from 29 
young adult healthy, WHV-na'lve woodchucks and their fragments were cryopreserved 
for subsequent DNA and RNA isolations, and fixed in formalin for histological 
examination. All woodchucks were intravenously infected with the same serum-
derived WHY/tm3 inoculum at a dose of 1.1 x I 010 DNase-protected vge (A Y334075; 
(Coffin et al. 2004) and they were randomly subdivided into groups, each comprised of 
at least two animals (see Table 5.1 ). Beginning at one hour post WHY injection, li ver 
biopsies (LBx 2) were collected according to the scheme shown in Figure 5.1. Follow-
up liver tissue samples (LBx 3) were obtained approximately 6 weeks thereafter (see 
Fig. 5.1 ). Serum and PBMC samples were collected weekly until I 0 w.p.i. and then 
monthly for up to 6 to 36 months until euthanasia. Liver tissue, PBMC and serum 
samples, including those collected at autopsy, were cryopreserved for analysis. 
5.2.2 Serological assays and assessment of liver inflammation 
Detection of serum WHsAg and anti- WHc was done using immunoassay 
reported previously (Coffin et al., 2004; Michalak et al., 2004: Michalak et al.. 1999). 
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Figure 5.1. Schematic representation ofthe time-line of acquisition of liver tissue 
samples from a cohort of WHY-infected woodchucks investigated in the current study. 
Liver biopsies (LBx 1) were obtained from each healthy, WHY-na'lve animal (n = 29) 
prior to inoculation with WHY. The animals were then blindly randomized, injected with 
a liver pathogenic does of WHY containing 1.1 x 1010 vge, and the second liver biopsy 
(LBx 2) was taken beginning from one hour post-inoculation (p.i.) as shown in the 
scheme. The third liver biopsy (LBx 3) was collected at approximately 6 weeks p.i. The 
animals (n = 29) were followed for 6 to 36 months prior to autopsy. 
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Table 5.1. Experimental groups according to the time elapsing between inoculation 
with WHY and acquisition of liver biopsy sample 
Groupffime period 
post-WHY inoculation 
·---·--- ---
umber of I iver biopsies Liver biop y sequ~::ntial 
number 
---------- --- ----- ----- --- ----··- -
0 
I - 3 hours 
3 - 6 hours 
18 - 48 hours 
48 - 72 hours 
4 - 8 days 
2 week 
3 week 
4 week 
S week 
6 week 
7 week 
8 week 
9 week 
10 week 
>6 months 
29 
s 
2 
3 
3 
10 
2 
2 
2 
4 
4 
9 
2 
2 
8 
29 
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I 
2 
2 
2 
2 
2 
2 
2 
2 
3 
3 
3 
3 
3 
4 
Histological examination of paraffin-embedded liver tissue fragments was performed 
following routine processing and staining with hematoxylin and eosin, as reported 
(Hodgson and Michalak, 2001). Morphological assessment ofhepatocellular. 
extrahepatocellular intralobular and periportal lesions was graded applying previously 
described criteria (Hodgson and Michalak, 200 I; Michalak and Lin, 1994; Mkhalak et 
al., 1990). 
5.2.3 Nucleic acid isolations 
Total DNA was extracted from 250-~1 serum samples or approximately 50 mg 
of liver tissue using proteinase K digestion, phenol-chloroform-isoamyl alcohol 
method, as reported (Michalak et al., 2004; Michalak et al., 1999). Total RNA was 
isolated from liver biopsy samples using Trizol reagent (Invitrogen, Carlsbad, CA). as 
per the manufacturer's instruction. RNA was treated with DNase to remove potent ially 
contaminating DNA (RNase-free, DNase digestion kit; Sigma, Oakville, 0 , Canada) 
prior to reverse transcription to eDNA, as described elsewhere (Guy et al., 2006). 
5.2.4 Detection of WHY DNA and RNA by real-time PCR or RT-PCR 
Quantitative assessment of WHY DNA load was done by real-time PCR 
analysis using 2 ~I of serum-derived DNA or 50 ng of liver biopsy DNA and the Roche 
lightcycler (Roche Diagnostics, Laval, PQ, Canada). WHY DNA amplicons were 
generated using the forward primer 5 ' -A TGCACCCA TTCTCTCGAC and reverse 
primer 5'-CTGAGCAGCTTGGTT AGAGT, yielding a 22 1-bp ti·agment which was 
detected by YBR green I incorporation. Copy numbers of WHY DNA were 
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calculated by extrapolation from a standard curve which was generated using I 0-fold 
serial dilutions of plasmid containing known copy numbers of WHY DNA. WHY 
RNA was similarly detected using 2 J..ll of eDNA or equivalent to SO ng total RNA. 
The speciticity of real-time PCR products was confirmed by nucleic acid hybridization 
(NAH), i. e., Southern blot hybridization analysis, using WHY-specific radiolabelled 
probes and autoradiography, as reported (Coffin et at., 2004; Michalak et al.. 2004). 
The sensitivity of the real-time PCR assay was <200 vge/J..lg DNA or RNA, or <50 
vge/ml serum. 
5.2.5 Detection of WHV cccDNA 
WHY cccDNA, representing virus genome replicative intermediate, was 
detected in liver biopsy samples by PCR amplification (sensitivity of I 02 vgchtg), as 
previously described (Lew and Michalak, 200 I; Michalak et al., 2004). Briefly, 4 ug of 
DNA was digested with mung bean nuclease prior to PCR amplification with 
oligonucleotide primers spanning the nicked region of the WHY DNA genome. PCR 
amplicons specificity was routinely confirmed by NAH, as reported (Coffin et al., 
2004; Michalak eta!., 2004). 
5.2.6 Identification of woodchuck cellular gene sequences 
To facilitate analysis of the spectrum and the dynamics of intrahepatic immune 
response to WHY infection, a number of woodchuck gene sequences encoding 
different immune cell specific markers, immune cell effector molecules and cytokines 
were determined applying a strategy previously reported (Guy et al., 2006). In generaL 
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woodchuck gene sequences were ident ified by RT-PCR using degenerate primers 
which sequences were deduced through interspec ies comparison of the sequences 
available in Genbank. The resulting amplicons were cloned into the PCRII TOPO TA 
cloning system (Invitrogen) and then the excised fragments sequenced in both 
directions. Table 5.2 presents the list of woodchuck genes for which hepatic 
expression was quantified in the current study and the primer pairs used for their 
amplification. 
5.2.7 Analysis of woodchuck gene expression by real-time RT-PCR 
Real-time RT-PCR assays were developed for each cellular, effector molecule 
and cytokine gene analyzed, using the Roche lightcycler and SYBR green I detection 
and PCR primer pairs given in Table 2. Changes in gene expression levels were 
determined by comparison to the baseline level of each gene transcription detected in 
the liver biopsy obtained prior to infection with WHY for each individual anima l after 
normalization to expression of the housekeeping gene P-actin. Following measurement 
of a given gene expression in a particular liver sample, the mean expression level was 
determined for all liver biopsy samples within the experimental groups, as shown in 
Table 5.1. 
5.2.8 Inactivation of WHV serum pool 
To ascertain that the observed changes in the intrahepatic gene expression 
levels were truly related to infection with WHY but not to injection 'vvith serum 
components present in the WHY inocolum, a control experiment was performed. Thus. 
166 
Table 5.2. Primer sequences used in the current study for real-time RT-PCR 
quantifications of expression of woodchuck genes encoding immune cell markers. 
cytokines and cytotoxicity effector molecules 
---------
Gene Primer Expected size GenBank 
sequence of amp Iicon access tOn 
(bp) number 
-----~--- ----
CD3 F -ctgggactctgcctcttatc 536 AF232727 
R -gctgccctttccggatgggctc 
CD4* F -ggagaataagaagatagagg 560 EF62 1765 
R-tcaagagtcacagtcagg 
CD8* F -aacgagggctactatttctgctc 309 EF62 1766 
R-gtttccggtggtgacagatga 
CD40 Ligand* F -agcatgtgtgctacagt 214 EF6:! 1770 
R -ccgccctgagtaagatt 
COld* F -tcctagattagggaagtcagaac 222 EF62 1767 
R -gctcggagataccacg 
NKp46* F -ttgccacctagtgacag 200 EF62 1768 
R-caccaggagcatcacc 
CD95 Ligand F-ccatttaacaggtaagccc 250 AF 152368 
R -tcatcatcttgccctcc 
Perforin F -gcatcaacaatgactggcggg 302 AF298158 
R -tgaagtgggtgccgtagttgtgg 
IL-4 F -tttgctgtccccaagaac 200 AF333965 
R-cctggattcactcacgg 
IL-8* F-ggtaacctgcctactttc 207 EF216348 
R -gttcaggcaaagctct 
ILI2p40 F-ttggattggcaccctgacac 198 X97019 
R-gcatctggctcagaacttcac 
IFNy F -aggagcatggacaccatca 215 AF232728 
R -ccgaccccgaatcgaag 
TN Fa F -tgagcactgaaagtatgatcc 283 AF333967 
R-tgctacaacatgggctacag 
2',5'-0AS F -tcaggcaaaggcactaccc 150 AF082498 
R -acttctctttcggacatgct 
F, forward primer; R, reverse primer. 
• Woodchuck gene sequence identified fo r the purpose of the current tudy. 
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WHY/tm3 infectious inoculum was inactivated by treatment ,~-,· ith 50 ~tg/ml psora kn 
(Sigma) combined with exposure to 365 nm UV for 90 min at 4° C. Animals Vv ere 
injected intravenously with 0.5 ml ofpsoralen-inactivated serum, containing equi va lent 
to 1.1 x I 010 vge, or with 0.5 ml of similarly treated healthy woodchuck serum. The 
animals were euthanized 3 days post injection. 
5.2.9 Accession numbers of woodchuck gene sequences identified 
The accession numbers for the woodchuck gene fragment equences established 
in the course ofthe current study and submitted to GenBank were a fo llows: 0 4 
gene, EF621765 ; CD8 gene, EF621766; CD40 Ligand (CD40L), EF62 11 70; CD I d, 
EF621767; NKp46, EF621768, and interleukin-8 (IL-8), EF-126348. 
5.3 RESULTS 
5.3.1 Serologic and hepatic profiles of WHV infection 
Inoculation of woodchucks with a WHY dose of 1.1 x I 010 vge resulted in 
transiently serum WHsAg-positive infection in all 29 animals. The mean time of 
WHsAg appearance was 18.5 days, while its average duration in the circulation was 
35 .8 days. Anti-WHc appeared on average at 32.6 days after inoculation with WHY 
and they were detectable until the end of the observation period (Fig. 5.2A). The 
pattern of serum WHsAg positivity implied, based on the known serological and 
histological profiles of experimental WHY infection induced with liver pathogenic 
doses of infectious WHY (Michalak et al., 2004), that a self-limited epi ode of AH had 
developed in all woodchucks investigated. 
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Figure 5.2. Serological and molecular analyses of WHY infection markers following 
inoculation with a WHY infectious pool containing l.l x 1010 vge per dose. (A) 
Circulating WHY surface antigen (WHsAg) and antibodies to WHY core (nucleocapsid) 
antigen (anti-WHc) were detected by specific ELISA in serial serum samples collected as 
described in Materials and Methods. WHY DNA was quantified by real-time PCR in 
DNA samples extracted from serum or liver biopsy samples. Levels of WHY RNA were 
detem1ined by real-time RT-PCR using eDNA transcribed from total RNA isolated from 
liver tissue. WHY DNA or WHY RNA copy numbers are presented as the mean 
expression levels determined for each experimental group of animals as identified in 
Table 1. (B) RNA was extracted from liver biopsies obtained at one hour (n = 2), 2 hours 
(n = 2) and 3 hours (n = 2) post-infection with WHY. RNA samples were treated with 
DNase prior to transcription (RT+) or not (RT-) to eDNA, as described in Materials and 
Methods. WHY eDNA equivalents to 50 ng of total RNA were subsequently quantifi ed 
by real-time PCR and amplicons visualized by agarose gel electrophoresis and Southern 
blot hybridization analysis using 32P-Iabeled recombinant WHY DNA as a probe. 
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In previous studies, hepadnaviral DNA in the circulation and its replication 
status in the liver was never assessed in the first few days after exposure to the virus. 
In the current study, WHY DNA was quantified in serum and liver tissue samples 
acquired from one hour p.i. forward. Not surprisingly, WHY DNA was detectable in 
serum at the first time point of examination, i.e. , one hour p.i. (Fig. 5.2A). This was 
due to carry over of WHY genomes from the inoculum which contained a massive 
amount of virus, i.e. , I. I x I 010 DNase-protected vge. Subsequently, the serum level of 
WHY DNA progressively decreased until48-72 hours p.i. and then slowly increased 
until a sudden expansion at 3 to 4 weeks p.i. (Fig. 5.2A), culminating in peak detection 
at week 7 p.i. (a mean level of 3.2 x 1010 vge/ml). The mean WHY DNA level in the 
circulation showed minor fluctuations during the peak phase of acute WHY infection, 
occurring between weeks 6 and 9 p. i., prior to a sudden protraction by more than 7 log 
after week 9 p.i. (Fig. 5.2A). However, in agreement with our previous studies 
(Hodgson and Michalak, 200 I), WHY DNA remained consistently detectable in serum 
at a mean level of 175 vge/ml during follow-up lasting up to 3 years p.i. 
WHY genomes were also detectable in hepatic tissue beginning from one hour 
after inoculation with virus. WHY DNA load transiently and uniformly in all animals 
declined slightly and not significantly between 3-6 hours p.i. and significantly (P = 
0.004) between 48-72 hours p.i. reaching a level approximately I 0-fold lower than that 
detected between one and 6 hours p.i. (Fig. 5.2A). Paralleling WHY DNA detection in 
serum, the intrahepatic level of WHY DNA exhibited a sudden exponential increase at 
3-4 weeks p.i. (Fig. 5.2A) prior to reaching the mean peak detection of 4 x I 09 vge/11g 
total DNA at 7 weeks p.i. Despite a greater than 4 log reduction in hepatic WHY DNA 
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load beginning at week 9 p.i., WHY genomes were consistently detectable in the liver 
for up to 3 years p.i. at a mean level of2.3 x 104 vge/11g total liver DNA. 
It remained unclear whether the WHY DNA detected in the liver in the first few 
hours post-exposure reflected the virus originating from the inoculum, which was 
passing through or was trapped within hepatic tissue, or from the virus active ly 
replicating in hepatocytes. However, the finding of a transient but significant (P = 
0.004) lowering in the hepatic load of WHY DNA at 48-72 hours p.i. which was 
replenished 24 hours later. strongly suggested that the virus was actively rep I icating, at 
least from 96 hours p.i. forward. 
To directly determine the status of WHY replication in the liver, a PCRINAH 
assay specifically detecting WHY cccDNA was employed. The resu lt showed that 
WHY cccDNA signal was not detectable between one and 6 hours p.i. , but was ev ident 
in the liver at 18 hours p.i. and forward (data not shown). 
By applying real-time RT-PCR detecting WHY RNA, low quantities of WHY 
transcripts (2.6 x I 02 copies per J..lg total RNA) were identifiable as early as one hour 
p.i. (Fig. 5.2A). In contrast with hepatic WHY DNA, which level only slightly 
increased until 3-4 weeks p.i., WHY RNA level showed a steady, prominent 
augmentation beginning at one hour p.i. and peaking at a mean level of 7.2 x I 08 WHY 
transcripts per J..lg total RNA between weeks 8 and 9 p.i. (Fig. 5.2A). A possibility of 
contamination of eDNA preparations with viral DNA was excluded by DNase 
treatment of RNA samples prior toRT reaction and by PCR amplification of both 
transcribed and non-transcribed mRNA samples. As shown in Figure 5.28, only RNA 
samples which were reversely transcribed demonstrated WHY eDNA signals, \~v hil e 
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those similarly treated in the absence of reverse transcriptase remained negative even 
when the amplification products were analyzed by-NAH. These results confirmed 
strict specificity of the WHY RNA detections. Taken together, the result showed that 
infection with a massive, liver pathogenic dose of WHY results in an immediate. 
although low-level infection ofthe liver as evidenced by detection of viral tran cripts 
as early as one hour p.i. 
5.3.2 WHV invasion promptly activates antigen presenting cells in the liver 
Since injection with WHY resulted in the initiation of virus replication in the 
liver as early as one hour p.i., it was of interest to determine whether the virus may 
activate APC, which should be the fist cell type recognizing viral intrusion . In this 
regard, the liver expression of IL-12, a key cytokine produced by APC involved in 
innate immune responses (Ma and Trinchieri, 200 I), I L-8, a strong chemoattractant 
mediating chemotaxis of phagocytic cells (Kobayashi, 2008), CD I d, a key molecule 
facilitating antigen presentation by APC to NKT cells (Baron et al., 2002: Kronenberg 
and Gapin, 2002), and CD40L involved in activation of APC via CD40-CD40L, were 
quantified by real-time RT-PCR assays specifically developed for the purpose of this 
study. 
Figure 5.3 shows that lL-12 achieved a maximum hepatic expression (- 20-fold 
increase over the pre-infection level ; P = 0.02) between 3 and 6 hours p.i. (Fig. S.J A, 
left panel). In contrast with this early increase, the remaining course of WH Y 
infection, including the period of histologically evident AH with peaking liver injury 
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Figure 5.3. WHY infection upregulates intrahepatic genes indicative of activation of 
antigen presenting cells. (A) Expression of IL-12 and LL-8 . (B) Expression of CD I d and 
CD40L. mRNA levels were quantified by real-time RT-PCR in liver biopsy samples 
collected at time points post-infection as outlined in Table 1. Data shown represent the 
mean expression levels for each group of animals analyzed at the time point indicated and 
are presented relative to the maximum level detected for each gene analyzed. Mean level 
of intrahepatic WHY DNA was determined as described in Materials and Methods and in 
the legend to Figure 2A. WHY DNA profiles are shown for the time periods between 0 
and 2 weeks p.i. and between 2 and 10 weeks p.i. is shown for reference in each panel. 
Abbreviations: h, hour; d, day and wk, weeks post-inoculation with WHY. 
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between weeks 6 and 8 p.i., was'' ithout an noticeable increase in expression nl' thi s 
cytokine (F ig. 5.3A, right panel) . 
The transcription level of I L-8 increased (P = 0.1) by 12.5-fold with in one to 3 
hours p.i. over that detected in the period prior to infection (Fig. 5.3A, left pam:l). 
llowever, the maximum expression of this cytokinc (a 35-fold increase over the pre-
in fcction level ; P = 0.05) occurred at week 7 p. i ., during the phase of acute I ivcr 
inflammation (Fig. 5.3A, right panel). 
Since strong induction ofiL-12 expression detected at 3-6 hours p.i. could be 
directly associated with activation of APC (Ma and Trinchieri, 200 I ), the intrahepatic 
expression of CD I d, which facilitates antigen presentation to NKT, cells was also 
evaluated. The results showed that the level of COld mRNA reached a peak (a - 3- lo ld 
increase over the pre-infection level ; P = 0.03) by 48 - 72 hours p.i. (F ig. 5.38, left 
panel). Then, the level subsided until WHY replication was drastically augmented at 3-
4 weeks p.i. (Fig. 5.38 , right panel). Thus, the upregulated expression of COl d at 48-
72 hours was associated with a significant one log decrease in the hepatic WHY DNA 
load. Furthermore, the concomitant increase (P = 0.02) in CD40L expression (Fig. 
5.38, left panel) suggested reciprocal activation of APC via CD40-CD40L interaction. 
5.3.3 Activation of hepatic NK and NKT cells immediately follows infection with 
WHV 
WHY infection appeared to induce two distinct phases of very early immune 
activation in the liver, one between 3- 6 hours and a second at 48 - 72 hours p.i . ' incc 
experimental evidence from other viral infections clearly indicate the abi lity or K and 
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KT cells to respond within minutes or hour to virus by secn.:tion of II ,.Ny or b) 
acquisition of cytotoxic function (Biron et al., 1999), C:\pression of the gene encoJ ing 
the NK receptor Kp46 was investigated. 
Furthermore, since IL-12 is recognized as a key cytokine which influences If- y 
secretion by K cells, and also increases NK-mediated cytotoxicity. which is primarily 
facilitated by the perforin pathway (Maretta et at. , 2007), perforin mRNA leve ls were 
also quantified. The results showed that the earliest increase in transcription or I L- 12, 
occurring between 3 to 6 hours p.i . (Fig. 5.3A, left panel) coincided with moderately 
increased expression ofNKp46 (a 2.5-fold induction; P = 0.13) and perforin (a 3.4-fold 
induction; P = 0.13) (Fig. 5.4A and Fig. 5.48, left panels, respectively), suggesting 
activation ofNK cells at this very early stage. Furthermore, transcription of IFNy was 
also significantly (a 3.3-fold; P = 0.0 18) increased at the same time (Fig. 5.48, left 
panel), further supporting possible activation ofNK cells. 
As it was shown in Figure 5.38, the early ex pre sion of CD I d peaked at 48-72 
hours p.i. This finding raised the possibility that APC may, at this stage, display an 
increased capacity to present antigens to CD I d-restricted NKT cells (Kronenberg and 
Gapin, 2002). The activation ofNKT cells may result in upregulated expressions of 
IFNy, as well as IL-4 (8endelac et at., 2007). As the data obtained indicated. enhanced 
CD I d expression was associated with relatively slight but noticeable increases in both 
IFNy (a 4-fold; P = 0.032) and IL-4 (a 2-fold; P = 0.065) transcription at 48 - 72 hours 
p.i. (Fig. 5.48, left panel) . 
After week 2 p.i., not surpri ingly. IFNy and perforin mRNA levels reacheJ 
their maximum at week 7 p.i ., during the peak of histologically evident liver injury, 
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Figure 5.4. Expression profiles ofhepatic genes indicative of activation ofNK and NKT 
cell subsets in woodchucks inoculated with WHY. Liver biopsy samples were analyzed 
by real-time RT-PCR for expression of cytokines and activation molecules associated 
with (A) NK cells, (B) NKT cells and (C) antiviral innate activity. Data shown represent 
the mean expression levels for each group of animals at the time point indicated, and are 
presented relative to the maximum level detected for each gene analyzed. Mean 
detection levels of intrahepatic WHY DNA was detennined by real-time PCR analysis 
and presented as described in the legends to Figures 2A and 3. 
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which is normally characterized by liver lymphornononuclear infiltration (see Fig. 
5.5/\) (Michalak. 1998). Intriguingly, intrahepatic transcription of IL-.f and th:11 nfth~: 
NK cell marker, NKp46, reached maximum at week 3 p.i., i.e .. before viral expansion 
in the liver (J7ig. 5.48. right panel). 
Activation of innate immune effector mechanisms in response to hcpadnaviral 
infection was further suggested by an augmented expression of the anti-viral 2'-5"-
0AS (Fig. 5.4C). Thus, detection of WHY DNA and WHY RNA, as early as one to 3 
hours p.i., was associated with a slight increase (I. 7-fold; P = 0.14) in 2 ·-5"-0AS 
mRNA level, as determined by real-time RT-PCR (Fig. 5.4C, left panel). Furthermore, 
a significant increase (P = 0.05) in 2 ' -5'-0AS at 48 - 72 hours p.i. (Fig. 5.4C, left 
panel) correlated with a significant (P = 0.03) elevation in IFNy expression (Fig. 5.48. 
left panel), a known inducer of2 ' -5'-0AS (Mullan et al., 2005; Wang et al. , 2007). 
Evaluation of the induction of2"-5'-0AS in all animals examined at 48 - 72 hours p.i. 
(including those presented in Figure 5.6; total n = 7), a significant increase increase in 
mRNA expression was observed (P = 0.02). This occurred at the time when hepatic 
WHY load significantly decreased. Taken together, this pattern of events strongly 
supports the possibility that the transient upregulation of hepatic IFNy occurring in the 
first 72 hours following hepadnaviral exposure was biologically relevant and exerted a 
strong antiviral effect. 
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5.3.4 Intrahepatic CD4+ and CD8+ T cells arc quiescent for weeks after WHY 
infection 
The prominent reduction in hepadnavirus replication and reso lution or /\II 
appear reliant upon a strong and multispecific antiviral T cell response which is 
characterized by secretion of IFNy and TN Fa (Guidotti et al., 1994; Guidotti and 
Chisari, 200 I). To assess whether the observed initial elevations in intrahepatic 
expression ofiFNy (Fig. 5.48, left panel) could be due to the presence ofactivated T 
cells, hepatic expression ofCD4, CD8 and CD3 T cell markers was quantified. It was 
found that CD4 and CD8 mRNA levels were slightly elevated (20-25% over the pre-
infection levels; P = 0.18 and P = 0.12, respectively) in the first 3 hours post WHY 
exposure, then their levels subsided and remained consistently low (I 0-15% of the pre-
infection levels; P = 0.3 and P = 0.2, respectively) until week 4 p.i. (Fig. 5.5A, left 
panel). However, not surprisingly, very prominent increases in the mRNA levels of 
CD4 (a 8.3-fold increase; P = 0.0 17) and CD8 (a 26.7-fold increase; P = 0.03) were 
detected during the peak of histologically evident liver inflammation, which al so 
correlated with detection of the maximal levels of IFNy mRNA (a 31.3-fold induction: 
P = 0.003) and TN Fa mRNA (a 17-fold induction; P = 0.07) (Fig. 5.5A, right panel) . 
In contrast to CD4 and CD8, the level ofCD3 mRNA showed a distinctive peak (a 2.9-
fold increase; P = 0.03) at 48 - 72 hours p.i. (Fig. 5.5A, left panel). Subsequently. the 
CD3 expression level became again augmented beginning from week 3 p.i .. preceding 
by approximately one week the rise in the CD4 and CD8 transcription. Then, the 
expression profiles ofCD3, CD4 and CD8 paralleled each other both during and after 
acute phase of hepatitis (Fig. 5 .SA. right panel). These results suggested that 
181 
Figure 5.5. Expression ofT cell-affiliated genes in sequential liver samples collected 
from animals infected with a liver pathogenic dose of WHY. (A) Real-time RT-PCR 
analyses of CD3, CD4 and CD8 T cell markers and expression of antiviral cytokines 
IFNy and TNFa in liver biopsy samples collected as outlined in Figure I. (B) The levels 
of the cytotoxic effector molecules CD95L mRNA and perforin mRNA were si milarl y 
determined. Data shown represent the mean expression levels for each group of animals 
at the time point indicated, and are presented relative to the maximum level detected for 
each gene analyzed. Mean detection levels of intrahepatic WHY DNA was detennined 
and presented as outlined in the legends to Figures 2A and 3. 
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upregulated intrahepatic expression of IFNy (F ig. 5.48, left panel) or T Fa (a 2.2-ruld 
increase over the pre-infection level; P = 0.08) (Fig. 5.5A, left panel) detected at 48 -
72 hours p.i . reflected activation of cells of the innate immune system rather than 
conventional T cell subsets, however a contribution of the latter cannot be cnmplctcly 
exc luded. The augmented expression ofCD3, COld (Fig. 5.38, left pane l) and IFNy 
(Fig. 5.48, left panel) at 48 - 72 hours p.i. implied that NKT cell.· also became 
activated shortly after exposure to pathogenic hepadnavirus. 
In addition, the enhanced expression ofCD3 , preceding the rise in CD4 and 
CD8 expression during the acute phase of WHY hepatitis (Fig. 5.5A, right panel) and 
co-occurring with the augmented transcription ofNKp46 may suggest that the 
activation of both NKp46-positive NK cells and CD3-positive NKT ce lls was taking 
place before major infiltration of the liver with CD4+ and CD8+ T lymphocytes (F ig. 
5.5A, right panel). In addition, it appears that CD3-positive NKT ce lls at this relatively 
late stage of infection, i .e., week 3 p.i., were responding by producing IL-4 (Fig. 5.48, 
right panel). 
5.3.5 Upregulated transcription of CD95L and perforin correlates with early 
immune response to WHV 
Figure 5.58 (left panel) and Fig. 5.4A (left panel) show that the intrahepatic 
expression of perforin was moderately elevated at 3 to 6 hours (3.4-fold: P = 0. 13) and 
also augmented ( 1.9-fold; P = 0.05) at 48 - 72 hours p.i. To ascerta in whether an 
increase in the liver local cytotoxic activity might be responsible to r the transient 
decrease in hepatic WHY DNA detected at 3-6 hours and 48-72 hours p.i .. e.\pression 
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ofCD95L, an effector molecule capable of inducing death ofhepatocytes which an: 
naturally endowed with CD95 (Ogasawara et al., 1993), \>Vas quantified by real-time 
RT-PCR. As sho\ n in Figure 5.58 (left: panel), CD95L was signi ficantly (P = 0.03) 
upregulated (a 2.6-fold) at 48 - 72 hours p.i., suggesting that indeed augmented hcratic 
cytotoxicity, possibly mediated by both perforin and CD95L, might contribute to the 
transient depletion of WHY DNA seen at 48-72 hours p.i . In the time period after 
week 2 p.i., CD95L expression in the liver became noticeably enhanced, reaching 
maximum (a 4.8-fold increase; P = 0.0 I) at week 4 p.i . (Fig. 5.58, right panel). 
Surprisingly, this CD95L mRNA peak preceded both the expansion of virus in hepatic 
tissue as well as the rise in CD4 and CD8 mRNA levels coinciding with histologically 
evident AH (Fig. 5.5A, right panel). On the other hand, this peak ofCD95L expression 
occurred together with the upregulated transcription of CD3, suggesting a possible 
contribution ofNKT cells to the increased intrahepatic detection ofCD95L. However, 
we have previously reported that also hepatocytes constitutively express CD95L (Guy 
et al., 2006). Thus, it cannot be completely excluded that increased intrahepatic 
detection of CD95L mRNA was not related to elevated expression by hepatocytes. 
5.3.6 WHY invasion reproducibly induces liver immune activation at 72 hours 
post-exposure 
To confirm that inoculation with a large dose of WHY was associated with 
activation of intrahepatic immune response as early as 72 hours p.i .. two additional 
healthy woodchucks were intravenously injected with 1.1 x I 010 vge of the WHY/tm3 
inoculum and were euthanized at 3 days p.i . In agreement with the first set of our data, 
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significant elevations in CD3, Kp46 and CD I d expression levels were detected T2 
hours after injection with virus, suggesting an accumulation and/or local activation of 
NK and NKT cells (Fig. 5.6A). However, tran criptions ofCD4 and CD8 were also 
meaningfully upregulated (by 4 7% and 21%, P = 0.00 I and P = 0.003. respectively) 
""hen compared with the hepatic expression of these genes prior to WilY infection 
(Fig. 5.6A). Despite these increases, we did not notice any morphological evidence of 
inflammatory infiltrations at this time point, which may suggest that this augmented 
expression could be due to the activation of the cells already residing within the liver. 
Quantification of the cytokine expression levels at 72 hours p.i. also confirmed 
the first set of data which showed significant elevations of IFNy and I L-4, possibly 
reflecting activation ofNKT cells (Fig. 5.68). Jn addition, a significant (P < 0.000 I ) 
increase in TN Fa may reflect activation of intrahepatic macrophages, as was previou ·ly 
suggested in regard to a transient elevation in IL-12 mRNA (Fig. 5.3A, left panel) at 3 
to 6 hours p.i., which had subsided by 72 hours p.i. (Fig. 5.3A, left: panel and Fig. 
5.68). Similarly, as shown in Figure 5.4C (left: panel), detection of2"-5'-0AS mRNA 
was significantly (P = 0.00 17) elevated at 72 hours (Figure 5.68), implying that the 
invading WHY is recognized by effector immune cells. Finally, expression of both 
cytotoxic effector molecules CD95L (P < 0.000 I) and perforin (P = 0.047) were 
significantly elevated at 72 hour p.i. (Figure 5.6C), rai ing the possibility that both 
noncytopathic as well as cytotoxic mechanisms may be activated in the liver against 
WHY at this very early stage of infection. 
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Figure 5.6. Challenge with a WHY inoculum, but not with inactivated hepadnavirus, 
upregulates genes indicative of intrahepatic immune response activation at 72 hours post-
infection. Two adult woodchucks were injected with a large infectious dose of WHY (I 
x 1010 vge) prior to euthanasia 72 hours later. Real-time RT-PCR analyses were 
performed to determine intrahepatic expression of selected markers denoting (A) immune 
cell subsets, (B) anti-viral cytokines and mediators or (C) cytotoxic effector molecules. 
Data represent the mean gene expression levels determined for both woodchucks, with 
each eDNA sample analyzed in triplicate. In control experiments (D), woodchucks were 
inoculated with 0.5 ml healthy woodchuck serum or with 0.5 ml of the previous serum 
WHY inoculum, containing I x 1010 vge, which had been inactivated by treatment with 
psoralen and UV light. Animals were sacrificed 72 hours p.i. and intrahepatic mRNA 
levels of selected genes indicated were quantified by real-time RT-PCR. Gene 
expression levels shown in panels A - D are presented relative to those determined in 
healthy liver biopsy samples of the same animals obtained prior to injection with the 
infectious WHY-serum pool or inoculation with healthy control or inactivated serum. 
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5.3.7 Infectious WHY is required to activate hepatic immune response 
To exclude the possibility that exposure not to WilY but to components or 
erum carrying the vi rus might be responsible for activating intrahepatic immune 
reactivity detected at 72 hours a llcr inoculation, additional control experiments "'ere 
performed using inacti vated inoculum or healthy control erum. For this purpos~.:, a 
sample of woodchuck serum serving as WHY/tm3 inoculum and containing 1.1 x 10 10 
WHY vge and serum from a healthy woodchuck were treated with psoralen and 
exposed to ultraviolet light, as outlined in Materials and Methods. As shown in Figure 
5.60, inactivated WHY inoculum or similarly treated control serum were unable to 
upregulate expression ofthe hepatic genes which have been previously found to be 
significantly augmented at 72 hours post-exposure. Specifically, there were no 
increases in IFNy or COJ mRNA levels and no induction of2'-5'-0AS (Figure 5.60). 
These results confirmed that productive WHY infection, but not exposure to vira l 
antigens or serum components, was responsible for activation of intrahepatic immune 
responses as depicted in our study. 
5.4 DISCUSSION 
A unique feature of hepadnaviral hepatitis is a prolonged incubation period 
where no apparent clinical symptoms or biochemica l evidence of I iver injury are 
ev ident. Previous studies, in both the woodchuck model of hepati ti B (Cote et al.. 
2000; Menne and Cote, 2007; Menne et al., 1998) and in HBY-infectcd chimpanzee 
(Murray et al., 2005; Wieland et al., 2004b), have suggested that viral replication 
remains largely undetectab le until 3-4 weeks p.i ., at which time exponential viru 
189 
expansion leads to infection of all or almost all hepatocytcs. These studies ha\ e al !:>o 
demonstrated that antiviral immunity, mediated predominantly by virus-spec ilie CDS 
CTL via both non-cytolytic and cytotoxic mechanism , is finally responsible for 
downregulation of hepadnaviral replication and clinical recovery from hepatitis. 
Furthermore, manipulations ofthe antiviral immune response in ~mY-transgenic mice 
have suggested an involvement of innate immune cell subsets in inhibition of vi ral 
replication (Kakimi et al., 2000; Kakimi et al., 200 I). Previous observations in HBY-
infected chimpanzees (Wieland et al., 2004b) and WHY-infected woodchucks 
(Hodgson et al., 1999) have also suggested an involvement of the innate immune 
system in controlling hepadnavirus infection. However, these studie commenced 
evaluation of virus replication and intrahepatic immune responses not earlier than one 
week (Wieland et al., 2004b) post-infection. It is expected, based on the data from 
experimental infections with other viral pathogens (Biron et al. , 1999), that the 
recognition of the early virological and immunological events could be paramount to a 
better understanding of the typically observed features ofhepadnaviral infection. 
Since the half-life of HBY in serum is estimated to be as short as 4 hours 
(Murray et al., 2006), it could be expected that infection of hcpatocytes may occur 
promptly after exposure to virus, at least in situations when the host is expo ed to large. 
liver pathogenic doses ofvirus exceeding 103- 104 virions (Michalak et al. , 2004). 
Furthermore, it is acknowledged that cells of the innate immune system are activated 
within minutes to hours following invasion with viral pathogens (Biron et al. , 1999). 
Taken together, we hypothesized that inoculation with WHY at doses known to induce 
erologically and histolog ically evident 1\H (Michalak et al. , 2004). should rc~u l t in 
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immediate infection of the liver and activation of the hepatic innate immunity. although 
one previous study on this subject performed in chimpanzees experimental!) inl\:ct~:d 
with HBY. in which expression of the innate immune response-affiliated genes \\as 
assessed by eDNA microarray analysis, concluded otherwise (Wieland ct al.. 200-la). 
To investigate these issues, a large cohort of WI-I Y -na"lve woodchucks was infected 
with a well-characterized WHY inoculum containing 1.1 x I 010 DNase-protectcd vge 
per dose. This large cohort of animals permitted reliable determination of viral kinetics 
and the status of intrahepatic immune activation starting from one hour p.i. 
Our quantitative analysis applying a real-time PCR assay demonstrated WHY 
DNA in serum(- 4 x I 06 vge/ml) and liver tissue(- 6 x I 05 vge/J..l.g total DNA) at one 
hour after injection with virus. However, these high levels of the WHY genomes 
detected almost certainly originated from the inoculum rather than as a result of an 
already established active virus replication. On the other hand, quantification of WHY 
RNA provided a direct insight into the status of virus replication in hepatic tissue. 
WHY transcripts were found at levels approximating 200- 400 copies per ~Lg RNA as 
early as one hour p.i. This indicated that the virus was in fact able to enter cells within 
one hour, repair its partially double-stranded DNA, and transcribe DNA to mRNA. In 
this regard, our study is the first where the evidence of such early replication of 
hepadnavirus in vivo has been documented. In our work, hepadnavirus mRNA was 
detected by sensitive real-time RT-PCR (sensitivity of <200 vge/J..l.g R A). as opposed 
to an RNase-protection assay used in one other pertinent study performed in H BY-
infected chimpanzees (Wieland et al., 2004a) . In this study, chimpanzees shov.ed HBY 
pregenomic RNA transcripts in the liver beginning from 3 - 4 weeks p.i .. with 
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subsequent exponential expansion between weeks 4 - 6 p.i. The dirtcrence bel\\een 
ours and the study mentioned above is almost certainly due to the greater sensiti" it) of 
our PCR-based WHY mRNA detection assay. 
Our attempt to detect WHY cccDNA in the liver in the first few hour after 
inoculation was not successful. This replicative intermediate of WHY genome, which 
constitutes an obligate prerequisite for the generation ofhepadnaviral mRN/\ 
transcripts (Mason et al.. 1983), was identified at 18 hours p.i. The di screpancy 
between the time of the first detection of WHY cccDNA and WHY mRNA was most 
likely a consequence of approximately a 10-fold higher sensitivity of the RT-PCR 
assay used for detection of viral mRNA than that ofthe PCR assay available for 
identification of WHY cccDNA (- I x 103 copies/flg oftotal DNA). 
Whi le the hepatic load of WHY mRNA transcripts progressively increased 
starting from one hour p.i., there was only a slight parallel increase in the WHY DNA 
leveluntil3 weeks p.i., when compared with that detected at 48-72 hours p.i. From 
week 3 to 6 weeks p.i. , a strong coordinated expansion ofhepadnav iral genomes and 
their replicative intermediates was apparent, suggesting exponential viral replication . 
This result remains in agreement with previous findings from HBY infection showing 
that exponential viral replication includes proportional increases in expression of both 
hepadnaviral genomes and replicative intermediates (Murray et al. , 2005; Wieland et 
al.. 2004b). Subsequently, a parallel increase in viral RNA transcripts and DNA, 
although of a lower magnitude, continued unti l 8-9 weeks p.i. However, there was 
noticeable transient, but overall statistically insignificant. decrease in the detection of 
both nucleic acid forms in the li ver and WHY D A in serum around wed. 6 p.i in the 
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majority of the animals. from week I 0 p.i. forward, progressive decline in hepatic 
loads of WHY RNA and D A occurred lasting until 30 wks p.i. Nonetheless, trac~:s of 
WilY DNA and RNA remained detectable in hepatic ti ssue until the end nf the 
observation period, which was as long as 3 years p.i . in some animals. This finding 
was not surprising and was consistent with the results of our previous studies where the 
I i fe-long persistence of low-level rep I ication of infectious WI-I Y a Iter seemingly 
complete serological and biochemical resolution of Al-l was documented (Hodgson ct 
al. , 1999; Hodgson and Michalak, 2001; Michalak et al., 2004; Michalak ct al., 1999). 
The microenvironment of the liver displays unique immunological properties 
which have been ascribed to hepatic antigen presenting cells, including liver si nusoidal 
endothelial cells and Kupffer cells, as well as to the disproportionate occurrence of K 
and NKT cells (reviewed in (Racanelli and Rehermann, 2006). Furthermore, 
recruitment ofNK and NKT cells into the liver from the splenic compartment has been 
observed following viral infection (Salazar-Mather and Hokeness, 2003). Our results 
suggested that hepadnaviral infection resulted in apparent sequential activation of APC 
and innate immune effectors within the liver, leading to a decrease in viral burden. 
Specifically, a significant (P<0.004) one-log decrease in hepatic WHY DNA load was 
detected in all animals which livers were sampled between 48 - 72 hours post 
infection . The hepatic WHY DNA level returned to that seen prior to this log-decrease 
24 hours later, suggesting that the rebound was due to active WHY rep lication. This 
temporary reduction of WHY DNA in the liver, and to a lesser degree in serum, \\ as 
accompanied by a parallelupregulated transcription of ce llular markers CD I d and 
CD3, anti-viral mediators IFNy, TN Fa and OAS. and cytolytic effector molecules 
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CD95L and perforin. This strongly suggested that a. transient activation or intrahepatic 
innate immunity was able to facilitate a brief but signilicant decline in th~.: li'va virus 
load, although did not apparently modify hepatic virus transcription . These n.:sults an.: 
in contrast to those reported by Wieland ct al. (2004) which suggested that II BY 
infection of chimpanzees did not induce activation of intrahepatic innate immunity, as 
determined by microarray analyses. However, our study commenced evaluation of the 
host response to hepadnaviral infection within I hour of virus inoculation, while the 
aforementioned study began analysis of liver biopsy tissue obtained beginning at 2 
weeks after inoculation with HBV. 
Experimental evidence accumulated clearly indicate that NK and KT cells 
have the ability to respond to virus by secretion of IFNy or by acquisition of a cytotoxic 
function within minutes or hours after infection (Biron et al., 1999). In thi s regard, 
recognition of viral antigens by the activating NK receptor NKp46 has been implicated 
as a key stimulus during influenza virus infection (Mandelboim et al., 2001). Our data 
demonstrated that as early as 3 to 6 hours after exposure to WHY, there was increased 
intrahepatic expression of the NK cell marker, NKp46, as well as a ignificant increase 
in IFNy mRNA. Together with an increased perforin expression, a key effector 
molecule mediating NK cell cytotoxicity, this argues that K cell were activated 
almost immediately following hepadnaviral infection . This set of events occurred in 
parallel with a significant upregulated expression oflL-12, further suggesting that the 
initial production of IFNy augmented the activation of APC leading to enhanced 
expression of a key antigen-presenting molecule CD I d. 
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Based on detection of WHY transcription shortly at1er exposure and that 
hcpadnaviral antigens, including large, middle and small envelope proteins, may 
activate NKT cells (Baronet al., 2002), it is reasonable to suggest that early activation 
ofNK cells could lead to enhanced presentation of WHY antigens to CD !d-n:strictcd 
NKT cells, culminating in elevations of intrahepatic IFNy and IL-4 at 48 - 72 hours 
post-infection. In support ofthis possibility. CD3 expression was also found to exhibit 
a distinct peak (a 2.9-fold increase comparing to the pre-infection level) at 48 - 72 
hours p.i.) (Fig. SA, left panel). Since COld-restricted NKT cells express aT cell 
receptor (TCR) comprised ofTCRa/p chains in combination with the CD3 receptor 
complex (Kronenberg and Gapin, 2002), significant elevations in CD3, but not CD4 or 
CD8 T cell markers, could be interpreted that WHY infection also transiently activated 
intrahepatic NKT cells leading to the increased expression of IFNy. Artificial 
activation of CD I d-restricted NKT cells has been shown to downregulate viral 
replication in HBY-transgenic mice via noncytopathic mechanisms mediated by IFNy 
(Kakimi et al. , 2000). Overall, ours is the first study demonstrating that hepadnavirus 
activates innate immune response in the liver shortly after invasion. The results 
obtained also suggest that hepadnaviral infection may first activate NK cells and 
subsequently NKT cells, with the latter possibly contributing to a transient decrease in 
viral DNA. The activation of intrahepatic innate immunity is transient, waning by 72 
hours post infection, and was therefore undetected in previous studie which 
commenced evaluation of anti-viral immunity at one (Wieland et al., 2004b) or 2 \-\-eeks 
(Wieland et al., 2004a) post inoculation. 
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LCMV infection has been shown to induce NKT cell activation, n: ulting in 
lFNy and lL-4 expression, which is immediately followed by a decrease in their k vels 
and subsequent increase several weeks later (I lobbs et al"., 200 I; Lin et al. . 2005b). 
Interestingly, peak expression of the K marker, NKp46, occurred in our stud) at 3 
weeks p.i ., coinciding with significant elevations in IL-4 expression, in the absence of 
upregulated expression of IFNy. Although we cannot determine the cellular site of lL-
4 augmented expression, the histological analysis showed a lack of 
lymphomononuclear infiltrations at this time point in the liver. Thus, NKT cells may 
represent the predominant cell type responsible for the increased hepatic expression of 
IL-4 in our experiment. Since woodchuck-specific antibodies for detection ofNKT 
cells or IL-4 are currently lacking, the explanation of this possibility will require further 
investigation when such reagents become available. Furthermore, WHY-mediated 
skewing ofthe immune response towards a TH2-type, characterized by lL-4 and the 
absence of IFNy, is another enticing possibility. Our data could suggest that transient 
activation ofT H2-type responses, coinciding with detectable levels of WHsAg in 
circulation at 3 weeks p.i ., may enable uninhibited viral expansion prior to activation of 
T11 1-type adaptive immunity and infiltration ofvirus-specific T cells into the infected 
liver. 
Despite evident activation of intrahepatic innate immune cell ubsets during the 
first hours and days following infection, coinciding with significant reductions in viral 
load, this initial anti-viral response waned and failed to promptly induce T cell 
response, characterized by CD4 and CD8 T cell infiltrations into the liver, until 5 to 6 
weeks later. These findings are in direct contrast to those observed during infec tions 
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with other viral pathogens which induce timely sequential activation of innate and 
adaptive immune cell subsets leading in many cases to the self-resolution of the 
infection. The prolonged period of immunological ignorance to hepadnaviral infection, 
as characterized in our study by a lack of expression ofT cell marker genes and liv~r 
inflammatory intiltrations following activation of the intrahepatic innate immune 
response or by others as a lack ofT cell specific responses to viral antigens (Bertoletti 
and Ferrari, 2003; Menne et al., 1998), may be partially explained by the tolerizing 
effect of the liver. The capacity ofthe liver to induce tolerance to oral or allogenic 
antigens is now well recognized (Berget al., 2006; Limmer et al., 2005). It is 
understood that it occurs via several mechanisms, including suboptimal T cell priming 
and induction ofT cell anergy (reviewed in (Bertolino et al., 2002; Crispe, 2003). In 
our study, the expression ofCD4 and CD8 T cell co-receptors was transiently elevated 
immediately following infection. In addition, inflammatory mediators, including IFNy, 
have been shown to influence the expression of adhesion molecules on endothelial 
cells, which have been implicated in mediating T cell trapping in the I iver (Mehal et al., 
200 I). Furthermore, transient activation of antigen-specific T cells has been observed 
in TCR-transgenic mouse models, wherein cognate antigen presentation was restricted 
to hepatocytes, leading to dysfunctional priming ofna'lve T cells (Bertolino ct al. , 2001; 
Bertolino et al., 1998). Thus, initial trapping ofCD4 and CD8 T cells, followed by 
suboptimal priming or deletion, may potentially facilitate hepadnaviral subversion of 
the adaptive immune response. 
Overall, our data show that hepadnaviral replication is not quiescent during the 
phase immediately following virus invasion but progresses at low level in the liver 
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beginning from one hour after exposure to virus. r:urthcrmorc. hcpaclnaviral infect inn 
stimulates almost immediately intrahepatic innate immune cells. including APC, K 
and NKT cells, which cause a transient downregulation of virus hepatic load. These 
findings are in contrast with those recently reported for experimental I !BY infection in 
chimpanzees, which suggested a lack of innate immune activation alter exposure to 
infectious hepadnavirus as reported by Wieland eta/. (2004). However, there are 
several important differences between our study and that in chimapnzees. First, the 
study mentioned, despite the intention to analyze whether HBV infection activates 
innate immunity in acutely-infected chimpanzees, commenced analysis of intrahepatic 
immune activation at two weeks p.i . As the data obtained in our study showed, the 
activation of this immunity has occurred and waned by one week p.i. Secondly, 
analysis of a small number ofHBV-infected chimpanzees was done by eDNA 
microarrays (Wieland et al., 2004a). Thus, examination of relatively a small group of 
animals by a technique of a lower sensitivity than real-time RT-PCR (approximately by 
5-l 0-fold) may have additionally contributed to omission of biologically important 
mediators or cellular markers. This was evidenced and realized in the work mentioned 
where a combination of the data from microarray analysis and the definitions used to 
include or exclude particular genes failed to include IFNy as a mediator of hepadnaviral 
clearance (Wieland et al., 2004a). 
In summary, our data indicate that hepadnaviral infection induced by a liver 
pathogenic virus dose is characterized by a rapid initiation of viral replication in the 
liver and activation of the local innate immune system. This early intrahepatic immune 
reactivity is capable of a profound downregulation of hepatic virus load. however, is 
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transient and, in contrast ·with other viral infections, docs not precipitate aS\\ ill 
adaptive immune response. A reason behind this inability is unknown and could bt.: 
due to as yet unidentified viral factors or a a po ·sible consequence of the inherent 
tolerizing action of the liver. 
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CHAPTER SIX: GENERAL DISCUSSION AND FUTURE DIRECTIONS 
The main purpose ofthe present series of studies was to investigate how the 
intrahepatic environment may influence the immunological response to hepadnaviral 
infection, with the following two consideration : (I) the liver i inherently immune 
tolerizing by as yet incompletely understood mechanisms and (2) the intrahepatic 
microenvironment is uniquely enriched for cells of the innate immune system which 
may rapidly recognize and respond to pathogens. 
The contribution of the liver towards maintenance of peripheral tolerance 
against oral or transplanted antigens is increasingly recognized (rev iewed in Cri pe, 
2003). Furthermore, studies suggest that the liver represents a final repository for 
activated lymphocytes (Huang et al. , 1994). While Kupffer cells and sinuso idal 
endothelial cells have been found to contribute to tolerogenic mechanisms and removal 
of activated cells, we investigated in our initial study whether hepatocytes may 
potentially contribute to cell removal via the intrinsic expression ofCD95L. We 
demonstrated that cultured, as well as freshly isolated, primary hepatocytes derived 
from healthy human and woodchuck livers inherently express biologically active 
CD95L capable of inducing killing ofCD95-positive cells. Interestingly, st imulation 
by exogenous IFNy orTNFa resulted in an upregulated express ion ofCD95 L by 
hepatocytes. These results challenged the previous view that hepatocytes were imply 
passive targets of activated cytotoxic lymphocytes, and suggested that they may work 
co-operatively with Kupffer or LSECs to mediate trapping and removal of activated 
lymphocytes as \-veil as other cel ls. Increased hepatocyte expre sion ofCD95L in 
response to inflammatory cytokines may suggest a contribution of hepatocyte tO\'vards 
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the development of liver disease, including viral hepatitis characteriLeJ by 
innammatory lymphomononuclcar infiltrates which secrete IF y and TNFu. 
Hepatocytes are sensitive to CD95-mediated apoptosis (Ogasawara ct al., 1993). 
The failure of hepatocyte-expressed CD95L to initiate autocidal or fratricidal death 
under normal physiological conditions may be reconciled by the segregated expression 
of ligand and receptor. It has been demonstrated in lymphoid cells that CD95L is 
contained within secretory granules and can be localized to the plasma membrane upon 
target cell recognition and degranulation (Kojima et al., 2002). In contrast, epithelial-
derived cell lines have been shown to transport translated CD95L directly to the plasma 
membrane (Biott et al., 200 I) . To determine how CD95L is sorted in hepatocytes. we 
constructed a plasmid containing full length mouse CD95L, fused at its amino terminus 
to the reporter green fluorescent protein (GFP). Since CD95L is a type II 
transmembrane protein, fusion ofGFP to the amino terminus would result in 
cytoplasmic retention ofthe reporter protein upon membrane expression and cleavage 
ofCD95L by extracellular metalloproteinases (Kayagaki et al., 1995). In contrast with 
293!-IEK cells, which rapidly transport GFP-fused CD95L to the plasma membrane, 
leading to apoptosis oftransfected cells (data not shown), WCM-260 hepatocytes retain 
the GFP-CD95L fusion protein within the cytoplasm and their survival was not 
adversely affected (Figure 6.1 ). Thus, while WCM-260 hepatocytes are susceptible to 
apoptosis mediated by anti-CD95 antibody treatment (data not shown), they are 
resistant to CD95L-mediated lysis when the ligand is expressed by hepatocytes 
themselves. Whether innammatory cytokines modulate the intra- or extracellular 
expression ofCD95 L by hepatocytes requires further investigation. 
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Fig 6.1. GFP-CD95L fusion protein exhibits cytoplasmic localization in WCM-260 
hepatocytes. Full length eDNA encoding murine CD95L was inserted into the pEGFP-
C2 eukaryotic expression plasmid designed to generate a GFP-CD95L fusion protein in 
transfected cells. WCM-260 hepatocytes were cultured to >90 % confluence on glass 
coverslips and were transiently transfected with empty pEGFP-C2 vector (A and 8), or 
with pEGFP-C2-CD95L vector encoding the GFP-CD95L fusion protein (C and D). 
Following 24 hours culture, cells were fixed in 2 % paraformaldehyde and imaged using 
laser scanning confocal microscopy. Arrows indicate intracytoplasmic GFP-positive 
structures suggesting CD95L localization in cytoplamsic vesicles. 
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Although our initial study demonstrated that hepatocyte expression ofCD95L 
was at least in part responsible for inducing apoptosis ofCD95-sensitive targets. 
inhibition experiments suggested that an additional cytotoxic pathway was 
concomitantly uti! ized by hepatocytes. The expression of components comprisi ng the 
perforin/granzyme 8 cyto lytic pathway has been previously determined to be restricted 
to ce lls of the immune system, primarily CD8+ CTL and NK or NKT cells. Our second 
study hypothesized that hepatocytes may also utilize the perforin pathway. alone or in 
combination with CD95L, to induce death of contacted cells. In this study, we found 
that hepatocytes express mRNA encoding perforin and granzyme B. Perforin protein 
was detectable in lysates derived from hepatocyte cell lines and freshly iso lated 
primary hepatocytes by Western blotting, while flow cytometric analysis confirmed 
that perforin expression was readily identifiable in these cells. The perforin cytotoxic 
pathway was determined to be biologically active, since hepatocytes mediated death of 
CD95-negative cells in a manner which could be at least partially attenuated by 
perforin-specific neutralizing antibodies or shRNA. In contrast with CD95L. IFNy or 
TN Fa were unable to influence hepatocyte expression of perforin or cytotoxicity 
mediated by the perforin pathway. Thus, we concluded that normal hepatocytes are 
constitutively able to remove other cells via either the CD95L- and/or perforin-
pathways, while inflammatory cytokines may differentially modulate the expression of 
CD95L but not perforin by hepatocyte effectors. 
Although we have demonstrated that hepatocytes express biologically acti ve 
CD95L and perforin effector molecules, it remains undetermined how hepatocytes 
recognize targeted cells, or whether hepatocytes exhibit indiscriminate cytotoxic 
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activity. CTL mediate directed lysis of target cells follo\-\>ing recognition and binding 
of antigen, in the context of MIIC class I molecules, to the TCR. K cells exhibit 
antigen-independent lysis of ce ll targets, however. the discrimination betv.-een target 
and non-target cells is facilitated by the balance of activating or inhibiting ligands 
expressed by the target which trigger or inhibit, respectively, activation of the NK cell. 
We hypothesize that hepatocytes are not indiscriminate cytotoxic effectors, but that 
they recognize target cells via an antigen-independent yet selective mechanism. in part 
analogous toNK cell effectors. ASGPR is essentially a hepatocyte-specific receptor 
which recognizes terminally desialyated glycoproteins. It has been shown that 
treatment of lymphocytes with neuraminidase, an enzyme which removes terminal 
sialic acid residues from glycoproteins, results in retention and removal of lymphocytes 
by the liver (Samlowski et al., 1984). The mechanism leading to lymphocyte removal 
was previously undetermined, but it was hypothesized that the in vitro-activated and 
subsequently transferred T cells underwent autocidal or fratricidal lysis. Using cultured 
WCM-260 hepatocytes or HepG2 cells, we have found that neuraminidase treatment of 
CD95-bearing PSIS (Figure 6.2A and C) or CD95-deficient K562 targets (Figure 6.28 
and D) leads to a dose-dependent increase in the level of target cell lys is. We propose 
that ASGPR-mediated recognition of target cells facilitates discrimination and removal 
of activated lymphocytes expressing the activated form of CD45 (i .e., the 8220 
epitope) by hepatocytes. 
Since we had found that hepatocytes were inherently capable of removing 
CD95-bearing or CD95-deticient cells, we further investigated whether hepadnaviral 
infection and accompanying liver inflammation could modulate the cytotoxic potential 
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of hepatocyte . Results from our initial studies '>\ould predict that inflammation 
associated with chronic viral hepatitis, or that continuing minimal to moderate 
in flam mat ion observed after recovery from 1\H, would modulate hepatocyte expression 
ofCD95L, but not perforin . As expected, and in agreement with previous studies from 
this laboratory (Hodgson and Michalak, 200 I), a slight but signiticant and continued 
elevation in intrahepatic expression of IFNy followed recovery from acute WHY 
hepatitis. This was associated with increased hepatocyte expression of CD95 L. 
Despite a greater degree of inflammation and increased intrahepatic levels o f IF y and 
TNFa during chronic WHY hepatitis, hepatocyte expression ofCD95L was not 
increased relative to that observed after recovery from acute infection. This suggests 
that a relatively moderate increase in liver inflammation may yield maximal 
upregulation ofCD95L expression by hepatocytes. 
Surprisingly, hepadnaviral infection also invariably increased hepatocyte 
expression ofperforin, and perforin-dependent capacity to kill CD95-deficient cell 
Since in vitro data suggested that perforin expression in hepatocytes and lymphoid cells 
was differentially influenced, with hepatocytes displaying resistance to IFNy-mediated 
increases, we hypothesize that as yet unknown mediators are responsible for 
upregulating perforin expression upon hepadnaviral challenge. 
The functional consequences of increased heptatocyte cytotoxic potential . as a 
result of resolved or chronic hepadnaviral hepatitis, arc as yet unrecognized. Yirus-
speci fie T cell responses are detectable during extended follow-up of patients which 
have resolved acute HBY infection (Rehennann et al.. 1996). Elevations of 
intrahepatic IFNy and CD3 mRNAs are consistently detectable for years following 
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recovery from acute WHY hepatitis (Hodgson and Michalak. 200 I), and they arc likely 
reflective of continued immune activation due to low-level viral replication and 
production of viral antigens (Michalak ct al.. 1999). It is possible that increased 
hepatocyte cytoxicity during recovery from hepadnaviral infection. may represent a 
physiological mechanism to protect hepatocytes from more extensive injury due to 
minimal to moderate continuous lymphomononuclear cell infiltrations by removing 
activated T cells. 
It is understood that the development of chronic hepadnaviral hepatitis is at 
least in part due to an insufficient anti-viral T cell response which is unable to inhibit 
viral replication through cytolytic and non-cytolytic mechanisms. In contrast with 
SLAI-1, Cl-1 is characterized by the persistence of evident inflammatory infiltrates and 
hepatocellular injury. In such a scenario, the hypothesized protection afforded the 
hepatocytes by cytokine-mediated upregulation of cytotoxic mechanisms, may be 
insufficient to prevent hepatocyte injury occurring as a result of overwhelming 
bystander recruitment of non-specific, activated lymphocytes and other immune cells. 
On the other hand, functional expression of CD95L and perforin effctor 
molecules by hepatocytes may also contribute to liver pathology. The development of 
several liver diseases, including alcoholic hepatitis (Galle et al., 1995), Wilson's 
disease (Strand et al., 1998) and I-ICC (Roskams et at., 2000) is associated with 
increased hepatocyte expression ofCD95L. While constitutive expression ofCD95L or 
perforin may serve a physiological role for maintaining tolerance or removal of 
activated T cells, as discussed previously, increase in these cytotoxic activities may 
contribute to liver injury. 
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Having demonstrated that hepadnaviral inf'cction and accompanied 
inflammation were associated with increased cytolytic capability ofhepatocytes, 
thereby possibly contributing to shaping of the immune response to hepadnavirus via 
tolcrogenic or pathologic mechanisms, we further evaluated if the intrahepatic innate 
immune system is activated by hepadnavirus infection and may contribute to local 
antiviral immunity. The liver is characterized immunologically by its unique 
composition of innate immune etTector cells (NK and N KT), unconventional T cell 
subsets, and an endothelium which displays inherent capacity to scavenge and present 
antigens to na"ive immune effectors. Initial studies in HBV-transgenic mice (Kakimi et 
al., 2000), suggested an involvement ofNKT cells in the downregulation of HBY 
replication, however, confirmation that innate immune effectors are activated during 
hepadnaviral infection had not been extensively or appropriately undertaken in a 
natural model. Specifically, IFNy-mediated downregulation of HBV -infected 
chimpanzees appeared to precede T cell infiltration into the liver (Guidotti et al., 1999) 
however the immune cell subsets responsible for expression of I FNy remained 
undetermined. Subsequent microarray analysis of intrahepatic gene expression in 
HBV-infected chimpanzees commenced at two weeks p.i. (Wieland et al. , 2004a) . It 
was concluded that HBV -infection does not activate intrahepatic innate immunity. 
however it remained conceivable that anti-viral innate immunity may have been 
initiated, and waned, prior to the initial sample collection at two weeks p.i . Using a 
large cohor1 of WHY-infected woodchucks, we were able to analyze viral kinetic and 
the intrahepatic immune response beginning at one hour post infection. The data 
clearly indicated that WHY is capable of entry and initiation of transcription as early as 
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I hour nllcr inoculation. WHY mRNA exhibited a progressive increase in the liver 
beginning rrom one hour post-exposure to virus. This may suggest that produced viral 
antigens or RNA species may in turn activate intrahepatic APC resu lting in subsequent 
elevations of the T 11 1-polarizing cytokine I L-12. as early as 3 - 6 hours p. i. Not 
surprisingly, given the known reciprocal activation oi'NK cells and APC. elevation. in 
IFNy, perforin, NKp46 and IL-4 expression were found, suggesting activation ofNK 
and NKT cells at 48 - 72 hours post WHY infection. In contrast with infection with 
other viral pathogens, activation of intrahepatic innate immune cells did not lead to 
significant activation of conventional CD4+ or CDS" T cells at early time points post-
inoculation, and their involvement did not become evident until the peak of WHY-
induced liver disease 5 -6 weeks post-viral exposure. 
Interestingly, the obtained data suggested that cytotoxic mechanisms were 
possibly upregulated at these early time points in the liver since both CD95L and 
perforin mRNA expression were elevated. While perforin expression may be 
upregulated in activated NK or NKT cells, it remained undetermined, based on RT-
PCR analysis of eDNA derived from liver biopsy tissue, if increased CD95L or 
perforin mRNAs were reflective of increased hepatocyte cytotoxic potential. To 
investigate this latter possibility, a second group of healthy woodchucks was 
challenged with a large infectious dose of WHY and were subsequently euthanized at 
72 hours p.i ., facilitating isolation ofhepatocytes and analysis of their cytotoxic 
potential. Hepadnaviral infection resulted in an upregulation ofCD95L as well as 
perforin and granzyme 8 mRNAs (Figure 6.3A), and an increased ab ility or 
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Fig 6.3. Hepadnavirus augments hepatocyte-mediated cytotoxicity 72 hours p.i. Primary 
hepatocytes were isolated from adult woodchucks (n = 2) at 72 hours p.i. with I x I 0 10 
WHV vge, or from healthy control animals (n = 2). Gene expression levels were 
quantified by real-time RT-PCR and were normalized against expression o f~-actin (A). 
The cytotoxic capacity ofhepatocytes (6 x 104/well) was examined by JAM DNA 
fragmentation assays using 4 x 104 CD95-bearing P815 cells (B) and CD95-deficient 
K562 cell targets (C) . Results are shown as mean values ± SEM of two animals per 
group, with each experiment perfonned with 8- 16 experimental wells per condition. 
Data bars marked with* are significant at P <0.005 and those with* * at P <0.000 I when 
compared with healthy controls. 
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hepatocytes to ly e both CD95-bcaring (rigurc 6.313) and CD95-(kli~..:icnt tarw:ts 
(Figure 6.3C), when compared with healthy controls. 
This series of studies suggest that hepatocyte cytotoxicity may in fa t contribute 
to hepadnaviral infection by removal of activated, virus-specific T cells in the liver. 
Hepatocyte-mediated removal of activated T cells may represent a component 
of the tolerogenic capability ofthe liver. Previou tudie in bone marrow chimeric 
mice which express a MHC class (-restricted antigen on hepatocytes but not on /\PC, 
indicated that na't've, antigen-specitic CD8+ T cells accumulate in the I iver where they 
exhibit transient activation followed by premature death by apopto i (Bertolino t..:t al., 
1998). ub equent investigations in this model revealed that this effect was pecific for 
CD8+ T cells, did not require help from CD4+ T cells or APC, and wa dependent on 
the expression of adhesion molecules by the liver endothelium or hepatocytes 
(Bertolino et al. , 2005; Bertolino et al., 1998). It was confirmed that the trapped CTL 
were antigen- specific (Bertolino et al., 2005), and were activated, as determined by 
their expression of B220 or the desialyiated isoform of CD45 which is capable of 
binding to hepatocyte ASGPR. Considering the results of these studies and our in vitro 
data, which demon trate that target cells exprcs ing de ialyiated glycoproteins are more 
efficiently targeted by hepatocytes, we propo e that hepatocytes are ab le to transiently 
activate na't've T cells, but in contrast with their activation by professional AP , their 
activation is dysfunctional and is promptly followed by hepatocyte-mediated T -cell 
apoptosis. A recent study utilizing transgenic mice which display a cognate TL 
antigen ubiquitou ly (Met-Kh) or restricted to hepatocytes (Aib-K"). suggests that 
primary activation of antigen-specific na'r've T cells by professional 1\P lead · to 
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hepatitis. while primary activation of the same cells by hepatocytes leads to tolerance 
(Bowen et al.. 200-l). Failure of adoptively transferred na'fve CTL to mediate hepatitis 
in Alb-Kb mice was due to reduced CTL survival, despite similar rates or initial 
activation as those observed in Met-Kb mice, possibly due to active removal mediated 
by hepatocytes. These findings may be of significance to the development of 
intrahepatic immune responses following hepadnaviral infection or infections with 
other hepatotropic pathogens. 
Our data clearly indicate that exposure to liver pathogenic WHY is followed by 
immediate activation of viral transcription and strongly suggests sequential activation 
of APC and NK or NKT cell subsets. Despite apparent activation of innate immune 
cell subsets, which by convention precedes activation of adaptive T cell responses, 
significant intrahepatic infiltrations ofT cells was not observed until several weeks 
following infection. We would propose that initial intrahepatic recognition of viral 
antigens by na'fve T cells which contact virus-infected hepatocytes results in transient 
activation and removal, despite an appropriate microenvironment characterized by the 
presence of activated APC and innate immune subsets. This potential tolerizing effect 
of the liver is overcome several weeks later (Menne et al., 1998), as evidenced by 
peripheral T cell responses directed against WHsAg and WHcAg. Our data suggest 
that exponential virus replication and translation of virus proteins beginning at 3 weeks 
p.i., may facilitate extrahepatic lymph-node or splenic priming ofT ce lls which, in 
contrast with T cells which are initially activated by hepatocytes (Bovven et al.. 2004), 
are functionally capable of infiltrating the liver and downregulating virus replication 
while mediating clinically evident hepatiti s. 
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Taken together and in the context of current I iteraturc. our studies sugge~ t that 
constitutive expression of CD95 Land perforin elfector molecules by hepatoc) tes ma) 
contribute to the inherent tolerizing capabi I ity of the I iver. Hepatic tolerance I i kely 
includes contributions from resident Kupffer cells (Mchal et al.. 200 I), L EC (Knolle 
and Limmer, 200 I), and hepatocytes which facilitate trapping and removal of 
systemically-activated lymphocytes wh ich enter the I iver. Furthermore, the abi I ity of 
hepatocytes to transiently activate na'ive T cells and induce cell death via apoptosis, 
may represent a physiological mechanism which also maintains peripheral tolerance to 
dietary or transplanted antigens. However, hepatotropic pathogens, many of which 
establish chronic infections, including hepadnaviruses, may usurp this protective 
mechanism, leading to removal of pathogen-specific effector T cells following antigen-
specific trapping (Bertolino et al., 200 I; Bertolino et al. , 2005; Bowen et al., 2004) and 
facilitating the expansion of virus replication. Hepadnaviral infection as well as other 
inflammatory liver diseases may influence hepatocyte expression ofCD95L and 
perforin effector molecules with as yet unrecognized consequences. Although 
increased hepatocyte cytotoxicity may facilitate removal of activated T cells and 
facilitate to some extent protection of the liver from pathogenic T cell intiltrations, the 
relative sensitivity ofhepatocytes to autocidal CD95L-mediated lysis during li ver 
inflammation is unknown. Furthermore, while hepatocytes appear to sor1 D95L to an 
intracellular compartment under normal culture conditions, it is possible that 
hepadnavirus infection may modulate the cellular expression of the ligand or D95 
receptor. For example, upregulation of CD95L by the WHY X gene may suggest that 
integration of this viral gene sequence into the genome may contribute to the 
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development ofHCC through cytolytic mechanisms mediated by CD95L-CD95 
interactions. These possibilities require further in vestigation to full y utH..lcrstand the 
importance of the cytotoxic potential ofhepatocytcs during the initial intrahcratic 
response to hcpadnavirus, recovery from hepadnaviral infection, or the development of 
chronic viral hepatitis. 
6.1 FUTURE DIRECTIONS 
The results of the current studies have further suppot1ed the potential 
importance of the intrahepatic microenvironment on regulation of peripheral immune 
responses in general, and in hepadnaviral infection, in particular. These findings raise 
the following issues and, among others, impose several intriguing questions: 
I. We have demonstrated that hepatocytes are constitutively capable of inducing death 
of target cells via CD95L or perforin pathways. CD95L and perforin have been 
determined to co-localize in secretory granules in CTL. Although preliminary data 
suggest that CD95L is sorted to an intracellular compartment in cultured hepatocytes, it 
remains unresolved if perforin and associated proteases, such as granzyme B, are co-
ordinately expressed in the same cellular location and if this phenomenon holds true for 
primary hepatocytes. While we have found that neuraminidase-treated targets are more 
susceptible to hepatocyte-mediated lysis. suggesting an involvement of A. GPR-
mediated recognition of targeted ce lls, key que tions to be investigated arc v. hether 
hepatocytes express multiple receptors capable of target cell recognition. and how do 
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these receptors harne s components of the cellular cytoskeleton to mediate release or 
intracellular effector molecules? 
2. IFNy, and to a lesser extent TNFa, were found to increase CD95L expression and 
upregulate hepatocyte-mediated CD95L cytotoxicity. It remains unrecognized, 
however, if increased lysis ofCD95-sensitive target cells following stimulation or 
hepatocytes with inflammatory cytokines is due simply to greater expression of the 
ligand, or whether IFNy or TN Fa may concomitantly increase the capability of 
hepatocytes to recognize target cells. Following our initial discovery that A GPR may 
facilitate recognition of target cells, examination of cytokine-mediated regulation of 
ASGPR expression is warranted. Furthermore, investigations using shRNA directed 
against either ASGPR subunit would permit testing of the hypothesis that ASGPR is 
responsible for target cell recognition, in the presence or absence of inflammatory 
conditions. 
3. In contrast with cytokine-mediated upregulation ofCD95L, exposure of hepatocytes 
to IFNy or TNFa did not influence perforin expression. However, hcpadnav iral 
infection invariably increased the capability ofhepatocytes to lyse both CD95-scnsitivc 
and unexpectedly, CD95-insensitive cells. Additional studies arc required to determine 
if: (I) in addition to increased CD95L expression. do other liver diseases result in 
increased hepatocyte expression ofperforin and (2) what biological mediator are 
responsible for regulation ofperforin expression and utilization by hepatocyte ? 
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4. The capacity ofhepatocytes to transiently activate na'lve T cells. resulting in their 
dysfunction and premature death, has been conclusively establi hed (Bertol·ino et al. . 
200 I: Bowen et al.. 2004). Hepatocyte-mediated activation and deletion of WH V-
pecific T cells may partially explain the observation that virus- peci tic T cell are 
undetectable for several weeks p.i. This concept is not readily tested using a natural 
model ofhepadnaviral infection, however, the use ofi-IBV-transgenic mice and TCR-
transgenic T cells specific for viral antigens could be used to determine the validity of 
this hypothesis. Furthermore, generation ofHBV-transgenic mice which are also 
C 095 L .f. or perforin·'· would facilitate examination of whether hepatocyte-med iated 
cytotoxicity is required for induction ofT cell apoptosis following transient activation. 
5. Our data clearly indicated that activation of intrahepatic innate immune subsets lead 
to a significant - 1 0-fold decrease in viral replication very early (48 - 72 hours) post-
infection. These are the first results to suggest that NK and NKT cell activation in fact 
occurs in natural hepadnaviral infection, which is in agreement with the previous 
observations that artificial activation ofNKT cells can downregulate virus replication 
in HBV-transgenic mice (Kakimi et al. 2000). Identification ofthe ligand/s 
responsible for activation of these cells during hepadnaviral infection, may represent an 
attractive therapeutic approach for potential suppression ofhepadnaviral replication in 
chronic hepatitis. 
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CHAPTER SEVEN: SUMMARY AND CONCLUSIONS 
Over the course of this series of studies, we investigated how hepatocytcs may 
contribute to liver immunological responses and characterized step-by-step the 
intrahepatic milieu accompanying establishment ofhepadnaviral infection and 
development of hepatitis in search for answers as to how the unique immunological 
environment of this organ may influence anti-viral responses against hepadnavirus. 
particularly in the early stages which appear to be critical to the outcome of hepatiti ~. 
To study these issues, we applied the woodchuck-WHY infection system, which is the 
closest animal model ofHBV infection and hepatitis B. The results obtained can be 
summarized and concluded as follows: 
I. Molecular and immunoprobing analyses of primary, freshly isolated, normal 
woodchuck and human hepatocytes, as well as cultured woodchuck hepatocytes and 
human hepatoma HepG2 cells demonstrated constitutive transcription ofCD95L and 
expression ofCD95L protein. Subsequently, we adapted the JAM DNA fragmentati on 
assay, which is conventionally used to assess lymphoid cell-mediated cytotoxicity, to 
examine the cell killing capability of freshly isolated or cultured hepatocytes. The 
study demonstrated that normal hepatocytes are constitutively capable of inducing 
death ofCD95-expressing target cells. Utilization of a CD95-specific blocking 
antibody to prevent CD95L-CD95 interactions significantly reduced target cell killing 
and confirmed that hepatocytes utilized CD95L to mediate killing ofCD95-bearing 
cells. Furthermore, it was found that hepatocyte stimulation with either exogenous 
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IFNy or TNFa resulted in upregulated expression ofCD95L and increased the 
cytotoxic capability of hepatocytes. These results provided the first ever evidence that 
hepatocytes may act as cytotoxic effector cells and that the local intrahepatic cytokinc 
environment may augment hepatocyte cell killing potential. 
2. During the study on hepatocyte-mediated, CD95L-dependent cytotoxicity, it 
became apparent that the CD95L-CD95 interaction was not entirely, although to a large 
degree, responsible for the observed hepatocyte-mediated cell death. Therefore, we 
investigated whether hepatocytes may utilize the perforin cytotoxic pathway. RT-PCR, 
Western blot and flow cytometric analyses demonstrated that hepatocytes indeed 
express perforin mRNA and display perforin protein. In addition, disruption of 
microtubule polymerization during JAM DNA fragmentation assays sugge ted that 
hepatocytes utilize the exocytic pathway to mediate killing of both CD95-bearing and 
CD95-deficient cell targets. Additionally, neutralizing anti-perforin antibodies and 
treatment ofhepatocytes with perforin-specific shRNA demonstrated that cultured as 
well as freshly isolated primary hepatocytes utilize perforin to kill target cells. In 
contrast with CD95L, IFNy- or TN Fa-treatment of hepatocytes failed to modulate 
perforin expression and increase cell killing. However, IFNy augmented perforin 
expression in lymphoid cells, suggesting that regulation of the perforin pathway by thi s 
cytokine may be cell-type specific. This study is the first which demonstrates that non-
lymphoid cells express perforin and can utilize the exocytic pathway to mediate killing 
of contacted cell targets. Furthermore, inflammatory cytokines may differentially 
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influence the usage ofCD95L- or perforin-dependent killing mechani sms by 
hepatocytes. 
3. Since we doc umented that hepatocytes constitutively express biological I) active 
CD95L and perforin effector molecules and may concomitantly utilize both cytolytic 
pathways to induce target cell death, we investigated whether hepadnaviral infection 
could alter the cytotoxic phenotype and potency of hepatocyte effectors. We 
discovered that hepatocytes in animals convalescent from acute WHY infection and in 
those with progressing chronic WHY hepatitis, transcribed significantly greater 
quantities ofCD95L and perforin in comparison with healthy hepatocytes used as 
controls. In addition, hepatocytes derived from convalescent or chronically infected 
animals were able to induce significantly greater killing of both CD95-bearing and 
CD95-deficient cells. In support of our in vitro data, increased liver expression of IFNy 
was correlated with increased hepatocyte-mediated, CD95L-dependent cytotoxicity. 
The results further suggested that transient, minimal to moderate hepatic inflammation, 
histologically evident during convalescence, was sufficient to maxima lly increase 
hepatocyte-mediated cell killing. Also, both resolution ofhepadnaviral infection and 
chronic WHY -induced hepatitis were accompanied by upregulated hepatocyte 
expression and usage ofthe perforin cytotoxic pathway. Since in vitro data suggested 
that IF y and TNFa do not influence hepatocyte expression of perforin, the 
mechanisms underlying augmented perforin expression in vivo are currently unknown. 
Moreover, using cultured woodchuck hepatocytes stab ly expressing complete WHY 
genomes or individual viral proteins, we have excluded a direct role for hepadnaviral 
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infection on the modulation of hepatocyte cytotoxicity. Based on the data co llected. we 
concluded that hepatic inflammation induced by hepadnavirus rather than replicat ion of 
hepadnavirus itself influences the cytotoxic phenotype of hepatocytes. 
4. Finally, we analyzed viral replication kinetics and activation of intrahepatic 
innate and adaptive immune responses following experimental infection with 
hepadnavirus. This study documented that while WHY RNA transcripts are detectable 
as early as one hour p.i., exponential replication of the virus does not occur in the liver 
until several weeks later. Nonetheless, WHY invasion due to inoculation with a large, 
liver pathogenic virus dose induced the sequential activation of intrahepatic APCs and 
then NK and NKT cells beginning 3 to 6 hours p.i ., which peaked at 48 - 72 hours after 
exposure to virus and was coincident with a significant decrease in the liver load of 
WHY genomes. Despite activation of innate immune cell subsets, characterized by 
increased intrahepatic expression of!L-12 and IFNy, increased lymphomononuclear 
infiltrations into the liver were not observed for several weeks and occurred after the 
exponential expansion of virus replication at 3 - 4 weeks following infection. Iso lation 
of hepatocytes 72 hours p.i. revealed that, in comparison with healthy controls, 
hepatocytes derived from WHY -infected livers demonstrated significantly greater 
expression ofCD95L and perforin, and possessed increased cytotoxic activity against 
both CD95-bearing and CD95-deficient target cells. The results of these 
multiparametric investigations indicate that hepadnavirus replication is promptly 
established in the liver after exposure to a liver pathogenic dose and that. in contrast to 
the previous data from HBY-infected chimpanzees, is capable of immediate activation 
223 
of hepatic innate immunity. However. th is very early innate immune n:. pons~ apr~:ars 
to be in ufficient to prime strong adaptive T ce ll immunity capable of early virus 
elimination. This might be due to hepatocyte-mediated removal of acti vated virus-
specific T cells or due to yet unrecognized tolerizing properties of the liver in regard to 
hepadnavirus which naturally replicate within hepatocytes. 
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Appendix A 
The following appendicie include woodchuck cellular gene sequences subm itted to 
GenBank throughout the course of the thesis work. 
A.l 
EF621770 600 bp mRNA linear ROD 19-A UG-2007 
DEFI ITION Marmota monax CD40 ligand mRNA, partial cds. 
ACCESSION EF621770 
SOURCE Marmota monax (woodchuck) 
AUTHORS Guy,C.S. and Michalak,T.l. 
TITLE Direct Submission 
FEATURES Location/Qualifiers 
source I .. 600 
/organism="Marmota monax" 
/mol_type="mRNA" 
/db _xref="taxon:t)t)C)5" 
D2.,~ < I .. >600 
ORIGIN 
/note=" co-stimulatory , activating T cell receptor" 
/codon start= I 
/product="CD40 ligand" 
/protein_id="ABL'40 147.1" 
/db xref="Gl:l55795879" 
/translation="RSVATGLPVSMKIFMCLL TVFLITQMIGSALFA VYLHRRLDKIE 
DERNLHEDFVFMKTIQRCNNCDGSLSLLNCEEIRSQFEGFVKDI MLNKEEKKKESVE 
M 
QKGDQNPQIAVHVVSEASKTASVLQWAKKGYYTMSNNLVTLENGKQLTVKREGL Y 
YVYTQVTFCSNREALSQAPFIVSLCLKSSSESERILLRAATSH" 
I cgatctgtgg ccactggact gcctgtcagc atgaaaattt ttatgtgttt acttactgtt 
6 I tttcttatca cccagatgat tggatcggca ctttttgctg tgtatcttca tagaaggttg 
I 2 I gacaagatag aagatgaaag gaatcttcat gaggattttg tattcatgaa aacgatacag 
I 8 I agatgcaaca attgcgatgg atctttatcc ttgctgaact gtgaggaaat ccgaagtcaa 
24 I tttgaaggct ttgtcaagga tataatgtta aacaaagagg aaaagaagaa agaaagtgtt 
30 I gaaatgcaaa aaggtgatca gaatccacaa attgctgtac atgttgtaag tgaggccagt 
361 aaaacagcat ctgtgctaca gtgggccaaa aaaggatatt acaccatgag caacaacttg 
421 gtaacccttg aaaatgggaa acagctgact gttaaaagag aaggactcta ttatgtctac 
481 acccaagtta ccttctgttc caaccgggaa gctttgagtc aagctccatt tatagtcagc 
54 I ctctgtctga agtcctcaag tgaatccgag agaatcttac tgagggcggc aaccagccac 
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A.2 
EF526216 441 bp mRNA linear ROD 21·MA Y -2007 
DEFlNlTIO Marmota monax Kp46 mRNA, partial cds. 
ACCESSION EF526216 
OURCE Marmota monax (woodchuck) 
AUTHORS Guy,C.S. and Michalak,T.l. 
TITLE Direct Submission 
FEATURES Location/Qualifiers 
source 1 .. 441 
/organism="Marmota monax" 
/mol_type= "mRNA" 
/db _xref="taxon :')')ll 5" 
CDS < 1 .. >441 
/codon start= I 
/product="NKp46" 
/protein_ id="/\13041326.1" 
/db xref="GI:I46744255" 
/translation="LSYHPGPEV ALGDSVTFFCHL VTA TSTFFLLKEGRSSSTQRSLG 
STQAEFPVGPYTV AHQGTYRCFGSYNNHA WSFPSNPVMLL VTGGAGNSSLA PTDPT 
DS 
PDSCDPYL VTTESGSQKDPTR WDHT AQNLLRMGLAFL VL V ALA WL" 
ORIGI 
I ctctctgttc atcccggacc tgaggtggcc ctgggggaca gcgtgacctt cttttgccac 
6 I ctagtgacag caaccagcac tttcmctg ctcaaagaag ggaggtccag cagcacacag 
12 I cgtagcctcg ggagcacaca ggcagagttc cctgtgggcc cggtgactgt ggcccaccag 
181 gggacctaca gatgcmgg ctcctacaac aaccacgcat ggtccttccc cagcaatccg 
24 1 gtgatgctcc tggtgacagg aggtgcgggg aacagcagtc ttgcacccac agacccgacg 
30 I gattccccgg attcctgtga cccctacctg gtgaccacag agtcggggtc ccagaaagac 
361 cccacccgct gggaccacac agcccagaac ctcctccgga tgggcctggc gttcctggtg 
421 ctggtggctc tggcgtggct c 
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A.3 
EF.62 1767 672 bp mRNA linear ROD 19-AUG-2007 
DEFINITION Marmota monax CD I d mRNA, partial cds . 
ACCESSION EF621767 
SOURCE Marmota monax (woodchuck) 
AUTHORS Guy,C.S. and Michalak,T.I. 
T ITLE Direct Submission 
FEATURES Location/Qualifiers 
source 1 .. 672 
/organism=" Marmota monax" 
/mol_ type="mRNA" 
/db_ xref="taxon :2_~~.?Y' 
CDS < 1..>672 
ORIGIN 
/note="antigen presenting molecule" 
/codon start= I 
/product=" CD I d" 
/protein_id="ABU (J 14-l.l" 
/db xref="GI : I55795873" 
/translation="ISFYKPWAQGTFS QQWVHLQNIFRVFRSSFTRDIQEFAKf\ IL L 
EY PMELQLSGGCEYHPGNYSEHFLHYA YQGEYILSFQGTA WEPAPQAPQRVDL \' IK 
VL 
NQDEGTKETVQWLLNDICPQYVNGLLXLGKSELEKQVKPEA WLSSGPSPG PG RLLP 
VC 
HYSGFYPKPYWYMWMRG EQEQQGTQRGDILP GDETWYLRA TLDV AAG EL AG LA 
CR VKHSSLGG" 
I atcagctttg tgaagccctg ggcccagggc accttcagca gccagcagtg ggtccacctg 
6 1 cagaatatat ttcgggtttt tcgaagcagc ttcaccaggg acatacagga attcgccaaa 
12 1 atgctgtcct tagagtatcc catggagctg cagctgtctg gtggctgtga ggtgcaccct 
18 I gggaacgtct cagaacactt tctccatgta gcatatcaag gagaatatat cctgagtttc 
241 cagggaactg cttgggagcc tgccccacag gccccccaga gggtagattt ggtcatcaaa 
30 I gtgctcaacc aggacgaagg gacaaaagaa acagtgcagt ggctcctcaa tgacatctgc 
36 1 ccccaatatg tgaatggcct cctagaktta gggaagtcag aactggagaa gcaagtgaag 
421 cccgaggcct ggctgtccag tggccccagt cctgggcctg gccgtttgct gccggtgtgc 
48 1 cacgtgtctg gcttctaccc aaagcccgtg tgggtgatgt ggatgcgagg ggaacaggag 
54 1 cagcagggca ctcagagagg tgacatcctg cccaatggtg atgagacgtg gtatctccga 
60 I gcaaccctgg atgtggcagc tggggagctg gctggcctgg cctgcagggt gaagcacagc 
66 1 agcctaggag gg 
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A.4 
EF621766 309 bp mRNA linear ROD 19-r\ UG-2007 
DEFINITION Marmota monax CDS mRNA, partial cds. 
ACCESSION EF621766 
SOURCE Marmota monax {woodchuck) 
AUTHORS Guy,C.S. and Michalak,T.I. 
TITLE Direct Submission 
FEATURES Location/Qualifiers 
source 1 .. 309 
/organism="Marmota monax" 
/mol_ type= "mRNA" 
/db_ xref="taxon:9~~~~ " 
Q.?..'-1 < 1..>309 
/note="T-cell co-receptor" 
/codon start= I 
/product="CD8" 
/protein_ id="ABl "40 1·13 .1" 
/db xref="GI: 155795871" 
/trans1ation="GGYQFGDILQSLGARLPASXASPTPAPRLPTPAPPTTLLPRSVR 
PETCRP ATGGAADTR WLDF ACDIYIWAPLAGTCA VLLLSL VITYICHHRKRRR YCKCP 
R" 
ORIGIN 
I ggtggtgttc aattcggaga tatccttcag tcccttggtg cccgtcttcc tgccagcgam 
61 gcctccccga cgcccgcgcc gcgactaccc accccggcgc cccccaccac gctgctgccc 
12 1 aggtccgtgc gccccgagac ttgccggccc gcgacgggtg gtgcagcgga caccaggtgg 
I 81 ctggacttcg cctgtgacat ctacatctgg gcgcccttgg ctgggacctg cgcggtcctt 
241 ctgttgtcac tggtcatcac tgtcatctgt caccaccgga aacgaaggcg tgtttgcaaa 
30 I tgtccccgg 
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A.5 
EF62 1765 975 bp mRNA linear ROD 19-r\ UG-2007 
DEFI ITION Marmota monax CD4 mRNA. partial cds . 
ACCES ION EF62 1765 
SOURCE Marmota monax (woodchuck) 
AUTHORS Guy,C.S. and Michalak,T.l. 
TITLE Direct Submission 
FEATURES Location/Qualifiers 
source 1 .. 975 
/organism="Marmota monax" 
/mol_ type="mRNA" 
/db_ xref=''taxon :~ll.~" 
CDS < 1 .. >975 
ORIGIN 
/note="T -cell co-receptor" 
/codon start= I 
/product="CD4" 
/protein _ id="ABl '40 I ·12. 1" 
/db xref="GJ: 155795869" 
/translation="TASQKKSMLFTWKHSNQKILG Q FL TKGSSHL DRTD KKSQ 
WDQGSFPLIISKLRMEDSGTYICEYENKKIEVELQVFRL TANPGTCLLQGQ L TL TLE 
SPPGIKPSYKFKQPGNKISTDVEVSVPNYGFQDSGTWTCFISQDQKSLEIKI IL VLG 
FQETLNTYYKKAGEQVELSFPLNIGDEDLRGELKWQAERSSS KTWVTFSLK KHFS 
v 
QKVTQDPKLQVAENLXALHLSQALPQYAGSGDL TVTLDKG LHK YKL YYM YT 
YHQNDLICEYLGPTPPKLMLSLKLKNQEAKVSKPEKRIRVPNPKAGMWQ LLR" 
l acagcttccc agaagaagag catgttgttt acctggaaac attctaacca gaagattctg 
61 ggaaatcaga acaacttctt gaccaaaggt tcctcccatc tgagtgatcg cactgactca 
12 I aaaaaatccc agtgggatca aggatccttt cctcttatca tctctaaact taggatggaa 
I 8 I gactcaggga cctacatctg tgaagtggag aataagaaga tagaggtgga attgcaagtg 
24 I ttcagattaa cggccaaccc gggtacctgt ctgctacagg ggcaaagcct gaccctgacc 
30 I ttggaatccc ctcctggtat taaaccttca gtgaaattca agcaaccagg gaataaaat1 
36 I agtactgatg tcgaggtctc agtacccaat gtgggattcc aggacagtgg cacctggaca 
421 tgcttcatct cccaggacca gaagagtctg gaaataaaaa taaacatctt ggtgttgggt 
481 ttccaggaga cgctcaacac agtctataag aaagcggggg agcaggtgga gttatctttt 
541 ccactgaata tcggagatga ggacctgaga ggggaactga agtggcaggc agagaggtct 
60 I tcttcctcca agacctgggt caccttctcc ttaaagaata agcacttttc tgtgcaaaag 
66 I gttacccagg acccaaagct ccaggtggct gagaatctcn stgcgcttca cctgtcccag 
721 gctttgcctc agtatgctgg ttctggagac ctgactgtga ctcttgacaa aggaaatctg 
78 I cataagaacg tgaagctggt ggtaatgaat gtgacttatc accagaatga cttgatctgt 
84 I gaggtgctgg gacccactcc tcccaagctg atgctgagct tgaagctgaa gaaccaggag 
90 I gctaaggtct caaagcccga gaagaggatt cgggtgccaa accccaaggc agggatgtgg 
96 I cagtgcctac tgaga 
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A.6 
EF216348 220 bp mRNA linear ROD 12-FEB-2007 
DEFINITION Marmota monax interleukin 8 mRNA. parti:~l cds. 
ACCESSION EF2 16348 
SOURCE Marmota monax (woodchuck) 
AUTHORS Pohling,J ., Guy,C.S. and Michalak,T.I. 
TITLE Direct Submission 
FEATURES Location/Qualifiers 
source 1 .. 220 
/organism="Marmota monax" 
/mo1_type="mRNA" 
/db _xref="taxon:2.'~~" 
/tissue_ type=" 1 i ver" 
L.U.S. <I .. >220 
/note="chemokine; I L8" 
/codon start=2 
/product=" interleukin 8" 
/protein_id="AB!\ 13986.1" 
/db xref="GI:I24574421" 
/trans1ation="VTCLLSATLREAA VLARIGTELRCQCIKTHSTPFHPK YIKELRV 
IESGPHCANSEIIVKLYDGRELCLNPKEK" 
ORIGIN 
I ggtaacctgc ctacmctg caactctccg tgaagctgca gttctggcaa ggattggcac 
61 agaacttcga tgccagtgca taaaaactca ttccacacct ttccacccca aatacatcaa 
121 agaactgaga gtgattgaga gtggaccaca ctgtgccaat tcagaaatca ttgtcaagct 
181 tgttgatgga agagagcm gcctgaaccc caaggaaaaa 
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A.7 
A Y993961 606 bp mRNA linear ROD 20-APR-2005 
DEFI ITION Marmota monax granzyme B mRNA, partial cds. 
ACCESSION A Y993961 
SOURCE Marmota monax (woodchuck) 
AUTHORS Guy,C.S. and Michalak,T.I. 
TITLE Direct Submission 
FEATURES Location/Qualifiers 
source I .. 606 
/organism="Marmota monax" 
/mol_ type="mRN A" 
/db_xref="taxon : ~?-'~>.,~" 
Q~ <1 .. >606 
/note=" protease" 
/codon start=2 
/product="granzyme B" 
/protein_id="At\ :\8Cl 1'21\.1" 
/db xref="G I :62632049" 
/translation="SKPHSRPYMA YLQFVAQGVQKKCGGFLIREDFVL TAAHCLGRPM 
NVTLGAHNIENLEKTQQVIPVKRTIPHPDYDAHYFYNDIMLLELEKKANLNPAVQPIK 
LPRGKDKVKPGKVCLVAGWGRMARNGKYPNTLQEVKLKVQKHQVCEREELLKE 
YYKSSIQICVGDPKENKASFQGDSGGPL VCNHV AQG I VS YGNKNGNL" 
ORIGIN 
I atccaagccc cactcccggc cctacatggc ctatcttcag tttgttgctc agggtgtaca 
61 gaagaagtgt ggtgggttcc tgataagaga agactttgtg ctgacggctg ctcactgctt 
I 2 I aggaaggcca atgaacgtca ctctgggggc acacaacatt gagaatctgg agaagaccca 
I 8 I gcaggtcatc ccagtgaaaa gaaccatccc ccacccagac tatgatgctc attatttcta 
24 I caatgacatc atgttattgg agctagagaa aaaagccaac cttaatccag ctgtgcagcc 
30 I tatcaagctg cccaggggca aggacaaggt gaagcctggg aaggtgtgcc ttgtggctgg 
361 ctggggcaga atggcccgaa atggcaaata ccccaacaca ctgcaggagg taaagttgaa 
421 agtgcagaag caccaggtgt gcgagcgcga ggaattatta aaagagtact acaagagtag 
48 I catccagata tgtgtggggg atccaaagga aaacaaagct tcctttcagg gggactccgg 
54 I aggccctctt gtgtgtaacc atgtggccca aggaattgtc tcttatggaa ataaaaatgg 
60 I aaacct 
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A.8 
A Y993960 499 bp mRNA linear ROD ~0-APR-2005 
DEFINITION Marmota monax FAS antigen CD95 mR A. partial cds. 
ACCESSION A Y993960 
SOURCE Marmota monax (woodchuck) 
AUTHORS Guy,C.S. and Michalak,T.I. 
TITLE Direct Submission 
FEATURES Location/Qualifiers 
source I . .499 
/organism="Marmota monax" 
/mol_ type="mRN A" 
/db_ xref="taxon:2_•)•l,2" 
CDS < I .. >499 
ORIGIN 
/note="TNF superfamily member CD95L receptor" 
/codon start=3 
/product="F AS antigen CD95" 
/protein_id="AAX89 I ::!7. 1" 
/db_xref="GI:62632047" 
/translation="WRA WLEYETNCTQTQNTKCRCKLNFYCETALCEHCDPCTTCEHG 
ITERCTPTSNTKCKKETTGFNYNWLWFLLLLLLPIIAFGI YRIFKYRSTKHGHH ELLP 
NNREIEPMNFSDYDLSKYllSIAEEMTI QYREFYRKNGINEAKIDEIKNDNPQDTAE 
QKLQLL" 
I gatggagggc atggttagaa gtggaaacaa attgtaccca gacccagaat accaagtgca 
6 I gatgtaaact gaacttttat tgtgaaactg ctctctgtga acactgtgac ccgtgcacca 
121 cgtgtgaaca tggaatcact gagagatgta cacccactag caataccaaa tgcaaaaaag 
18 I aaactacagg tttcaattat aactggctgt ggttcctcct gctactgcta ctcccgatta 
24 I tagcttttgg gatatacaga atttttaagt accgcagtac aaaacatggt caccatgaac 
30 I ttctacccaa caatcgggaa atagagccaa tgaatttctc agatgttgac ctgagtaaat 
361 acatcattag tattgctgaa gagatgacga tcaatcaagt tagagaattt gttcgtaaga 
421 atggtatcaa tgaagccaag atagatgaga tcaagaatga caatccgcaa gatacagctg 
48 I agcagaaact ccagctgct 
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